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Abstract
Ubiquitination is a well characterised modification that has a role in the regulation of
diverse cellular processes such as proteasome mediated proteolysis, ribosomal
function and postreplicative DNA repair (Pickart, 2001). The deubiquitinating
enzymes (DUBs) are required in the cell to recycle ubiquitin, process ubiquitin
precursor proteins and possibly to edit ubiquitin chains (Chung and Baek, 1999;
Wilkinson, 2000). Sequence homology searches have revealed that there are 18
predicted DUBs in the Schizosaccharomyces pombe genome (C. Semple, M. Stone
and C. Gordon, unpublished).
Studies using deletion strains for each of the Saccharomyces cerevisiae DUBs have
shown that none is essential and that there is a high level of redundancy (Amerik et
al., 2000). Therefore, it is proposed that the functional specificity of the DUBs may
be determined by their cellular localisation. Regulation of 26S proteasome-mediated
degradation is a major function of ubiquitination, implying that there might be a
subset of redundant DUBs localised at the proteasome.
Two putative proteasome-associated DUBs were identified in S. pombe. Uch2 had
previously been suggested to copurify and colocalise with the proteasome (Li et al.,
2000). A second DUB, Ubp6, was identified in a sequence homology search for S.
pombe proteins containing a ubiquitin-like (UBL) domain (C. Semple and C.
Gordon, unpublished). This domain has been shown to mediate interactions with the
proteasome, implying that Ubp6 might also be proteasome-associated (Wilkinson et
al., 2001).
In the first part of this study, both Uch2 and Ubp6 are shown to be proteasome-
associated DUBs. The S. pombe proteasome is purified and Uch2 and Ubp6 are both
demonstrated to be present. In support of this finding, immunofluorescence
microscopy reveals that Uch2 and Ubp6 colocalise with the proteasome at the
nuclear periphery (Wilkinson et al., 1998).
iv
Construction of uch2 and ubp6 null mutants and the uch2ubp6 double mutant is
described. These mutants do not have any obvious phenotype, suggesting that other
redundant DUBs may be present at the proteasome. ubp6 is shown to be synthetically
lethal with the mtsl, mts2 and mts3 proteasome mutants, however uch2 is not
synthetically lethal with any proteasome mutant tested (Gordon et al., 1993; Gordon
et al., 1996; Penney et al., 1998; Wilkinson et al., 1997; Wilkinson et al., 2000, C.
Gordon, unpublished).
The DUBs function to cleave the aNH-peptide and the eNH-isopeptide bonds
between ubiquitin and other species (Chung and Baek, 1999; Wilkinson, 2000).
Purified 26S proteasomes and recombinant Uch2 are shown to cleave peptide linked
ubiquitin using an in vitro assay and Uch2 is identified as the major ubiquitin
hydrolase of the proteasome. Both Uch2 and Ubp6 are demonstrated to be capable
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Ubiquitin is a small protein of 76 amino acids, which is remarkably conserved
throughout eukaryotes (Weissman, 2001; Ozkaynak et al., 1984). Multiple mRNAs
encode ubiquitin and in each case the protein is synthesised as a precursor of either
tandem copies of ubiquitin or ubiquitin fused to ribosomal proteins (Finley et al.,
1989; Lund et al. 1985; Ozkaynak et ah, 1987). The crystal structures of ubiquitin
from several eukaryotes have been solved, showing a highly conserved, compact
structure comprising a five stranded |3-sheet and an a-helical section (Vijay-Kumar
et ah, 1987b; Vijay-Kumar et ah, 1987a). The C-terminus of the ubiquitin protein
protrudes from the core structure, probably to expose the C-terminal Gly residue for
conjugate formation (Vijay-Kumar et ah, 1987a).
1.1.2 Functions of Ubiquitination
In eukaryotic cells, a vast array of proteins is modified by the covalent conjugation of
ubiquitin, or ubiquitination. Therefore, this modification has a role in diverse
cellular processes such as proteasome mediated proteolysis, endocytosis and
postreplicative DNA repair (Pickart, 2001; Weissman, 2001). Proteins may be
modified by either a single ubiquitin or a chain of isopeptide linked ubiquitin
monomers and in almost all cases the C-terminal Gly of ubiquitin is ligated to a Lys
residue in the target protein. Monoubiquitination has been found to have several
functions including histone regulation, viral budding and the internalisation of
plasma membrane proteins (Hicke, 2001). Ubiquitin chains are formed by the
covalent attachment of ubiquitin monomers through internal Lys residues and of the
seven Lys residues found in ubiquitin, four (Lysll, Lys29, Lys48 and Lys63) are
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able to mediate chain formation in vivo (Dubiel and Gordon, 1999). Mutation of
each of the Lys residues in budding yeast ubiquitin demonstrated that only Lys48
was essential; cells expressing ubiquitin K48R arrested at G2-M and were deficient
in the degradation of canavanine-containing proteins, indicating a defect in
proteolysis (Finley et ah, 1994; Spence et al., 1995). The role of Lys48 linked
ubiquitin chains in targeting proteins for degradation by the proteasome has been
well documented and a chain of four ubiquitins is the minimal targeting signal
(Thrower et al., 2000). Mutation of any of the other Lys residues in ubiquitin was
not lethal, however, the ubiquitin K63R mutant was found to be defective in DNA
repair (Spence et al., 1995). Further studies of Lys63 linked ubiquitin chains have
confirmed that they are involved in regulating of the DNA repair response and also
demonstrated that they function in endocytosis and targeting yeast transporters for
vacuolar degradation (Weissman, 2001; Hicke, 2001).
1.1.3 The Process of Ubiquitination
Ubiquitination is catalysed by a cascade of three enzymes: an El ubiquitin-activating
enzyme, an E2 ubiquitin-conjugating enzyme and an E3 ubiquitin ligase (Figure 1.1).
Several rounds of catalysis by these enzymes can result in the formation of a
ubiquitin chain. The specificity of ubiquitination increases through the pathway with
few Els, a number of E2s and many E3s. The activities, structures and specificities
of each of these families of enzymes will be discussed below.
1.1.4 E1 Ubiquitin-Activating Enzymes
The first step in ubiquitination is the activation of ubiquitin by an El ubiquitin-
activating enzyme. Initially, a ubiquitin adenylate intermediate is formed by the
sequential binding of MgATP and ubiquitin to the El. The ubiquitin adenylate is
then converted to a ubiquitin thiolester and a second ubiquitin is activated as a
ubiquitin adenylate. Therefore, the process results in the formation of a ternary
2
Ubiquitin Activation <rur> T [_
V
Figure 1.1: The Ubiquitin Pathway
Ubiquitin is covalently attached to a substrate protein by the sequential action of three
enzymes. The El Enzyme activates ubiquitin as a thiol ester, the activated ubiquitin is
then carried by the E2 ubiquitin conjugating enzyme to the E3 enzyme, which facilitates
the ligation of ubiquitin to the substrate. The ubiquitinated substrate, the E2 and E3 are
released and further rounds of conjugation may be used to create a multiubiquitin chain.
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complex of El-Ub-AMP-Ub and involves the hydrolysis of two ATP molecules.
The thiol ubiquitin in this complex is activated, ready to be received by the E2
enzyme (Haas and Rose, 1982).
The ubiquitin activation reaction is carried out by a single El in most species. In S.
cerevisiae and S. pombe the E1 enzymes are encoded by the UBA1 and ptr3 genes
respectively and both have been shown to be essential for viability. Ptr3 is 59%
homologous to Ubal and the human El and all three proteins contain a conserved
glycine rich motif. Both Ptr3 and Ubal are localised in both the nucleus and the
cytoplasm (McGrath et al., 1991; Azad et al., 1997). In human cells, two isoforms of
the El ubiquitin-activating enzyme exist: Ela and Elb. The larger Ela isoform is
phosphorylated and is found only in the nucleus, whereas Elb is found
predominantly in the cytoplasm (Handley-Gearhart et al., 1994; Stephen et al., 1997).
1.1.5 E2 Ubiquitin-Conjugating Enzymes
The function of the E2 enzymes is to carry ubiquitin between the El and E3 enzymes
as an active thiol ester. There are 11 E2s in the S. cerevisiae genome and 14 are
predicted to be present in S. pombe. There is considerable homology between E2s,
with all containing a conserved region of approximately 150 amino acids, which
includes the active site cysteine. A number of the E2s also contain N- or C-terminal
extensions that have been suggested to confer specificity (Jentsch, 1992).
X-ray crystal structures of the A. thaliana UBC1, S. cerevisiae Ubc4 and clam E2-C
show that the E2 core structure of four a-helices and a four stranded (3-sheet is
highly conserved. All major secondary structures align well between E2s but the
highest conservation of tertiary structure is seen in a group of buried hydrophobic
residues and in the surface around the ubiquitin-accepting Cys (Cook et al., 1992;
Cook et al., 1993; Jiang and Basavappa, 1999). NMR studies of the human E2,
HsUbc2b, demonstrated that ubiquitin interacts with an area on this surface via its C-
terminal amino acids 70-76, Lys48 and Gln49 (Miura et al., 1999).
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The roles of E2s are diverse, with some having a general role in proteolysis of short¬
lived and misfolded proteins and others being involved in more specific processes
such as cell cycle progression, development and spermatogenesis (Hershko and
Ciechanover, 1998). Two conserved E2s that have been characterised in S. pombe
are UbcP4 and Rhp6. UbcP4 is a mitotic E2, which is required for G2-M
progression and the metaphase to anaphase transition (Osaka et al., 1997). Rhp6 and
its homologue in S. cerevisiae, Rad6, are both involved in regulation ofDNA repair,
UV mutagenesis and sporulation (Reynolds et ah, 1990).
Many reports have focused on the interactions of E2s with their cognate E3s (Pickart,
2001). These studies have shown that a single E3 may interact with several different
E2s, for example, the E6AP hect domain E3 can interact with both UbcH7 and
UbcH8 E2 (Kumar et ah, 1997). Conversely, a particular E2 may bind a number of
E3s, as is the case for UbcH7, which can bind both HHARI and H7-AP1 E3s
(Moynihan et ah, 1999). The specific nature of the E2-E3 association have been
investigated using binding assays and x-ray crystallography (Pickart, 2001). Using
chimaeric E2s, the region of UbcH5 that includes the active site Cys and a conserved
Phe have been shown to be crucial for its interaction with hect E3s (see section
1.1.6.1; Nuber and Scheffher, 1999). The crystal structure of the SCF and E6AP-
UbcH7 complexes have been solved, providing insights into the mechanism of action
(sections 1.1.6.1 and 1.1.6.2.1; Nuber and Scheffner, 1999; Zheng et ah, 2002).
1.1.6 E3 Ubiquitin Ligases
The E3s are the largest family of proteins in the E1-E2-E3 cascade and they facilitate
the transfer ofubiquitin from E2 to substrate, and bring specificity to the system. The
two major classes of E3s that have been characterised are the hect domain E3s and
the RING domain containing E3s and until recently, it was thought that almost all
E3s belonged to one of these groups. However, further study has identified a novel
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family of E3s named the U-box proteins, which contain RING-like domains. Each of
these three groups of E3s will be discussed below.
1.1.6.1 hect domain E3s
Numerous hect E3s have been identified in the available genome databases, however,
the first hect domain protein to be characterised was E6AP from oncogenic human
papilloma virus (Pickart, 2001; Scheffner et al., 1993) . E6AP was found to act in a
complex with E6 to ubiquitinate p53 and while E6 was shown to provide specificity
for p53, E6AP was demonstrated to be the active ubiquitin ligase (Scheffher et al.,
1993). Further studies identified several proteins that showed similarity to a domain
of approximately 350 amino acids found at the C-terminus of E6AP, named the hect
domain. In each case this domain was found at the C-terminus, with the proteins
being divergent at their N-termini. A number of the hect domains were shown to
form thioester bonds with ubiquitin and a conserved Cys residue within the domain
was found to be critical for this activity (Huibregtse et al., 1995). Therefore, it was
suggested that all hect domains would function as ubiquitin ligases using a similar
mechanism, a proposal that has been supported by subsequent work (Pickart, 2001).
The crystal structure of E6AP bound to the UbcH7 E2 has been solved and shows
that the hect domain is composed of two lobes joined by a hinge. These two lobes
make a U-shaped structure with the E2. The active site Cys of E6AP is located at the
junction between the two lobes; however, this is not close enough to the E2 active
site for nucleophilic attack to mediate the transfer of the ubiquitin thioester.
Therefore, the mechanism of hect E3 activity remains undetermined (Nuber and
Scheffner, 1999). As the C-termini of hect domain E3s provide the E2 binding site
and the catalytic activity, it is the N-termini that bring substrate specificity, for
example, Rsp5 hect E3 binds its substrate Rbpl (the large subunit of RNA




The RING family of E3 ubiquitin ligases all contain a protein with a RING (Really
Interesting New Gene) finger domain, which has a structure containing conserved
Cys and His residues that allow the incorporation of two zinc ions (Pickart, 2001).
The function of RING E3s appears to be as a molecular scaffold that brings the E2
linked ubiquitin thioester and the substrate protein into close proximity. Unlike the
hect E3s, there is no evidence that RING E3s can form a ubiquitin thioester (Joazeiro
and Weissman, 2000; Pickart, 2001). RING E3s may be a single protein, for
example, c-Cbl, which is involved in the down-regulation of receptor protein tyrosine
kinases and Mdm2, which regulates p53 turnover. Other RING E3s are multisubunit
complexes, where just one subunit contains a RING finger domain (Joazeiro and
Weissman, 2000; Pickart, 2001). Examples of these multisubunit E3s are the well-
characterised SCF and APC complexes, both ofwhich are discussed in further detail
below (Tyers and Jorgensen, 2000).
1.1.6.2.1 SCF
The SCF complex has been well defined as a highly conserved multisubunit E3
ubiquitin ligase, which has a wide range of substrates including many cell cycle
regulators. The SCF complex is made up of a core complex containing the Rbxl
RING finger protein, Skpl protein, a cullin and an E2. An additional variable
subunit, an F-box protein, associates with the core and provides the substrate
specificity of the SCF (Pickart, 2001; Tyers and Jorgensen, 2000).
Rbxl is a small, highly conserved protein containing a RING finger, which was first
identified in the VHL ubiquitin ligase complex, but is also found at the heart of the
SCF complex (Kamura et al., 1999a). Rbxl brings the subunits of the E3 together, as
it can interact with cullins and promotes association of cullin with E2. The
importance of this function is indicated by the fact that Rbxl is essential in budding
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yeast and that its assembly into the SCF complex results in potent activation of
ubiquitin ligase activity (Kamura et ah, 1999a; Skowyra et ah, 1999).
A variety of F-box proteins associate with the SCF to act as receptors for specific
substrates, for example, the F-box protein, Cdc4, recognises phosphorylated Sicl as a
substrate and Grrl recognises Clnl (Feldman et al., 1997; Skowyra et al., 1997). The
phosphorylation state ofmany SCF substrates is controlled in a cell cycle dependent
manner, and provides a mechanism for cell-cycle stage dependent ubiquitination and
degradation of regulatory factors (Laney and Hochstrasser, 1999; Pickart, 2001).
The interaction of the F-box proteins with the SCF is via the Skpl subunit, which
recognises the F-box motif found in all F-box proteins. As well as regulation of
substrate specificity by the F-box proteins, the SCF is also regulated by modification
with the small ubiquitin-like modifier, Rubl/Nedd8. The ubiquitin ligase activity of
the SCF is promoted by conjugation of Rubl/Nedd8 to the SCF cullin subunit (see
section 1.1.8.1.2).
The crystal structure of the Cull-Rbxl-Skpl-F-boxskp2 SCF complex has recently
been solved. The structure reveals that Cul 1 acts as a scaffold and has an elongated
structure with its N-terminus binding to Skpl-F-boxSkp2 and the C-terminus binding
Rbxl. The Cull C-terminal domain is made up of a five-stranded (3-sheet, with the
second strand provided by the conserved Rbxl N-terminus, indicating that Rbxl
binds Cull via strand insertion. When combined with data from other E2-E3
structures, it is predicted that the E2 and substrate will be positioned on the same side
of the complex, thus allowing ligation of the activated ubiquitin (Zheng et al., 2002).
1.1.6.2.2 APC
The APC is a second type ofmultisubunit RING E3, but with at least 12 subunits in
budding yeast, it is a much larger complex than the SCF. The APC is similar to the
SCF in that it contains a cullin, Apc2, and a RING finger protein, Apcl 1. Both of
these subunits are essential in budding yeast indicating that they are likely to be at
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the core of the complex, as for the SCF. Apcl 1 is crucial for the function of the APC
as it is the only APC subunit that is able to show ubiquitin ligase function in vitro
(Gmachl et al., 2000). The function of the APC as an E3 is of particular importance
in cell cycle regulation, as it is required at anaphase, mitotic exit and to maintain G1
(Page and Hieter, 1999; Zachariae and Nasmyth, 1999).
Regulatory subunits of the APC are required for specific activation of APC mediated
ubiquitination of cell cycle components. Genetic studies in yeast and Drosophila
have shown that APC dependent degradation is regulated by Cdc20/Fizzy/Slpl and
Cdhl/Fizzy-related/Srwl/Ste9. These proteins both contain WD repeats, which are
implicated as substrate specific binding sites (Zachariae and Nasmyth, 1999). The
association of Cdc20 and Cdhl with the APC is dependent on their phosphorylation
state and both are phosphorylated in vitro by Cdc2-Cyclin B. Cdc20 must be
phosphorylated to activate the APC but conversely, Cdhl must be in its
unphosphorylated form for activation (Kotani et ah, 1999). The result of Cdc20 and
Cdhl mediated activation is a cell cycle stage specific regulation of the APC, with
Cdc20 required at mitosis and Cdhl at G1 (Zachariae and Nasmyth, 1999).
Therefore, ubiquitination by both the SCF and APC is regulated by cell cycle
dependent phosphorylation. However, an important difference is that the SCF is
constitutively active and it is the substrates that are phosphorylated, whereas for the
APC it is the activity of the E3 complex itself that is regulated by phosphorylation.
Polo-like kinases also play a role in the regulation of the APC, as they are able to
phosphorylate three APC subunits. There is considerable evidence that in yeast,
Xenopus and mammalian cells Plks act as positive regulators of the APC (Nigg,
1998). Plx activity is required in Xenopus for cyclin degradation and Cdk
inactivation, to allow exit from mitosis: expression of a dominant negative inactive
version of Plx prevents mitotic exit and depletion of Plk from Xenopus oocyte
extracts results in inhibition of degradation of known APC substrates (Descombes
and Nigg, 1998). The budding yeast Polo-like kinase, Cdc5p is a positive regulator
of APC dependent cyclin ubiquitination and Cdc5p is also a substrate of the APC,
permitting coordinated cell cycle stage specific regulation of APC activity (Charles
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et al., 1998; Nigg, 1998). The physiological relevance of Plk activation of the APC
may be to provide further substrate specificity, as Plk was found to activate
mammalian APC specifically for ubiquitination of cyclin B but not Cut2 (Charles et
al., 1998; Kotani et al., 1999).
1.1.6.3 U-Box Proteins
The U-Box is a domain that resembles the RING finger domain, except that it uses
salt-bridges to stabilise its structure as it lacks the zinc binding motifs (Cyr et al.,
2002). UFD2 was the first protein to be found to contain a U-box domain and a role
for this domain in ubiquitination was suggested by the fact that UFD2 was found to
act as a ubiquitin chain elongation factor. It promoted the extension of ubiquitin
chains, but required the presence of an E3 for this activity, as it was unable to
interact with E2s directly. UFD2 was therefore originally termed an E4, rather than
an E3 (Koegl et al., 1999). However, further studies with the mammalian homologue
ofUFD2 and other U-box proteins suggest that the U-box acts in a similar way to the
RING finger, as an E3 ubiquitin ligase (Cyr et al., 2002). A possible role for the U-
box in promoting the ubiquitination and degradation of misfolded proteins has been
proposed (Cyr et al., 2002). The U-box protein CHIP was found to ubiquitinate
unfolded proteins with a requirement for the U-box domain. CHIP can interact
directly with the chaperone proteins Hsp90 and Hsp70 and can thus ubiquitinate
chaperone-bound misfolded substrates (Murata et al., 2001). Binding of the BAG-1
chaperone cofactor, which contains a ubiquitin-like domain, is thought to target
CHIP to the proteasome (Demand et al., 2001 and see section 1.1.9.2). Therefore,
the U-box proteins are emerging as a new family of E3 ubiquitin ligases that may act
specifically in the ubiquitination ofmisfolded proteins.
10
1.1.7 Targeting Proteins for Ubiquitination
A wide range of proteins are targeted for ubiquitination and the modification may be
of a specific Lys, any one of the target's Lys residues, or in many cases several Lys
residues (Weissman, 2001). Proteins that are destined for proteolysis by the 26S
proteasome are marked for ubiquitination by a number of sequence motifs and
modifications, which may be recognised by specific E3 ubiquitin ligases. The
simplest of ubiquitination signals is the N-terminal residue of the protein. In a
process named the N-end rule, proteins where the N-terminal residue is either a basic
(Arg, His, Lys) or hydrophobic (Phe, Leu, Tyr, Trp, lie) are recognised by the N-end
rule E3, Ubrl (Xie and Varshavsky, 2000; Pickart, 2001). Ubiquitination of
substrates of the APC, including many cyclins, depends on a nine residue motif
called the destruction box, or D-box that contains key Arg and Lys residues (Koepp
et al., 1999; Laney and Hochstrasser, 1999). An alternative signal is the PEST
region, which lacks a consensus sequence but is enriched for Proline (P), Glutamic
Acid (E), Serine S and Threonine (T). This motif is found to target G1 cyclins and
IkBoc for ubiquitin dependent proteolysis, but its mechanism of action remains
ambiguous (Rechsteiner and Rogers, 1996). In the case of the SCF, many substrates,
such as the Sicl Cdk inhibitor and the G1 cyclins, bind to the F-box subunits in a
phosphorylation-dependent manner (Laney and Hochstrasser, 1999; Pickart, 2001).
Finally, for the mating type transcription factor a2, a 19 amino acid hydrophobic
region is required for ubiquitination (Laney and Hochstrasser, 1999). These
examples indicate the diversity of signals for ubiquitination and show a further level
of complexity in the ubiquitin pathway.
1.1.8 Ubiquitin-like Proteins
There are a number of proteins that have significant sequence homology to ubiquitin,
and are thus called ubiquitin-like proteins. These can be divided into two subclasses,
first, there are the ubiquitin-like modifiers, which show homology to ubiquitin
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throughout all or most of their sequence and may be covalently attached to other
proteins in the same manner as ubiquitin. The second class comprises the ubiquitin-
domain proteins, which have just one domain with homology to ubiquitin and are not
conjugated to other proteins (Jentsch and Pyrowolakis, 2000).
1.1.8.1 Ubiquitin-like Modifiers
In addition to ubiquitin, a number of small ubiquitin-like modifying proteins have
been identified. Some of these proteins, such as SUMO and Rubl/Nedd8 are related
in sequence and structure to ubiquitin but others such as Apgl2 show no obvious
homology (Jentsch and Pyrowolakis, 2000). However, generally they are related to
ubiquitin in the mechanism by which they modify other proteins: they bind to Lys
residues in their target proteins and use enzymes that resemble Els, E2s and E3s
(Hochstrasser, 2000; Jentsch and Pyrowolakis, 2000; Yeh et al., 2000). In the case of
SUMO, and possibly for Rubl/Nedd8, deconjugating enzymes have also been
identified (see section 1.2.5). The ubiquitin-like modifiers are involved in diverse
cellular processes including regulation of localisation, ubiquitination, E3 ubiquitin
ligase activity, autophagy and polarised morphogenesis (Jentsch and Pyrowolakis,
2000; Dittmar et ah, 2002). As SUMO and Rubl/Nedd8 have each been described in
number of studies, they are discussed further below.
1.1.8.1.1 SUMO
The best characterised of the ubiquitin-like modifiers is SUMO (also named PIC1,
UBL1, GMP1, sentrin, Pmt3, SMT3C and DAP1), which is a highly conserved
eukaryotic protein. SUMO is about 18% homologous to ubiquitin and has a short N-
terminal extension (Jentsch and Pyrowolakis, 2000; Muller et ah, 2001). Despite this
relatively low homology, analysis by NMR shows that the SUMO structure contains
the ubiquitin fold and is closely related to the ubiquitin structure (Bayer et ah, 1998).
SUMO is essential in S. cerevisiae, although in S. pombe cells lacking SUMO are
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viable, but are slow growing and stress sensitive (Jentsch and Pyrowolakis, 2000;
Tanaka et al., 1999).
Several proteins that are modified by covalent attachment of SUMO have now been
identified and the evidence so far is that the function of SUMO conjugation or
sumoylation may be to regulate the localisation or ubiquitination of its targets
(Muller et al., 2001). The first sumoylated protein to be described was RanGAPl,
the GTPase-activating protein for the Ran GTPase. Sumoylation of RanGAP 1 was
shown to cause it to redistribute from the cytoplasm to the nuclear pore complex
(Matunis et al., 1996). The cellular localisation of the RING finger protein, PML
was also found to be affected by SUMO conjugation. In this case, the modified form
was shown to localise to the PML nuclear bodies, whereas the unmodified form was
distributed in the nucleoplasm. The sumoylation ofPML was found to be dependent
on its phosphorylation state, with hyperphosphorylated PML being resistant to
SUMO attachment (Muller et al., 1998). The effect of phosphorylation on
sumoylation is reminiscent of the relationship between phosphorylation and
ubiquitination (see section 1.1.7). The sumoylation of another substrate, IkBcx has
also been shown to be regulated by phosphorylation. However, for this target
protein, the effect of sumoylation is on its ubiquitination state. IkBoc can be modified
by either SUMO or ubiquitin, but as both attach via the same Lys residue, this
binding is competitive and phosphorylated form of IicBa that can be ubiquitinated, is
not sumoylated. Ubiquitination of IkBoc leads to its degradation, so that its binding
partner NF-kB is released can translocate into the nucleus, where it functions as a
transcription factor. Therefore, the sumoylation of IxBa prevents its ubiquitination
and therefore inhibits NF-kB mediated transcription (Desterro et al., 1998). This
competition between ubiquitination and sumoylation has also been observed for
Mdm2, which is the E3 ubiquitin ligase for p53 (Buschmann et al., 2000).
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1.1.8.1.2 Rub1/Nedd8
The ubiquitin-like modifier, Rubl/Nedd8 shows greater homology to ubiquitin than
SUMO, with approximately 50% sequence identity and a greater similarity in
structure (Jentsch and Pyrowolakis, 2000; Yeh et al., 2000). Unlike SUMO,
Rubl/Nedd8 has a narrow target specificity, as it appears to exclusively modify
members of the cullin family, which are components of the multisubunit RING
finger E3 ubiquitin ligases (see section 1.1.6.2). Rubl/Nedd8 modification of cullins
promotes ubiquitination of substrates by the E3 complex, for example, the SCF'3Trcp
cullin, Cull, is modified by Nedd8, which promotes its association with the
substrates iKBa and (3-catenin (Read et ah, 2000). In S. cerevisiae, modification of
the cullin component of SCFSkp2 by the Nedd8 homologue, Rubl is required for the
ubiquitination of the cyclin dependent kinase inhibitor p27Kipl (Kamura et ah, 1999b;
Podust et ah, 2000).
1.1.9 Ubiquitin-Domain Proteins (UDPs)
The ubiquitin-domain proteins (UDPs) each contain a characteristic domain that has
homology to ubiquitin. This domain has largely been characterised through studies
of two of the UDPs that are multiubiquitin binding proteins, Dphl/Dsk2/HPLIC and
Rph23/Rad23. Invesigation of these proteins has shown UBL domain is similar to
ubiquitin both in sequence and in structure: the UBL domains found in Dsk2 and
Rad23 are 36% and 22% homologous to ubiquitin and the NMR structure of the
hPLIC-2 UBL domain reveals that it closely resembles ubiquitin (Watkins et ah,
1993; Biggins et ah, 1996; Walters et ah, 2002). In the case of Rad23, deletion of the
UBL domain results in UV-sensitivity. However, substitution of the UBL domain
with ubiquitin is sufficient to rescue this phenotype, indicating the close homology
between ubiquitin and the UBL domain (Watkins et ah, 1993). There is gathering
evidence from a number of studies that the UBL domain may function as a
proteasome-binding domain and Mts4/Rpnl has been identified as a potential
receptor for these domains within the proteasome (R. Hartmann-Petersen and M.
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Seeger, unpublished). In S. pombe, there are 11 predicted UDPs and in human there
are homologues for most of these proteins as well as other unique UDPs (Table 1.1;
C. Semple and C. Gordon, unpublished; Jentsch and Pyrowolakis, 2000). The
discussion here will focus on those conserved UDPs that have been characterised in
S. pombe.
1.1.9.1 Multiubiquitin Binding UDPs
Two of the UDPs, Dphl/Dsk2/HPLIC and Rhp23/Rad23, function in the recognition
and delivery of multiubiquitinated substrates for the proteasome. These proteins
have similar domain structure as each contains not only a UBL domain, but also at
least one multiubiquitin-binding UBA domain (Hofmann and Bucher, 1996;
Wilkinson et al., 2001). The UBL domains mediate association with the proteasome
and UBA domains are responsible for binding to multiubiquitin chains. Mutation of
the UBL domain and the UBA domain of Rhp23 indicated that both are required for
its in vivo function (Wilkinson et al., 2001). The binding of the UBL domains to the
proteasome has been shown to be via a direct interaction with the Mts4/Rpnl 19S
subunit (R. Hartmann-Petersen and M. Seeger, unpublished). The observation that
Dphl and Rhp23 could bind both the proteasome and multiubiquitin suggested that
they might act in a similar way to Pusl/RpnlO, which shares these binding properties
(see section 1.3.2.2.1). Genetic experiments in S. pombe using null mutants for each
of these proteins showed that although the single null mutants dphlA, rhp23A and
puslA were able to grow, the triple mutant dphlArhp23ApuslA was not viable. This
implied that these three proteins act in parallel, redundant pathways to target proteins
to the proteasome (Wilkinson et al., 2001). Further support for this model came from
studies in S. cerevisiae, where dsk2 and dsk2rad23 mutants were found to be
defective in the degradation proteasome substrates (Rao and Sastry, 2002; Funakoshi
et al., 2002). A more recent study has supported this work by showing that the
redundancy observed in S. pombe is conserved in budding yeast, where the
dsk2rad23rpnl0 triple mutant is temperature sensitive, with significant enhancement
of the double mutant phenotypes and accumulation of large amounts of
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UDP Pompep ID Alternative Names Proposed
Function








Udp3 SPBC16G5.11C Bagl Chaperone cofactor
Udp4 SPAC6G9.08 Ubp6 Deubiquitinating
Enzyme
Udp5 SPBC1E8.02 Bat3, Bag6, Scythe Chaperone cofactor
Udp6 SPAC4G9.01 Alpl 1, TFC-B Tubulin folding
Udp7 SPCC1442.07C Wssl SUMO pathway?
Udp8 SPBC1271.05C - DNA binding
Udp9 SPBC646.07C TSC13 Lipid biosynthesis
UdplO SPBC1921.02 - ?
Udpl 1 SPBC16H5.03C El, Uba2 Ubiquitin
activation
Table 1.1: The Ubiquitin-like Domain Proteins of S. pombe
Eleven UDPs have been identified in the S. pombe genome and many have been assigned
functions in diverse cellular processes - see text for details.
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multiubiquitinated proteins (Saeki et al., 2002). A further UBA domain containing
UDP, Ddi 1 has been identified in S. cerevisiae, however its homologue in S. pombe,
Mudl, lacks the UBL domain. The function of Ddil/Mudl remains to be
determined, but if it is involved in the recognition and delivery of proteins, Mudl is
likely to interact with other proteins to bind the proteasome.
1.1.9.2 Chaperone Co-Factor UDPs
Another UDP that has been widely investigated is the chaperone regulatory cofactor,
BAG-1, which was first identified due to its anti-apoptotic function. It has been
shown to bind the Hsp70/Hsc70 chaperones via its BAG domain and to act as a
nucleotide exchange factor, promoting the release of substrates (Takayama and Reed,
2001). Studies of human BAG-1 have shown it is able to interact with the
proteasome and more recently this has also been demonstrated for S. pombe BAG-1
(Luders et al., 2000; M.Stone and C.Gordon, unpublished). As was the case for
Dphl and Rhp23, the N-terminal region of human BAG-1, containing the UBL
domain, was found to be required for interaction with the proteasome (Luders et al.,
2000). In addition to binding chaperones and the proteasome, BAG-1 is also able to
interact with the E3s, CHIP and Siah-IA (Matsuzawa et al., 1998; Demand et al.,
2001). It appears that BAG-1 acts at the interface between chaperones, the
proteasome and ubiquitination, perhaps to coordinate ubiquitination of misfolded
proteins bound to Hsp70/Hsc70 and their release at the proteasome prior to
degradation. BAG-1 is not essential in S. pombe, therefore other proteins may act in
a redundant manner or its function may only be important for specific cellular
conditions, such as stress (C.Gordon, unpublished). Two other UDPs have been
shown to bind chaperone proteins: human Dsk2 can associate with Hsp70 and
Bat3/Scythe binds to and inhibits Hsp70 (Kaye et al., 2000; Thress et al., 2001).
The significance of these interactions remains to be determined, but it appears that a
subset of the UDPs may act as coupling factors between chaperones and the
proteasome.
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1.1.9.3 Ubiquitin Pathway Enzyme UDPs
One of the UBP family deubiquitinating enzymes, Ubp6, was identified in S.
cerevisiae and was shown to have deubiquitinating activity against artificial
substrates (Park et al., 1997). Subsequently, a UBL domain, named the SUb domain,
was identified at its N-terminus and was found to be conserved in all Ubp6
homologues. Although the human Ubp6 UBL domain was found to be only 20%
similar to ubiquitin, structure prediction programs indicated that it was likely to form
a ubiquitin-like fold, as was observed for the hPLIC-2 UBL domain crystal structure
(Wyndham et al., 1999; Walters et ah, 2002). In addition, the El ubiquitin-
activating enzyme from S. pombe contains a putative UBL domain and the human E3
ubiquitin ligases Parkin and VCB are members of the UDP family (Jentsch and
Pyrowolakis, 2000).
1.1.9.4 Other UDPs
As well as the proteins already discussed, several other UDPs have been
characterised to a lesser extent. The first of these is Wssl, which was identified as a
high copy suppressor of a S. cerevisiae Smtl (SUMO) mutant. Deletion ofWssl
did not result in any significant phenotype, apart from mild cold sensitivity and it is
unclear whether the genetic interaction with Smtl is due to Wssl being a substrate, a
regulator or a protein with overlapping function (Biggins et al., 2001). Other UDPs
include TSC13, which is an enoyl reductase involved in very long chain fatty acid
biosynthesis and Alpl 1, which has a role in tubulin folding (Kohlwein et al., 2001;
Radcliffe and Toda, 2000). Therefore, it appears that UDPs participate in a variety
of cellular processes, through domains other than their UBL domains.
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1.2 Deubiquitination
Ubiquitination is a dynamic process and therefore there is a requirement for enzymes
to catalyse not only the ligation of ubiquitin but also its removal from proteins and
multiubiquitin chains. This activity is also required in the cell to release free
ubiquitin by processing of the ubiquitin precursor proteins (Figure 1.2). The
cleavage of ubiquitin, or deubiquitination, is carried out by a family of enzymes
called the deubiquitinating enzymes (DUBs).
1.2.1 Classification of DUBs
Based on their sequence homology, the DUBs can be divided into two classes: the
Ubiquitin C-terminal Hydrolases (UCHs) and the Ubiquitin Specific Processing
Proteases (UBPs) (Wilkinson, 2000; Chung and Baek, 1999). Both types of DUB
are members of the cysteine protease family, which has members in all organisms
from bacteria and archaea to human. Based on their evolutionary similarity to other
cysteine proteases, both families of DUBs have been assigned to Clan CA, which
contains all papain-like proteases (Barrett and Rawlings, 2001). The UCHs are more
closely related to papain than the UBPs and their active site contains one Cys and
one His that are highly conserved (see section 1.2.2.1). There is significant
homology between members of the UCH family and they are all relatively small
proteins, usually of less than 40kD (Chung and Baek, 1999; Wilkinson and
Hochstrasser, 1998). Conversely, the UBPs are generally large proteins of between
50 and 250kD (Wilkinson and Hochstrasser, 1998). There is considerable diversity
within the UBP family, with the exception of two conserved regions that contain
catalytically important residues: the Cys box contains the active site Cys and the His
box contains two conserved His residues (Wilkinson and Hochstrasser, 1998). There
is no apparent similarity between the regions of the UCHs and the UBPs surrounding
the Cys and His residues (Wilkinson and Hochstrasser, 1998; Chung and Baek,
1999). Evidence so far is that the UCHs are a much smaller family of proteins
compared to the UBPs with only two UCHs and 16 UBPs in S. pombe and one UCH
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C Editing Ubiquitin Chains
Figure 1.2: The Functions of Deubiquitination
The DUBs have several cellular functions including: cleaving ubiquitin from the
precursor proteins (A); recycling ubiquitin (B), for example from proteins that are
destined for degradation by the proteasome; and by editing ubiquitin chains (C). The
arrows indicate cleavage sites.
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and 16 UBPs in S. cerevisiae (Table 1.2) (Amerik et al., 2000; C. Semple and M.
Stone, unpublished).
1.2.2 Biochemical Activities of the DUBs
1.2.2.1 Activity of the UCHs
The catalytic mechanism of the papain-like cysteine proteases has been well
described and based on their homology it is thought that the DUBs operate in a
similar manner (Figure 1.3). Cleavage of a peptide bond begins with formation of a
tetrahedral intermediate by the nucleophilic attack of the substrate carbon and by the
active site Cys. This is converted to an acyl-enzyme intermediate as the C-terminal
peptide leaving group is released. A deacylation reaction then takes place with a
water molecule acting as a nucleophile to form a second tetrahedral intermediate.
Finally, the ubiquitin is released and the Cys thiol sidechain is restored. The role of
the active site His imidazole group is to enhance the nucleophilicity of the catalytic
Cys (Storer and Menard, 1994; Johnston et al., 1999). Support for this mechanism is
provided by the crystal structure of UCH Yuhl bound to Ubal, which shows the
formation of a tetrahedral structure analogous to the tetrahedral intermediate
(Johnston et al., 1999).
The activity of several UCH proteins has been well described. The conserved active
site Cys and His residues of UCH-L1 were identified and mutation of the Cys
abolished activity and mutation of the His residue resulted in little or no activity
(Larsen et al., 1996). Ubiquitin fusions appear to be the major substrate for the
UCHs as none of those tested are able to cleave isopeptide linked ubiquitin chains.
Human UCH-L1 and UCH-L3 and S. cerevisiae Yuhl were all shown to prefer to
cleave ubiquitin from short fusions or small adducts (Baker et al., 1992; Larsen et
al., 1998). There is some degree of specificity within the UCH family; UCH-L1 and








































Ubp9 SPBC1703.12 UBP9 YEAST
P39967










Ubp12 SPCC1494.05C UBPC YEAST
P39538*
Q9W117 CG387 Q9UNP0














Ubp16 SPCC1682.12C Q9VRP5 CG5505 Q9H9C5
FLJ12851*
Table 1.2: The S. pombe Deubiquitinating Enzymes
Putative S. pombe DUBs were identified by a bioinformatics search for the UCH and
UBP domains. Candidate orthologues in S. cerevsiae, D. melanogaster and H.
sapiens were predicted using BLAST searches. Asterices indicate the proteins




















Figure 1.3: Catalysis by Ubiquitin C-terminal Hydrolases
The cleavage of ubiquitin (Ub) from a peptide (R) begins with the nuclophilic attack by
the active site Cys. A tetrahedral intermediate is formed and subsequently the peptide is
released. A water molecule then acts as a nuclophile to form a second tetrahedral
intermediate before release of the ubiquitin molecule. The active site His imidazole
group (Im) enhances the nucleophilicity of the active site Cys thiol group. The high
energy tetrahedral intermediates are indicated by the boxes.
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precursors (Larsen et al., 1998). In addition, there is evidence that precursors are
cotranslationally processed, as a substantial increase in activity is observed when
enzyme and substrate are coexpressed (Larsen et al., 1998). In general, it is accepted
that the in vivo function of UCHs is to process ubiquitin precursors and remove
small adducts from ubiquitin (Wilkinson, 2000; Chung and Baek, 1999).
7.2.2.2Activity of the UBPs
A large number of UBPs have been assayed for ubiquitin cleavage activity, and a
range of activities and specificities has been observed. The conserved Cys and His
residues have been mutated in many UBPs including those from mouse (Unp),
Drosophila (Faf) and S. pombe (Ubp21) (Gilchrist and Baker, 2000; Huang et al.,
1995; Richert et al., 2002). In each case, mutation resulted in loss of activity. As
with the UCHs, cotranslational processing ofubiquitin precursors has been proposed,
as S. cerevisiae Ubpl and Ubp2 are unable to process the polyubiquitin precursor
unless coexpressed with the substrate (Baker et al., 1992).
The UBPs are able to cleave most ubiquitin substrates with peptide or isopeptide
linkages and small or large leaving groups. However, there is often preference for
particular substrates, for example, S. cerevisiae Ubp6 is most active against ubiquitin
fused to small extensions with charged amino acids although it does have some
activity in cleaving isopeptide-linked ubiquitin and larger ubiquitin fusions (Park et
al., 1997). Other UBPs that show substrate preference are the testis specific UBPs,
which have high activity against isopeptide linked ubiquitin and linear ubiquitin-
protein fusions but low activity for linear diubiquitin (Lin et al., 2001). Isopeptidase
T and its homologues are unusual in the UBP family in having a specific role in the
cleavage of ubiquitin in Lys48 linked chains. Thus, their cellular function is to
recycle ubiquitin from multiubiquitin chains. (Hadari et al., 1992; Amerik et al.,
1997; Doelling et al., 2001). It therefore appears that there are subtle variations in
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activity between the UBPs and that only by further analysis in vivo will their true
specificities be determined.
1.2.2.3 Inhibition of DUB activity
Cysteine protease activities, including those of the DUBs, can often be characterised
by their sensitivity to the alkylating agents iodoacetamide and N-ethylmaleimide
(NEM), which block the active site cysteine by binding to the thiol group. Another
valuable tool in the study of DUB activity is the inhibitor Ubiquitin-Aldehyde
(Ubal). This was originally identified as a potent inhibitor for several purified UCH
activities. These activities were also inhibited by iodoacetamide and manganese,
suggesting that they were thiol proteases and that the Ubal would bind as a
tetrahedral intermediate (Mayer and Wilkinson, 1989). This model was confirmed by
kinetic and structural studies, which showed the formation of an extremely stable
tetrahedral Enzyme-Ubal complex (Dang et al., 1998; Johnston et al., 1999).
1.2.3 Structure of the DUBs
Structural characterisation of the DUBs has so far been restricted to members of the
UCH family with no structure for a UBP yet determined (Barrett and Rawlings,
2001). The crystal structures of two UCHs have been described: the human UCH-L3
and the budding yeast Yuhl bound to Ubal. Although they are only 33% identical,
both proteins share a conserved overall structure of an anti-parallel (3-sheet
surrounded by a-helices, which is similar to that of the papain-like proteases
(Johnston et ah, 1997; Johnston et ah, 1999). UCH-L3 shows greatest general
structural similarity to cathepsin B with the positions of the Cys, His and Asp active
site residues also conserved (Johnston et ah, 1997). The active sites of the UCHs are
buried in between the two lobes of the proteins, making them relatively inaccessible
to substrates. Comparison of the UCH-L3 and Ubal bound Yuhl structures reveals
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that the UCH undergoes a conformational change on binding to its substrate, with the
N-terminal residues that block the UCH-L3 active site being moved on a hinge to
allow substrate binding. Therefore, it appears that ubiquitin binding is coupled to
opening of the active site chamber (Johnston et ah, 1997) (Johnston et ah, 1999).
The Yuhl-Ubal structure also explains the specificity for the C-terminal di-Gly of
ubiquitin as conserved UCH residues posses side chains that block the access of
residues larger than Gly (Johnston et al., 1999).
1.2.4 DUB Function
1.2.4.1 Cellular Roles of the DUBs
The roles of the UBPs on a cellular level are proposed to be in processing ubiquitin
precursor proteins, recycling conjugated ubiquitin and editing of multiubiquitin
chains (Figure 1.2). Understanding of the specificity and control of these functions
within the cell has been advanced by studies in yeast and using cell culture systems.
Regulation of proteasome mediated proteolysis is a major function of ubiquitination,
suggesting that DUBs must be involved in this process. One indicator of a defect in
proteolysis is sensitivity to the arginine analogue, canavanine. Mutation of several
DUBs in S. cerevisiae and A. thaliana has been shown to result in canavanine
sensitivity, implying that these DUBs promote proteolysis (Amerik et ah, 2000; Yan
et ah, 2000). However, overexpression of the S. cerevisiae DUB Ubp2 was found to
confer sensitivity to canavanine, implying that it may act in the opposite manner to
restrict proteolysis (Gilchrist and Baker, 2000). Another DUB that has been shown to
be involved in proteasome dependent proteolysis is Isopeptidase T, which is
proposed to regulate proteolysis by recycling ubiquitin from the multiubiquitin
chains of proteolytic substrates (Hadari et ah, 1992; Amerik et ah, 1997; Doelling et
ah, 2001). Genetic studies in S. cerevisiae have implicated the Doa4 UBP in
controlling proteasome directed proteolysis via ubiquitin homeostasis. The doa4 null
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mutant has a pleiotropic phenotype, including accumulation of low molecular weight
ubiquitin conjugates, compromised degradation of 26S proteasome substrates,
defective DNA repair and temperature sensitivity (Papa and Hochstrasser, 1993;
Amerik et al., 2000a). This suggests that Doa4 functions in a number of cellular
processes, an observation that is supported by the finding that doa4 shows genetic
interactions with mutants of both the proteasome and vacuolar degradation pathways.
(Papa and Hochstrasser, 1993; Amerik et ah, 2000a; Dupre and Haguenauer-Tsapis,
2001). Silencing is another process that has been proposed to be regulated by DUB
activity. In S. cerevisiae, Ubp3 was identified due to a direct physical interaction
with the Sir4 silencing protein. Deletion of UBP3 was demonstrated to increase
silencing at the telomeres and mating type loci, indicating a function for Ubp3 in the
positive regulation of silencing. Although the mechanism by which Ubp3 regulates
silencing is unknown, the most favourable model is that it promotes the degradation
of a negative regulator of silencing, which would provide a means to regulate
silencing in response to a change in environmental conditions, such as the carbon
source (Moazed and Johnson, 1996). Ubp3 has also been implicated in the control of
the cell cycle in response to the environment, via the regulation of the pheromone
response pathway. Cells deleted for UBP3 were found to accumulate
multiubiquitinated Ste7 MAPK kinase as well as unconjugated multiubiquitin chains.
The ubiquitination of Ste7 is stimulated by pheromone and its deubiquitination and
degradation are promoted either directly or indirectly by Ubp3. It is proposed that,
by this mechanism, Ubp3 acts to restrict the MAPK pathway, as ubp3 null mutants
show enhanced signalling in response to pheromone compared to wild type cells.
(Wang and Dohlman, 2002).
In higher eukaryotes, a number of DUBs have been shown to be regulated by
external stimuli. Investigation of human UBPY in fibroblasts showed that it is
upregulated in response to serum stimulation of and downregulated once the cells
became confluent. In these cells it was found to be required for entry into S phase.
However in transformed cells levels of UBPY remained high and cells lacking
UBPY arrested in S phase. Taken together, these data indicating that UBPY has a
role in growth regulated cell cycle control (Naviglio et al., 1998). A subset of
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mammalian DUBs, including mouse DUB-2, have been suggested to function in the
regulation of cell growth and differentiation as they are immediate-early genes
induced by cytokines (Zhu et al., 1997; Baek et ah, 2001). Another DUB that is
involved in controlling cell growth and differentiation is encoded by the tre-2
oncogene, which was originally identified as a DUB based on its homology to Doa4
(Papa and Hochstrasser, 1993). Tre-2 protein was found to have transforming activity
in 3T3 fibroblasts and its murine homologue, Unp, has been demonstrated to be
tumourigenic in transgenic mice (Gupta et ah, 1993; Gupta et ah, 1994; Nakamura et
ah, 1992).
1.2.4.2 Roles in Multicellular organisms
Two of the best described DUBs in higher eukaryotes are the Drosophila Fat facets
(Faf) protein and its murine homologue Fam. Faf is expressed widely in the CNS,
regulates synaptic development at the neuromuscular junction and is required for
normal eye development (Huang et ah, 1995; DiAntonio et ah, 2001). Using genetic
analysis, Liquid facets, a homologue of the endocytic protein epsin, was identified as
a substrate of Faf, suggesting that Faf mediates its developmental function via the
regulation of endocytosis (Cadavid et ah, 2000; Chen et ah, 2002). In mouse, Fam is
expressed in expanding cell populations at gastrulation and neurulation, in apoptotic
regions between the digits, and like Faf, in the CNS. There is evidence that the cell-
cell adhesion protein, AF-6, which is a target of Ras, is a Fam substrate, indicating a
link between Ras signaling and ubiquitination in the control of cell growth and
differentiation (Taya et ah, 1998). There are many other examples ofDUBs that are
involved in developmental processes in a range of organisms. In A. thaliana, Ubpl4
(a homologue of isopeptidase T) is required for early embryo development as
homozygous mutants fail to produce viable mature seeds (Doelling et ah, 2001). The
temporal and spatial regulation of development in Dictyostelium is partly controlled
by the MEK kinase MEKKa, which is also regulated by ubiquitination. A DUB
named UbpB has been identified as a negative regulator ofMEKKa; it is proposed to
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promote MEKKa degradation and therefore allow prespore cell differentiation
(Chung et al., 1998). Another DUB that, like Faf, functions in synaptic control, is
Aplysia Ap-Uch, which is required for long term memory storage (Hegde et al.,
1997). In addition, two murine DUBs of the UCH family have been found to
function in the CNS. Mice that are homozygous mutants for Uch-Ll and Uch-L3
show axonal degeneration in the medulla and dorsal root ganglia, with the
corresponding phenotypes of posterior paralysis and dysphagia (Kurihara et al.,
2001). The observation of neurodegeneration in these mutants is in keeping with the
finding that a missense mutation in Uch-Ll is linked to familial Parkinson's disease
(Leroy et al., 1998). Although only a small fraction of the known DUBs have been
characterised, it appears that their key functions include regulation of MAP kinase
signaling pathways and roles in the nervous system.
1.2.5 UDP Deconjugating Enzymes
Like ubiquitination, the conjugation of ubiquitin-like modifiers is a reversible
process and several enzymes that catalyse the deconjugation of SUMO have been
identified. A Nedd8 specific deconjugating enzyme has yet to be identified, but
deneddylating activity has been found for a subset ofDUBs and also associated with
the COP9/signalosome (Muller et al., 2001; Yeh et al., 2000).
S. cerevisiae has at least two SUMO specific proteases, Ulpl and Ulp2, and both
have conserved homologues in S. pombe (Li and Hochstrasser, 1999; Li and
Hochstrasser, 2000; Taylor et al., 2002). Ulpl was the first SUMO protease to be
characterised, and was shown to be specific for SUMO as it was unable to cleave
ubiquitin and its activity was unaffected by Ubal. Deletion of Ulpl is lethal, and its
activity was shown to be required for cell cycle progression from G2-M (Li and
Hochstrasser, 1999). The second SUMO protease, Ulp2 is not essential, although the
deletion strain has pleiotropic defects including enhanced chromosome loss and
sensitivity to HU and DNA damage (Li and Hochstrasser, 2000). Both Ulpl and
Ulp2 are able to cleave peptide and isopeptide linked SUMO. However, as the
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phenotype, including the pattern of SUMO conjugate accumulation differs between
the two mutant strains, indicating that they have different in vivo specificities (Li and
Hochstrasser, 1999; Li and Hochstrasser, 2000). In S. pombe, a Ulpl homologue has
been characterised, however, unlike in S. cerevisiae, deletion of ulpl+ is not lethal.
This probably reflects the fact that SUMO is essential in S. cerevisiae but not in S.
pombe (Jentsch and Pyrowolakis, 2000; Tanaka et ah, 1999). The phenotype ofulpl
null mutant cells suggests that its major role is in processing of the SUMO precursor,
to maintain cellular levels of SUMO. However, ulpl cells are sensitive to UV and
are slow growing and neither of these defects can be rescued by the expression of
mature SUMO. Therefore, Ulpl is also likely to function in the deconjugation of
SUMO from specific substrates involved in cell cycle regulation and the DNA
damage response (Taylor et ah, 2002). The Ulps show no sequence or structural
similarity to the DUBs except that they are both members of the cysteine protease
family (Li and Hochstrasser, 1999; Li and Hochstrasser, 2000; Mossessova and
Lima, 2000). Comparison of the Ulpl-SUMO and Yuhl-Ubal crystal structures
shows that the mechanism of substrate recognition by the two enzymes is largely
different, although both recognise the substrate diGly via van der Waals contacts
(Mossessova and Lima, 2000). Surprisingly, Ulpl and Ulp2 show greatest similarity
with adenoviral proteases (Li and Hochstrasser, 1999; Mossessova and Lima, 2000).
There are at least seven SUMO specific proteases in human but only one, SENP1,
has been characterised. SENP1 is only able to cleave SUMO conjugates and not
ubiquitin or Nedd8 conjugates and shows substrate specificity as it could cleave
SUMO-PML but not SUMO-RanGAPl (Yeh et ah, 2000). The conservation between
the SUMO specific proteases is limited to a region of about 200 amino acids,
including the active site residues, in a manner which is reminiscent of the UBP
family ofDUBs (Li and Hochstrasser, 2000; Yeh et ah, 2000).
Studies to date suggest that unlike deconjugation of SUMO, the deconjugation of
Nedd8 may overlap with deubiquitination. The UCH-L3 ubiquitin C-terminal
hydrolase has been shown to have Nedd8 cleaving activity and a human ubiquitin-
specific processing protease, UBP21 is able to deconjugate ubiquitin and Nedd8, but
not SUMO (Wada et ah, 1998; Gong et ah, 2000). These observations are perhaps to
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be expected, as the homology between Nedd8 and ubiquitin is much higher than
between SUMO and ubiquitin. However, as these experiments have been conducted
in vitro, it is unclear whether the deneddylating activity of the DUBs will be relevant
under physiological conditions. A series of reports have identified the
COP9/signalosome complex as a positive regulator of deneddylation (Lyapina et al.,
2001; Zhou et al., 2001; Yang et al., 2002). The COP9/signalosome complex has
homology to the 19S regulator lid and although its function is unclear, it has been
shown to regulate a number of cellular processes including signal transduction
(section 1.3.2.1.1; Wei and Deng, 1999). The cullin component of the human SCF
complex was found to interact with the COP9/signalosome, and this association was
conserved in S. pombe (Lyapina et al., 2001). Furthermore, the S. pombe
COP9/signalosome was able to promote cleavage of Nedd8 from the Pcul cullin and
COP9/signalosome mutants accumulated Nedd8 conjugated cullins (Lyapina et al.,
2001). A second study showed that Nedd8 conjugated to the Pcu3 cullin, which is
found in a stress specific ubiquitin ligase, was also removed in the presence of the
COP9/signalosome. In addition, its ubiquitin ligase activity was increased in
COP9/signalosome mutants (Zhou et al., 2001). Finally, degradation of the p27Kipl
cyclin-dependent kinase inhibitor, a known proteasome substrate, has been found to
be regulated by the COP9/signalosome. Nedd8 that is conjugated to the SCF is
removed in a COP9/signalosome dependent manner, reducing the SCF ubiquitin
ligase activity against p27Kipl, and therefore decreasing p27Kipl degradation (Yang et
al., 2002). The proposed Nedd8 deconjugating activity of the COP9/signalosome has
not yet been attributed to any subunit; the Csn5 subunit has homology to the cysteine
proteases but mutation of the putative active site cysteine had no effect on promotion
of Nedd8 deconjugation by the COP9/signalosome (Lyapina et al., 2001). Further
studies will be required to identify the active subunit or associated factor and to
determine whether the deubiquitinating activity found in the 19S complex and the
Nedd8 deconjugating activity associated with the COP9/signalosome are mediated
by homologous subunits (see section 1.3.2.1.1).
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1.3 26S Proteasome
One of the major functions of ubiquitination is to target proteins for 26S proteasome-
mediated degradation. The 26S proteasome is a multisubunit complex that is
composed of two 19S regulatory complexes positioned at either end of a 20S
catalytic core complex (Figure 1.4). The 19S complexes function to activate the
proteasome for the degradation of ubiquitinated proteins (Voges et al., 1999). A
second regulator of the 20S proteasome, the 11S (or PA28) complex, is found only in
higher eukaryotes and is thought to be involved in antigen presentation and the
immune response (Kloetzel, 2001). However, as the focus here is on ubiquitin
dependent proteolysis, it is the 20S and 19S complexes, which make up the 26S
proteasome, that will be described in detail below.
1.3.1 20S Core
1.3.1.1 Structure of the 20S Core
The 20S core of the 26S proteasome resembles proteasome complexes found in
archaea. Studies of these complexes have given an insight into the structure of the
eukaryotic complex with the first X-ray crystal structure of a 20S complex coming
from the archaea, Thermoplasma acidophilum. This structure revealed that two types
of subunit, a and (3, make up the 20S core and that these subunits are arranged in
stacked, seven-membered rings, in a pattern of 7a,7(3,7(3,7a (Lowe et al., 1995).
Using electron microscopy, these stacked rings can be seen to form a barrel shaped
structure (Figure 1.4) (Walz et al., 1998). The 20S complex contains three chambers
and the (3 subunit rings form the central chamber, which is the site of proteolysis
(Lowe et al., 1995; Groll et al., 1997). The archaeal 20S complex is a simplified
version of that found in eukaryotes. The eukaryotic 20S complex is made up of
fourteen different subunits and, based on their homology to the archaeal subunits,
seven of these have been classed as a-subunits and seven as (3-subunits. The crystal
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Lid
Figure 1.4: The Structure of the 26S Proteasome
The 26S proteasome comprises a barrel-shaped 20S catalytic core with a 19S
regulatory complex bound at either end. The 20S core is made up of a and p
type subunits, which are arranged in stacked rings.
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structure of the budding yeast 20S complex has been solved and although there are
seven distinct subunits of both the a and (3 types, the overall eukaryotic 20S structure
was found to very similar to that of the archaeal complex (Groll et ah, 1997). A
major difference between the two structures is that the channel into the archaeal 20S
complex is constitutively open whereas entry into the eukaryotic 20S complex
appears to be controlled by a gating mechanism. The N-terminal 13 residues of the
a3 subunit, which are disordered in the T. acidophilum structure, were found to have
an ordered structure covering the opening into the budding yeast 20S core. Analysis
of proteasomes purified from a strain deleted for the a3 N-terminal tail using x-ray
crystallography demonstrated that the channel was opened and biochemical assays
revealed a corresponding increase in protease activity. As with most other subunits
of the proteasome, deletion of the entire a3 subunit is lethal. However, a strain
deleted for only the N-terminal tail of the a3 subunit was viable, indicating that the
gating function of a3 is not essential (Groll et ah, 2000). This is in keeping with the
proposal that the gate may be opened in vivo by the binding of the 19S complex to
the a-subunit rings.
1.3.1.2 Activity of the 20S Core
The catalytic function of the 26S proteasome is provided by the 20S core complex,
which has been shown to function as an N-terminal nucleophile hydrolase (Voges et
al., 1999). Mutation and structural studies of the T. acidophilum proteasome have
demonstrated that the (3-subunits act as threonine proteases to provide the catalytic
activity of the 20S complex (Wlodawer, 1995; Seemuller et al., 1995). At least five
proteolytic activities have been assigned to the 26S proteasome: chymotrypsin-like,
trypsin-like and peptidylglutamyl activities have widely been described but in
addition cleavage between small neutral amino acids and at the C-side of branched
chain amino acids has been reported (Orlowski et al., 1993; Voges et al., 1999). It
has been proposed that the size of products released from the proteasome might be
determined by the distance between active sites in a mechanism described as a
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molecular ruler (Wenzel et al., 1994). However, several studies have provided
evidence that this is not the case, for example, both mammalian and archaeal
proteasomes have been shown to produce a similar distribution of product sizes in
spite of the fact that the archaeal proteasomes contain many more active sites
(Kisselev et al., 1999b). Protein degradation is observed to be processive, without
release longer breakdown intermediates and the oligopeptides generated by the
proteasome are in the range of 3-30 amino acids long with an average size between
6-9 residues (Akopian et al., 1997; Nussbaum et al., 1998; Kisselev et al., 1999b;
Kisselev et al., 1999a).
1.3.2 The 19S Regulator
In eukaryotes, the 26S proteasome complex is formed by the association of two 19S
complexes with the 20S core, one at either end. This structure has been observed
using three-dimensional electron microscopy, which revealed that the 20S complex is
connected by a flexible linkage to the 19S regulators (Walz et al., 1998). The 19S
regulator (or 19S Cap, PA700) provides the specificity of the 26S complex for
ubiquitinated substrates and activates the 20S complex for degradation in an ATP
dependent manner. The specific functions of the 19S complex are the recognition of
ubiquitinated substrates; unfolding of substrates by chaperone activity; opening of
the gate into the 20S core to allow substrate entry and recycling of ubiquitin by a
deubiquitinating activity. Each of these functions will be discussed further below;
however, first, the structure of the 19S complex will be described.
1.3.2.1 The Structure of the 19S Complex
It is generally agreed that 17 subunits make up the 19S complex and these can be
divided into two groups, the ATPases and the nonATPases (Voges et al., 1999; Holzl
et al., 2000; Li et al., 2000). In certain species, additional 19S subunits have been
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proposed, however, as these are not conserved members of the 19S complex they are
unlikely to be essential for proteasome function (Voges et al., 1999). In addition, the
sum of the masses of the 18 conserved subunits is in close agreement with the
experimentally determined mass of the 19S complex (Holzl et ah, 2000). The
subunits of the 19S complex have been assigned unique names in several different
organisms. Here, the subunits will be referred to using both the original S. pombe
nomenclature and the unified nomenclature of RPT (Regulatory Particle ATPase)
and RPN (Regulatory Particle Non-ATPase) that was proposed by Finley et al
(1998).
The 19S complex is highly conserved in terms of subunit composition. It also shows
functional conservation, as is demonstrated by the fact that 19S complexes from
human erythrocytes are able to activate the S. pombe 20S complex (Seeger et ah,
1996). Studies using a S. cerevisiae strain deleted for the RpnlO 19S complex
subunit, showed that the 19S complex can be dissociated into two subcomplexes: the
base and the lid (Figure 1.4; Glickman et ah, 1998). Ubiquitin dependent proteolysis
requires the presence ofboth of these subcomplexes (Braun et ah, 1999)
1.3.2.1.1 The 19S Base
The base of the 19S Regulator is composed of all six ATPases, of the AAA ATPase
family, and three non-ATPases (Glickman et ah, 1998). Several other AAA
ATPases including katanin, dynein and those of the proteasome-activating
nucleotidase (PAN) archaeal complex have been shown to adopt a hexameric ring
structure (Neuwald et ah, 1999; Zwickl and Baumeister, 1999). Therefore, it has
been proposed that the ATPases of the base also form a heterohexameric ring. Two
of the non-ATPases of the base are the two largest subunits of the complex,
Mts4/Rpnl and Rpn2, which are related in sequence, but of unknown function. The
third nonATPase in the base is the multiubiquitin binding protein Pusl/RpnlO (see
section 1.3.2.2.1) (Glickman et ah, 1998; Voges et ah, 1999). The base alone is
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sufficient to activate the 20S complex for peptide degradation, but not
multiubiquitinated proteins (Braun et al., 1999).
1.3.2.1.1 The 19S Lid
The lid subcomplex is made up of eight non-ATPases and its function remains
elusive. However, there is considerable sequence homology between subunits of the
lid and those of the COP9/signalosome and eIF3 translation initiator complex.
Indeed, two structural motifs, the PINT/PCI domain and the MPN domain are found
uniquely in subunits of these complexes (Glickman et al., 1998). The similarity of
the lid and the COP9/signalosome is also reflected on a structural level (Kapelari et
al., 2000; Henke et al., 1999). The significance of these homologies remains unclear,
however, it has been suggested that it may reflect a common evolutionary ancestor
for the complexes (Glickman et al., 1998; Braun et al., 1999).
1.3.2.2 Functions of the 19S Complex
1.3.2.2.1 Recognition of Multiubiquitinated Proteins
The 19S complex is required for the degradation of ubiquitinated substrates implying
that it must contain multiubiquitin recognition factors. The first of these to be
identified was the Pusl/RpnlO subunit, which contains a multiubiquitin-binding
domain called the UIM (ubiquitin-interacting motif) (Deveraux et al., 1995; van
Nocker et al., 1996; Wilkinson et al., 2000; Hoffnann and Falquet, 2001). However,
as Pusl/RpnlO was found to be non-essential, it was suggested that other
multiubiquitin binding proteins must exist (van Nocker et al., 1996; Wilkinson et al.,
2000). Further studies have revealed that this redundant function is provided not by
proteasome subunits but by two proteasome-interacting, multiubiquitin-binding
proteins, Rhp23 and Dphl (Wilkinson et al., 2001 and see section 1.1.9.1). These
proteins both contain a UBL domain and bind to the Mts4/Rpnl subunit of the 19S
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regulator to deliver multiubiquitated substrates. A third UBL domain protein, BAG-
1 is also proposed to be involved in delivery of substrates to the proteasome (see
section 1.1.9.2). Finally, the Cdc48/Valosin-Containing Protein (VCP), which, like
Rhp23 and Dphl, is able to bind multiubiquitin chains and associate with the
proteasome, has also been implicated in the recognition and delivery of proteasome
substrates. However, in this case the interaction with the proteasome has not been
shown to be direct, so other accessory proteins may be involved (Dai et al., 1998;
Verma et al., 2000).
In addition to these proteins, the base of the 19S regulator has also been recently
implicated in the binding of multiubiquitin. This interaction was shown to be ATP
dependent and the Rpt5 ATPase subunit was found specifically to crosslink to
multiubiquitin chains (Lam et al., 2002). These findings were based on in vitro
studies, and therefore require verification in vivo. However, one possible model is
that substrates may be selectively delivered to the proteasome by Pusl, Dphl, Rph23
and possibly BAG-1 and Cdc48/VCP then subsequently bound to Rpt5.
1.3.2.2.2 Deubiquitinating Activity
Two studies have described intrinsic deubiquitinating activity for the 26S proteasome
(Eytan et al., 1993; Lam et al., 1997). The first used 26S proteasomes from rabbit
reticulocytes and identified an activity capable of releasing free ubiquitin from
ubiquitin-protein conjugates or ubiquitin fusions. This activity was found to be
insensitive to the ubiquitin C-terminal hydrolase inhibitor, ubiquitin aldehyde
suggesting that it may not be a thiol protease (Eytan et al., 1993). A later study using
bovine 19S complexes identified a ubiquitin aldehyde sensitive isopeptidase likely to
be a thiol protease, which was capable of editing multiubiquitin chains by removing
ubiquitin sequentially from the end of the chain (Lam et al., 1997). Therefore, it
appeared that the 26S proteasome might contain two distinct deubiquitinating
activities, however, the subunits responsible for this activity have yet to be identified.
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1.3.2.2.3 Chaperone Activity
It has been proposed that 19S regulator chaperone activity may be necessary for the
unfolding of substrates prior to degradation, as the opening into the 20S catalytic
core is too small to allow the entry of folded proteins (Groll et ah, 1997). This
activity has been observed in proteasomes from human erythrocytes, which can
reactivate denatured citrate synthase and inhibit its aggregation. The presence of
AAA ATPases in the base of the 19S regulator suggests that this may be the site of
chaperone activity as many members of this family are known chaperones (Neuwald
et ah, 1999; Zwickl and Baumeister, 1999). In support of this observation, a binding
site for unfolded proteins has been localised to the base subcomplex (Braun et ah,
1999).
Understanding of the chaperone activity of the 26S proteasome has been advanced
by studies using the PAN complex, which contains AAA ATPases homologous to
those in the 19S base. PAN can catalyse protein refolding or unfolding and promotes
degradation by 20S proteasomes (Benaroudj et al., 2001). The hexameric ring of the
AAA ATPases is proposed to mediate unfolding of proteasome substrates via
coordinated conformation changes coupled to ATP hydrolysis (Neuwald et al., 1999;
Zwickl and Baumeister, 1999).
1.3.2.2.4 Regulation of Entry into the 20S Channel
Opening of the gated channel into the 20S core is thought to be mediated by the
binding of the 19S complex to the 20S a-subunit rings (Groll et al., 2000). The 19S
regulator base subunit Rpt2 has been proposed to be crucial for this function.
Mutations in the ATPase domain of Rpt2 decrease the activity of proteasomes but
when combined with an open channel mutant, activity is restored. Therefore, it is
suggested that Rpt2 acts in an ATP dependent manner to regulate gating of the 20S
core (Groll et al., 2000).
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1.3.3 Identification of Genes Encoding 26S Proteasome Subunits in S. pombe
Several genes encoding subunits of the 26S proteasome in S. pombe were identified
in a screen to isolate mutants that were resistant to the microtubule destabilising
drug, MBC (methylbenzylcarbamylate) and temperature sensitive for growth. Five
different genes were found to be mutated and these were named mts (for MBC
resistant and temperature sensitive). Subsequent work revealed that each of the mts
genes encoded a subunit of the 19S regulator: mtsl+ (Rpn9), mts3+ (Rpnl2), mts4+
(Rpnl) and mts5+ {padl+, Rpnll) encode non-ATPase subunits and mts2^ (Rpt2)
encodes an ATPase subunit (Gordon et al., 1993; Gordon et al., 1996; Wilkinson et
al., 1997; Penney et al., 1998; C. Gordon unpublished).
The mts mutations are all loss of function mutations as deletion of any of the mts
genes is lethal (Gordon et al., 1993; Gordon et al., 1996; Wilkinson et al., 1997;
Penney et al., 1998; C. Gordon unpublished). Each of the mts mutants has a similar
phenotype, with cells at the restrictive temperature arresting during mitosis at
metaphase indicating a defect in the metaphase to anaphase transition. The arrest at
metaphase probably reflects the requirement for ubiquitin dependent proteasome
mediated degradation of Cut2 for sister-chromatid separation and thus the
progression from metaphase to anaphase (Funabiki et al., 1996).
Analysis of extracts from mutant cells has indicated an accumulation of high
molecular weight ubiquitin conjugates at the restrictive temperature for mts2, mts3
and padl, providing evidence that Mts2, Mts3 and Padl function in the degradation
ofmultiubiquitinated proteins in vivo (Gordon et al., 1993; Seeger et al., 1996). In
support of this observation, proteasomes purified from the mts2 and mts3 mutants
17S • •
were found to be defective in degradation of ubiquitin I Lysozyme conjugates in
vitro at the restrictive temperature (Seeger et al., 1996).
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1.3.4 Localisation of the Proteasome
The localisation of the proteasome has been investigated in many cell types from
yeast to human, using a variety of cytological and biochemical methods. There
appears to be a clear difference between the cellular localisation of proteasomes in
yeast and higher eukaryotes, therefore each will be discussed in turn.
1.3.4.1 Proteasome Localisation in Yeast
Complementary studies in both fission and budding yeast have demonstrated that the
proteasome is primarily localised to the nuclear periphery in a punctate pattern
(Figure 1.5). The localisation of the proteasome in S. pombe was first investigated
using immunofluorescence microscopy, which revealed punctate spots of staining at
the nuclear periphery (Wilkinson et al., 1998). More detailed examination using
immunogold electron microscopy confirmed that the precise localisation of the
proteasomes was inside the nucleus (Wilkinson et al., 1998). In S. cerevisiae, the use
of a GFP tagged proteasome subunit demonstrated that proteasomes have a punctate
localisation at the nuclear periphery and colocalise with Kar2/Bip, a marker for the
nuclear envelope-ER network. Confirmation of these findings was provided by
biochemical fractionation experiments showing that the proteasome is enriched in the
nuclear envelope-ER network (Enenkel et ah, 1998). Although alternative nuclear
localisation has been proposed, the accumulated evidence suggests that the nuclear
periphery is the major site of proteasome localisation in vegatively growing yeast
cells (Wilkinson et al., 1998; Enenkel et al., 1998; Russell et al., 1999).
The localisation of the proteasome during mitosis and meiosis has been investigated
in live cells using a S. pombe strain in which the 19S subunit Padl has been tagged
with GFP. In mitosis the proteasomes remained localised at the nuclear periphery,
except that a spot of staining was observed between the separating nuclei at
anaphase. In meiosis, a change in distribution of the proteasome was seen firstly
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Figure 1.5: Localisation of the Proteasome in S. pombe
Using a strain that has the Padl 19S subunit tagged with GFP, the proteasome can be
seen to localise at the nuclear periphery in a puncate pattern (Wilkinson et al, 1998).
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during karyogamy and horsetail movement. Proteasome staining was found
throughout the nucleus with the exception of the nucleolus and a distinct spot was
also observed. Although the localisation in meiosis I resembled that of mitosis, in
meiosis II, the proteasomes were dramatically relocalised to a concentrated spot at
the centre of the nucleus between the separating DNA. This signal dispersed at the
end of meiosis II and relocalisation to the nuclear periphery was observed once
spores had formed. It therefore appears that events in spore formation may require a
specific localisation of proteasomes (Wilkinson et al., 1998).
The localisation of the proteasome at the nuclear periphery may be maintained due to
interactions with other factors. Recently, Cut8 has emerged as a possible proteasome
tethering protein; Cut8 localises in a proteasome-like manner and proteasomes in a
cut8 null mutant are delocalised. The degradation of multiubiquitinated proteasome
substrates was delayed in cut8 mutants, indicating that the Cut8-dependent
localisation of proteasomes has a functional significance (Tatebe and Yanagida,
2000).
1.3.4.2 Proteasome Localisation in Mammalian Cells
Although there are many studies that have examined the localisation of proteasomes,
a clear consensus on their distribution in mammalian cells has yet to be reached.
What is evident, is that in most cell types proteasomes are found both in the nucleus
and the cytosol and are often associated with the ER (Rivett, 1998; Hirsch and
Ploegh, 2000). The presence of variant proteasome types in mammalian cells further
complicates the issue of proteasome distribution. Immunoproteasomes, which
contain specialised 20S subunits, have been reported to be concentrated in the ER ,
although the regulatory 11S complexes could not be detected (Brooks et al., 2000).
However, a second study using several cell types showed that in response to IFNy,
immunoproteasomes and 11S regulatory complexes are both directed to PML
(promyelocytic leukaemia oncoprotein) bodies. This is in keeping with previous
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indications that PML bodies have a role in regulating the immune response (Fabunmi
et al., 2000).
A number of studies have revealed a distinctive localisation of proteasomes with
microtubule dependent protein aggregates called aggresomes (Kopito, 2000). These
structures were first identified in a study examining the degradation ofmutant forms
of the cystic fibrosis transmembrane conductance regulator (CFTR) that is
inefficiently folded, and thus degraded in a ubiquitin dependent manner by the
proteasome. In conditions where the mutant CFTR was able to accumulate, it was
found to aggregate at a perinuclear structure, which was named the aggresome
(Johnston et al., 1998). Further investigation has demonstrated that this structure is
composed of aggregated protein surrounded by a cage of vimentin filaments
(Johnston et al., 1998; Garcia-Mata et al., 1999). The 20S, 11S and 19S complexes
have all been detected in the aggresome, and it has been found to be active in the
degradation of proteins (Garcia-Mata et al., 1999; Wigley et al., 1999). In addition,
molecular chaperones such as Hsp70 have also been identified in aggresomes
(Wigley et al., 1999). Both cytosolic and membrane proteins can incorporate into
aggresomes and it has been shown that they first form aggregates throughout the cell
which are then relocalised to the centrosome region in a microtubule dependent
manner, possibly through the action of dynein/dynactin motor proteins (Garcia-Mata
et al., 1999). Although the microtubule network is required for the redistribution of
protein aggregates it is not necessary for the transfer of proteasomes to the
aggresome (Garcia-Mata et al., 1999; Wigley et al., 1999). In terms of cellular
function, aggregation has been shown to interfere with the process of ubiquitin
dependent proteolysis. Therefore, it has been suggested that aggresomes may
acquire a large number of proteasomes, leaving a reduced number for normal cellular
functions (Bence et al., 2001). This loss of normal activity, may contribute to the
cell death seen in diseases which are characterised by protein aggregation, such as




Studies using deletion strains for each of the S. cerevisiae DUBs have shown that
none is essential and that there is a high level of redundancy. Indeed, cells in which
up to five DUBs had been deleted were found to be viable. (Amerik et al., 2000).
Therefore, it is proposed that the functional specificity of the DUBs may be
determined by their cellular localisation. Regulation of 26S proteasome-mediated
degradation is a major function of ubiquitination, implying that there might be a
subset of redundant DUBs localised at the proteasome.
Two putative proteasome-associated DUBs have been identified in S. pombe. Uch2
had previously been suggested to copurify and colocalise with the proteasome (Li et
ah, 2000). A second DUB, Ubp6, was identified in a sequence homology search for
S. pombe proteins containing a ubiquitin-like (UBL) domain (C. Semple and C.
Gordon, unpublished). This domain has been shown to mediate interactions with the
proteasome, implying that Ubp6 might also be proteasome-associated (Wilkinson et
ah, 2001).
Both Uch2 and Ubp6 are highly conserved proteins with homologues in higher
eukaryotes (see Figures 1.6 and 1.7). S. cerevisiae, has a Ubp6 homologue but no
Uch2 homologue is found. Therefore, in this respect, S. pombe appears to be more
similar to higher eukaryotes than S. cerevisiae, making it a good model system for
the investigation ofproteasome-associated DUBs.
The aims of this study are firstly to determine whether Uch2 and Ubp6 are associated
with the proteasome. If this was found to be the case, genetic experiments would be
undertaken to investigate the possibility that Uch2 and Ubp6 have redundant
functions. Finally, the biochemical activities of both DUBs would be analysed to
provide information about their substrates.
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Figure 1.6: The Uch2 Protein Sequence is Conserved
Alignment of the protein sequence of S. pombe Uch2 (SpUch2 - SPBC409.06)
with those of its homologues in Human (HsUCH37 -Q9Y5K5), Mouse
(MmUCH-L5 -AF175903) and Drosophila (Dmp37a -CGI950). Conserved


















aqlfaltg| qparqk v vkgg tlkddd-wg : 59
aqlfaltgj qparqr vm vkgg tlkddd-wg : 59
aqlfaltg5 qpd rqkvm ckgg ilkddq-w- : 58
skaee ltQ| psa rqk ym kgg lsgeesiki : 61
HQLYSiltQfi ppe rqk|V0mkggQLKDDVLLG : 57
->
HsUSPl4 NIK ikNGMT*|^ADALP-EEgSAKTVFve T- LASAMELgC !S iTnreuiiin manian 119
OcUbp6 NIK ikngmtBPBSBSADALP-EEBSAKTVFve T- S: LASAMELBcB. . mjjjjaH 119
DmUbp6 NLQ ikdgavBI®89KESVP-EVBATPVKFjie dHN- 3AHaatamrlBAB JSjBSSffl SHSAH 118
ScUbp6 YPL ikpgstBSmHpdanliskSAKKNNF ie dHAP gufflvqqfaqlBVBf 123



















HsUSPl4 QFfflHMAF PS3KG- QE LqqdaN sag IQBMRV lQQKLEAIEDDSVKETDSSSASAATPS 237
OcUbp6 qfBHMAF MBHkg-Su qB LqqdaN ScH IQBMRV;lQQKLEAIEDDSVKETDSSAAAVA-PS 236
DmUbp6 qaBHRAS I1!|tg-H: tB RqqdaN Scm MLKM lQQKLRP KNQEPSN TVQK 224
ScUbp6 NTBRKCY K^HRDSBe; FB Kqqdae 5 HtqBFHSi SIVFGD 227












sgttn fm rnSSlegBnIkB 284
smhts ymtobHlegBt fflK0 261
HSUSP14 T ^QSPTLQRBAL IKSSK isrlp0ylOTOM;vrf jykEKESVNAkvlk K F pLMLffiltfYELCM 360
OcUbp6 TSqSptlqrHal IKSSK isrlpBy l■q mvrf | EKESVNAkvlk dmK fpLML&/YELCB 359
DmUbp6 VSkBetlgrBak IRTYLvsrlpByl®qfvrf BykGKEGINAkvlk nK fp IDFm\felcB 347
ScUbp6 eHrSdltgaBsi SVEKK isrlpBflsHq yvrf |wkRSTNKKSkilrkmV fpFQL&/adml0 346

















































HsUSPl4 i v tpedHi dwhlgyvllygprrBeimeeeseq 494
OcUbp6 i e tpedBlrBsKdwhibyvllygprrBeimeeeneq 493
DmUbp6 avatdrh: b DWHCBYvllyaprrBekl 475
ScUbp6 V eke ?;HE SBAKesdsBl ilmykgfgB 499
SpUbp6 i paekBet® st eadsBy illykakdqa 467
Figure 1.7: The Ubp6 Protein Sequence is Conserved
Alignment of the protein sequence of S. pombe Ubp6 (SpUbp6 - SPAC6G9.08) with
those of its homologues in Human (HsUSP14 - P54578 ), Rabbit (OcUbp6 - L37420),
Drosophila (DmUbp6 - CG5505) and budding yeast (ScUbp6 - NC_00138).
Conserved amino acids are highlighted, the ubiquitin-like domain is indicated by the
arrows and the proposed active site Cys (*) and His ("^residues are marked.
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Chapter 2 Materials and Methods
Unless otherwise stated all chemicals were supplied by Sigma and all molecular
biology reagents by Roche.
2.1 Fission Yeast Methods
2.1.1 Fission Yeast Strains
I O I
The strains used in this study were derived from the 972h and 975h~ strains
(Leupold, 1950). The standard background of strains was: leul-32, ura4-D18, his3-
Dl, arg3-D4 and either ade6-M210 or ade6-M216.
2.1.2 Growth Conditions and Media
2.1.2.1 Growth of Fission Yeast
Fission yeast was routinely grown on or in YES media at 25°C. Strains on agar
plates were kept for up to 2 months at 4°C. Strains were frozen for long term storage
at -70°C in 30% (v/v) Glycerol. Frozen strains were reisolated by streaking a loopful
of the frozen culture onto a YES plate. The plate was then incubated at 25°C until
colonies had grown.
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2.1.2.2 Fully Supplemented Medium
YES









For growth of fission yeast on solid medium, YES Agar was made by adding 20g/L
Micro Agar (Duchefa) to YES.
2.1.2.3 Minimal Media







Salts (50x stock) 20ml
Vitamins (lOOOx stock) 1ml
Minerals (10 OOOx stock) 0.1ml
h2o to 1L
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PMG was made up as EMM, except that 3.75g Glutamic acid was used in place of
the 5.0g ofNH4CI.
Additional growth supplements, such as leucine or uracil, were added as required,
before autoclaving to give a final concentration of 0. lg/L.
For repression of the nmtl promoter, thiamine was made up as a lOOmM stock, filter
sterilised and stored at 4°C. It was added after autoclaving to give a final
concentration of 2p.M.
For growth of on solid medium, EMM or PMG Agar was made by adding 20g/L






























Malt Extract Agar was used to induce sporulation and meiosis.
Malt Extract Broth (Oxoid) 30g
Micro Agar 20g
H20 to 1L
2.1.3 Genetic Manipulation of Fission Yeast
2.1.3.1 Crosses
Crosses were set up by mixing a loopful h+ cells and loopful of h~ cells with
approximately 15pl of water on a ME. The crosses were checked for the formation




A sample from a 2-3 day old cross was streaked onto a YES plate and using a Singer
Micromanipulator, asci were picked and placed on a grid system on the plate. The
plate was left at 20°C overnight or 25-30°C for 8h. Each ascus was then dissected
and the four spores arranged on the grid. The spores were then left for 3-5 days at
25°C until colonies had formed.
2.1.3.3 Random Spore Analysis
A sample from a 2-3 day old cross was checked under the microscope to confirm the
presence of asci. A loopful of the cross was then resuspended in 1ml H2O containing
2|il glusculase {Helix pomantia juice). The cells were incubated overnight at 37°C.
The cells were then washed once in 30% ethanol and once in water. The pellet was
resuspended in 1ml H2O and 5|li1, 20|il, 100(0.1 and 875(0.1 samples plated on selective
plates. The plates were then incubated at 25°C until colonies had formed.
2.1.3.4 Lithium Acetate Transformation of S. pombe
The lithium acetate method for transformation of S. pombe was routinely used
(Moreno et al 1991). A 100ml culture of cells was grown until an OD600 of 0.5-1.0
7 7
(1x10 -2x10 cells/ml) was reached. The cells were spun down at 2000rpm for 2
minutes and washed once in H2O and once in 0.1M Lithium Acetate pH4.9. The
pellet was resuspended in 0.1M Lithium Acetate pH4.9 to give a final concentration
of 2xl07 cells/ml. Approximately l(ig DNA, 5(j.l lOmg/ml transfer RNA and 370)0.1
50% polyethylene glycol 3350 was added to a lOOp.1 aliquot of the cell suspension.
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This was then incubated at 25°C for 45-60 minutes, and then heat shocked at 46°C
for 20 minutes. The cells were spun out at 13 OOOrpm for 1 minute and the
supernatant removed. The pellet was resuspended in 1ml YES and incubated at 25°C
for 1-3 hours. The cells were plated on selective media and left at 25°C until
colonies had formed. For selection of G418 resistance, cells were plated on YES
plates, incubated for 24 hours at 25°C and then replica plated onto YES plates
containing 100(J,g/ml geneticin.
2.1.3.5 Plasmid Vectors for Expression in S. pombe
pREP 1/41/81 based vectors were used to express a given gene in S. pombe. The
promoters in these vectors are based on the nmtl thiamine repressible promoter from
S. pombe (Maundrell, 1990). These vectors also contain the S. cerevisiae LEU2 gene
for selection in fission yeast and the S. pombe ars origin of replication. The REP
family of vectors is made up of shuttle vectors that contain an AmpR cassette for
selection in E. coli.
The nmt promoter is fully derepressed in the absence of thiamine, allowing high level
expression of the cloned gene. The relative strengths of the three nmt promoters
found in REP1, pREP41 and pREP81 are 80, 12 and 1 respectively. The addition of
thiamine, which is present in fully supplemented media or added to minimal media,
results in repression of the nmt promoter leaving only a small residual level of
promoter activity (Tommasino and Maundrell, 1991; Maundrell, 1993).
2.1.3.6 Gene Disruption by PCR
Oligonucleotide primers were designed with 60-80bp homology to either end of the
gene and 20bp homology to the selection cassette to be used (Bahler et al., 1998).
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Ten PCRs were carried out as described in section 2.2.2.2.1 and the total DNA was
pooled and ethanol precipitated for one transformation, using the Lithium Acetate
Method (see section 2.1.3.4) into the desired strain.
2.1.4 Cytological Methods
2.1.4.1 Paraformaldehyde Fixation of Fission Yeast
A 100ml culture of cells was grown in YES at 25°C, to an OD of less than 1 at
595nm. 30ml of 2.4M Sorbitol in 2xYES was added to 30ml of cells. 6.6ml of 38%
parformaldehyde fixation stock solution were added and the cells were incubated at
25°C for between 5-30 minutes depending on the antibody to be used. After
incubation, the cells were spun out at 2000 rpm and washed with 20ml of PEMS.
The cells were spun out, 5ml of PEMS + 0.25mg/ml Zymolyase T100 (ICN
Biomedicals Ltd) was added and the suspension was incubated for 30 minutes at
37°C. The cells were spun out and resuspended in 1ml of PEMS and transferred to
an eppendorf. Using a benchtop centrifuge the cells were spun out. The cell pellet
was resuspended in 1ml PEMS + 1% Triton X100 (Sigma) and incubated for 5
minutes at room temperature. The cells were spun out and washed three times with
lml of PEM. The cell pellet was resuspended in 1ml PEMBAL, incubated for 30
minutes at room temperature and then stored at 4°C.
2.1.4.2 Antibody Staining of Paraformaldehyde Fixed Cells
A 10-lOOp.l sample of fixed cells in PEMBAL was spun down and resuspended in
1 OOjj.1 of PEMBAL containing the primary antibody. The cells were incubated at
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4°C on a rotating wheel overnight. The cells were spun out in a benchtop centrifuge
and the supernatant carefully removed. The cells were then washed three times with
lml PEM. lOOpl of PEM containing the secondary antibody was added to the cell
pellet, which was then incubated at 4°C on a rotating wheel overnight. The cells
were washed three times in PEM, resuspended in PEMBAL and stored at 4°C.
2.1.4.3 Mounting, DAPI Staining and Analysis ofAntibody Stained
Paraformaldehyde Fixed Cells
Coverslips and slides were washed with detergent and cleaned with 70% ethanol
before use. Coverslips were prepared for mounting by coating in Poly-L-Lysine
Solution (0.1% w/v in water, Sigma). lOpl of stained cells were spread on a
coverslip and left to air dry. 30-50jll1 of DAPI in Vectashield Mounting Medium
(Vector Laboratories Inc) was added to the coverslip, which was then covered with a
microscope slide and blotted dry. Slides were stored at 4°C in the dark. The cells
were viewed using a Zeiss Axoiplan2 fluorescence microscope, digital images were
captured with a Princeton Instruments digital camera and analysed using in house
scripts for the IPLab Spectrum 3.2 software (Scanalytics).
2.2 Molecular Biology
2.2.1 E. coli Methods
2.2.1.1 E. coli Strains
Subcloning Efficiency™ DH5a™ Competent Cells (Gibco BRL or Invitrogen Life
Technologies) were used for routine plasmid preparation.
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2.2.1.2 Media and Growth Conditions









For growth of bacteria on solid medium, LB Agar was made by adding 15g/L Agar
to LB. Bacteria were grown at 37°C using an incubator for growth on plates and in
an orbital shaker for growth in liquid media.
2.2.1.3 Antibiotic Selection
All antibiotics were stored at -20°C and added to autoclaved media. Stock solutions
were made up as follows: a 2000x stock of lOOmg/ml of ampicillin in dH20, a
1 OOOx stock of 34mg/ml chloramphenicol dissolved in ethanol and a 500x stock of
5mg/ml tetracycline dissolved in ethanol.
E. coli were stored on plates at 4°C for up to one month or at -70°C in LB containing
25% glycerol for longer term storage. Strains were reisolated from stocks by
spreading a loopful of frozen cells onto a LB plate and incubating at 37°C overnight.
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2.2.1.4 Transformation of DNA into E. coli
Bacterial transformations were carried out using commercially produced chemically
competent cells: Subcloning Efficiency™ DH5a™ Competent Cells (Gibco BRL or
Invitrogen Life Technologies). 1-1 Oja.1 DNA was transformed into the competent
cells according to manufacturer's instructions.
2.2.1.5 Preparation of plasmid DNA from E. coli
Minipreps of plasmid DNA from E. coli were carried out using one of the two
following methods:
1. Qiaprep Spin Miniprep Kit (Qiagen Ltd) was used as manufacturer's instructions
using l-5ml cultures.
2. For DNA extraction from a large number of colonies, 96 well plates were used to
grow overnight cultures which were then processed by the MRC Human Genetics
Unit Technical Services, using the BioMek R 2000 Workstation Robot according to
the manufacturers instructions.
2.2.2 DNA Manipulation
2.2.2.1 Agarose Gel Electrophoresis of DNA
DNA fragments were separated by electrophoresis through an agarose gel. The
agarose was made up at 1% w/v in TBE buffer and heated to dissolve. Ethidium
bromide solution (Sigma) was added to cooled agarose to give a final concentration
of lOOng/ml. Loading buffer was added to each of the DNA samples and they were
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loaded onto the agarose gel once it had set. The gel was run in TBE buffer for 15-
120 minutes, depending on the size of the DNA fragments. 1Kb DNA Ladder size





DNA Loading Buffer (lOx stock)
40% Glycerol




PCR was carried out using AmpliTaq™ DNA Polymerase and supplied buffers and
MgCl2 (Roche). A PCR mix was made up as below. 10-100ng template DNA was
used and negative control reaction without DNA was run for each reaction. Oligos




10XPCR Buffer II 10.0
25mM MgCl2 6.0
1:1:1:1 dNTPs lOOmM 0.4
Forward Oligo 100ng/(il 1.0
Reverse Oligo 100ng/p.l 1.0
AmpliTaq™ DNA Polymerase 0.5
dH2Q to 100.0
The following program was then run using either a Hybaid Omnigene, in which case
each reaction was overlayed with two drops ofmineral oil, or a Dyad™ DNA Engine
Thermal Cycler, which has a heated lid.
94°C 2 minutes
50°C 1 45 seconds
72°C 1 minute 2
94°C 30 seconds
50°C 45 seconds
72 °C 10 minutes
2.2.2.2.2 High Fidelity PCR
For increased efficiency PCR, the Expand High Fidelity PCR System (Roche) was
used. Reactions were set up as follows using the supplied buffer. DNA and oligos







10X PCR Buffer with MgCl2 5.0
1:1:1:1 dNTPs lOOmM 0.4
Forward Oligo 100ng/pl 1.0
Reverse Oligo 1 OOng/fil 1.0
Expand DNA Polymerase 0.75
dH2Q to 50.0
The following program was run using the same thermal cyclers as for Amplitaq PCR:
94°C 2 minutes
50°C 1 1 minute





Annealing temperature was decreased to 45°C or 40°C if increased yield was
required.
2 The elongation time was varied depending on the length of the PCR product,
allowing a time of 1 minute of elongation per lkb of PCR product.
2.2.2.2.3 Colony PCR from S. pombe
For PCR from S. pombe colonies, the PCR mix was made up as for standard PCR





mixture became cloudy, and this suspension was boiled for 5 minutes. The mixture
was spun for 2 minutes at 5000rpm to pellet the cells. 0.5)0.1 of AmpliTaq™ DNA
Polymerase was then added to each tube and the PCR reaction was run using the
standard program.
2.2.2.3 Restriction Enzyme Digestion of DNA
DNA was cut using restriction enzymes from Roche or New England Biolabs
according to the manufacturer's instructions. Digests were typically carried out using
l-5|ig DNA in a final volume of 20-1 OOjol, at 37 °C, for 1-20 hours.
2.2.2.4 Ligation of DNA
Following digestion with restriction enzymes, reactions were performed to ligate
DNA fragments with compatible cohesive ends using T4 DNA ligase (Roche) with
the supplied reaction buffer. A total volume of 20pi was used, including ljil T4
DNA ligase, 2jll1 T4 DNA Ligase buffer and 10-lOOOng DNA. Vector and insert
DNA was used in a ratio of approximately 1:3. Reactions were routinely carried out
for 16 hours at 20°C.
2.2.2.5 Purification of DNA
PCR DNA was purified using the Qiaquick PCR Purification Kit (Qiagen Ltd) and
DNA from restriction digests or alkaline phosphatase treatment was purified using
the Qiaquick Nucleotide Removal Kit (Qiagen Ltd). Both kits were used according
to manufacturer's instructions.
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To gel purify DNA, it was first run on a 1% agarose gel. The DNA band was cut
from the gel and the DNA extracted using the Qiaquick Gel Extraction Kit (Qiagen
Ltd) according to manufacturer's instructions.
2.2.2.6 Site-DirectedMutagenesis
Site-Directed Mutagenesis was carried out using the Quickchange™ kit (Strategene)
according to the manufacturer's instructions.
2.2.2.7DNA Sequencing
Sequencing reactions were set up using 500ng plasmid or 200ng PCR product, with
the Big Dye Sequencing Kit (Applied Biosystems) according to manufacturers
instructions. The following PCR program was used:
96°C 30 seconds }
50°C 15 seconds } 25 cycles
60°C 4 minutes }
DNA was then ethanol precipitated by adding 1/10 volume NaOAC (pH?) and two
volumes of absolute ethanol. The samples were spun for 10 minutes at 14 OOOrpm, at
4°C in a refrigerated benchtop centrifuge. The ethanol was then removed and one
volume of 70% ethanol was added to wash the DNA pellet. The samples were spun
as before but for two minutes. The 70% ethanol wash was removed and the DNA
pellets were air dried before sequencing.
Sequencing was carried out by the MRC Human Genetics Unit Technical Services.
DNA pellets were resuspended in 2-4)0,1 loading dye (PE Applied Biosystems) and
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heated for 2 minutes at 90°C. Samples were incubated at 4°C and then loaded onto
an Applied Biosystems DNA sequencer (Model 373A or 377) according to
manufacturers instructions. Raw sequence data was processed using the Sequencing
Analysis Version 3.0 program (PE Applied Biosystems).
Sequence data was analysed using the Sequencer Version 3.0.1 software (Gene
Codes Corp.).
2.3 Protein Purification andManipulation
2.3.1 Preparation of Total Protein Extracts from S. pombe
A 100ml culture was grown in YES at 25°C until mid-exponential phase with an
OD600 of 0.5-1.0. The cells were spun down for 2 minutes at 2000rpm and washed
once in H2O. The cell pellet was resuspended in 1ml of Lysis Buffer and transferred
to 2ml screw capped tubes. This cell suspension was centrifuged for 2 minutes at
13000rpm and the pellet resuspended in 100(0.1 Lysis Buffer. 300|ol of Braun Glass
Beads were added and the sample cooled on ice for 10 minutes. The cells were then
ribolysed three times for 10 seconds in a Hybaid RiboLyser at a speed of 6.5, with 2
minutes incubation on ice between each burst. A further 250|ol Lysis Buffer was
added and the sample ribolysed once for 1-10 seconds at a speed of 6.5. The beads
were spun down and the supernatant removed to a fresh eppendorf tube. The
supernatant was then spun at room temperature for 10 minutes to clear cell debris.







Immediately before use, Complete™ Protease Inhibitor Cocktail Tablets (1 tablet in
50ml) and PMSF (100 |lg/ml) were added.
2.3.2 Purification of 26S proteasomes from S. pombe
2.3.2.1 Immunoprecipitation of 26S Proteasomes
A 200ml culture of a padl+ or pusl + Protein A tagged strain was grown in YES, at
25°C, to late logarithmic or stationary phase. Cells were harvested by centrifugation
at 2000rpm for 1 minute and washed once with 20ml dFEO and once with l-3ml 26S
Binding buffer. The final pellet was resuspended in 1 ml of 26S Binding buffer and
transferred to 2ml screwcap tube. The tube was then stored on ice between each of
the following steps and all centrifugation steps were carried out at 4°C. The cells
were spun down in a microcentrifuge at 14 OOOrpm for 1 minute. The cell pellet was
resuspended in 100 |itl 26S Binding Buffer and approximately 1ml of ice-cold glass
beads (Braun). The sample was ribolysed using a Hybaid RiboLyser three times for
10 seconds at a speed of 6.5, with 2 minutes incubation on ice between each burst.
The 2ml tubes were then filled completely with 26S Binding buffer and ribolysed
once for 2-10 seconds at 6.5. The glass beads were spun down in a microcentrifuge
at 14 OOOrpm for 1 minute and the supernatant was transferred to a fresh eppendorf
tube. The cell debris was spun down by centrifuging the sample twice at 14 OOOrpm
for 30 minutes, each time removing the supernatant to a fresh tube. The final volume
of the sample was adjusted to 1ml with 26S Binding buffer. 40-60 jllL IgG
64
Sepharose beads were added to the cleared lysate, which was then incubated on a
wheel overnight at 4°C. The beads were washed twice with 26S Binding buffer and
resuspended in 26S Binding buffer.
For SDS-PAGE, the final pellet was resuspended in 40 (J.L 2x SDS sample buffer and





Glycerol 20 (v/v) %
DTT 1 mM
ATP 5 mM
Triton-XlOO 0.1 (v/v) %
The pH was adjusted to pH to 7.2 and, immediately before use, Compete™ Protease
Inhibitor Cocktail Tablets (1 tablet in 50ml) and PMSF (100 (ig/ml) were added.
2.3.2.2 TEV Protease Cleavage of Proteasomes bound to IgG Beads
As the Protein A cassette contains a TEV protease cleavage site, proteasomes were
cleaved from the IgG beads using rTEV protease (Gibco BRL) according to the
manufacturers instructions.
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2.3.3 Expression and Purification of GST-fusion Proteins in E. coli
2.3.3.11nduction of GST-fusion protein Expression
Expression of recombinant proteins was carried out in the BL21 pLysS strain:
pLysS:F', ompT, hsdSb (re-, me-), dcm, gal, pLysS, Cmr
The cDNA for the gene of interest was subcloned into the appropriate expression
vector: pGEX-KG (GST tag) (Guan and Dixon, 1991) and pQE or pET (6 His tag)
(supplier). This plasmid was then transformed into BL21 pLysS. Cells were plated
on LB AC (LB containing 50|ig/ml ampicillin and 68|ig/ml chloramphenicol).
An overnight culture of the strain was grown in 20ml LB AC at 37°C. This was used
to inoculate a 400ml culture, which was grown at 20-25°C until an OD600 of 0.4-0.8
was reached. A 1ml sample was then taken as a negative control for non-induced
cells. Expression of the recombinant protein was induced by the addition of 0.5mM
IPTG. The cultures were then grown for a further 3-3.5h at 20-25°C and then a 1ml
sample was taken to check for induction. The 1ml cell samples taken before and
after induction were spun down and the negative control sample was resuspended in
250pl Cracking Buffer and the induced sample in 500|il Cracking Buffer, to allow
for the increase in cell number during induction. A 1 OjllI sample of each was run on a







50jll1 P-mercaptoethanol was added to 950jlx1 cracking buffer before use.
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2.3.3.2 Purification of Recombinant GST Fusion Proteins
The 400ml induced culture was spun down at 5000rpm for 10 minutes. The cell
pellet was resuspended in 20ml GST Binding Buffer containing protease inhibitors,
frozen on dry ice and stored at -20°C. The samples were defrosted at room
temperature and kept on ice during the following purification stages. The cell
suspension was sonicated three times for 10 seconds at power 18-20 and then mixed
on a roller for 1 h at 4°C. The insoluble proteins were spun out by centrifugation at
12500rpm for 30 minutes at 4°C. The supernatant was removed to a fresh tube and
incubated with 400|al TBS washed Glutathione Sepharose™ 4B (Amersham) on a
roller at 4°C for lh.
The samples were centrifuged at 3000rpm for 5 minutes, the supernatant was
removed and the Glutathione Sepharose beads resuspended in 2ml GST Binding
Buffer with protease inhibitors. To confirm that the recombinant protein had been
purified, 5|al of the beads were added to 5|il SDS Loading Buffer and analysed by
SDS-PAGE and Coomassie staining.
2.3.3.3 Thrombin Cleavage of Recombinant GST-Fusion Proteins
A sample of recombinant protein bound to Glutathione Sepharose beads was washed
four times in GST Binding buffer to remove the protease inhibitors. The beads were
then resuspended in 400|il GST binding buffer containing 20 units of Thrombin
Protease (Amersham) and incubated on a wheel overnight at room temperature. The
beads were spun out and the supernatant containing the cleaved recombinant protein







Immediately before use, Complete™ Protease Inhibitor Cocktail Tablets (1 tablet in
50ml) and PMSF (100 pg/ml) were added.
2.3.4 SDS-PAGE Protein Analysis
2.3.4.1 SDS-PAGE
Proteins were separated under denaturing conditions using discontinuous gels
(Laemmli, 1970). The BioRad Mini-Protean II dual slab cell apparatus for miniature
polyacrylamide gels was used to pour the gels.
The lower resolving gel solution was poured first, leaving about 2cm empty at the
top of the apparatus. This was then overlayed with H2O and left for 30 minutes to
polymerise. The H2O was removed and the remaining space filled with the upper
stacking gel solution. A comb was immediately inserted into the upper gel and the
acrylamide was left for 30 minutes to polymerise. The polymerised gel was then
fitted into the buffer tank, which was filled with Tris-Glycine buffer.
Before loading the protein samples were denatured by boiling for 2-5 minutes in
SDS-Loading Buffer. The samples were loaded onto the gel and 7(0.1 Prestained
Protein Marker Broad Range (New England Biolabs) was run for molecular weight
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size markers. Gels were run for 45-60 minutes at 200V. Following electrophoresis,
gels were removed for staining or Western blotting.
Resolving Gel Monomer Solutions
12% 15%
1.5M Tris.Cl pH8.8 2.5ml 2.5ml
10% sds 0.1ml 0.1ml
30/0.8% Acrylamide 4.0ml 5.0ml
h2o 3.35ml 2.25ml
Immediately before pouring, lOOfil 10% APS and 1 OjllI TEMED were added to the
solution.
Stacking Gel Monomer Solution
4%




Immediately before pouring, 100|al 10% APS and lOjil TEMED were added to the
solution.









0.2 % Bromophenol blue
20% Glycerol
2.3.4.2 Coomassie Staining
Coomassie staining of SDS-PAGE gels was routinely carried out using Biosafe™
Coomassie Stain II (BioRad) or GelCode® Blue Stain Reagent (Pierce) according to
the manufacturer's instructions. Stained gels were dried onto 3MM Whatman paper
using a vacuum drier at 80°C.
2.3.5 Western Blot Analysis
2.3.5.1Transfer
Western blots were routinely carried out using the Millipore Graphite Electroblotter
System Type II apparatus. Seven sheets of Whatman 3MM paper, a sheet of
nitrocellulose membrane and the SDS-PAGE gel containing the proteins to be blotted
were soaked in Cathode buffer. They were then assembled in the following order
from negative to positive: three sheets of Whatman 3MM paper, nitrocellulose
membrane, SDS-PAGE gel, four sheets of Whatman paper. A current of 25mA/cm






For analysis of high molecular weight Ubiquitin conjugates gels were blotted using
cathode buffer containing 10% methanol and a current of 40mA/cm .
2.3.5.2 Probing and Developing of Western Blots
Ponceau Stain was used to visualize proteins on nitrocellulose following Western
blotting.
Blots for Western analysis were blocked by immersion in a blocking solution of 5%
Sainsbury's dried skimmed Milk powder in PBST for lh.
The filter was incubated in the antibody at 4°C or room temperature, overnight, with
agitation in a tube containing the primary antibody diluted in blocking solution. To
remover the primary antibody, the filter was washed three times for 10 minutes in
TBST. The secondary horseradish peroxidase (HRP) conjugated antibody was then
diluted in TBST and the filter was incubated with this solution for lh at 4°C or room
temperature. The filter was again washed three times for 10 minutes in TBST. The
filter was developed using the ECL+ Plus Western Blotting Detection System
(Amersham Pharmacia Biotech AB) according to the manufacturer's instructions.
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2.4 Biochemical Assays
2.4.1 In vitro Binding Assays
To prepare the extract for in vitro binding assays, the desired protein was expressed
in E. coli as described (section 2.3.3). The pellet from 400ml of cells was
resuspended in 10ml GST binding buffer containing protease inhibitors, frozen on
dry ice and stored at -20°C. The samples were defrosted at room temperature and
kept on ice during the following purification stages. The cell suspension was
sonicated three times for 10 seconds at power 18-20 and then mixed on a roller for
lh at 4°C. The insoluble proteins were spun out by centrifugation at 12500rpm for
30 minutes at 4°C. The extracts were then filtered through a 0.22 |om filter and
stored in 1 ml aliquots at -20°C. One aliquot was used for each binding assay.
Protein concentration of the extracts varied between 10 and 50 mg/ml depending on
the expression level of the protein.
For each assay, 0.5 ml of the cleared extract were mixed with 2-30 fj.1 of beads bound
to GST or GST fusion protein. The relative amount of each protein bound to the
beads was assessed by Coomassie stain, and the beads volume adjusted to ensure
equal amounts of each protein were used. The extract was then incubated with the
beads for 2-16 hours at 4°C. The bead volumes were made up to 30|ol to make them
clearly visible during washes. The beads were washed 5 times in GST binding buffer
and resuspended in 30)0.1 2xSDS sample buffer. 5-10|ol of the samples were separated
by 12 % SDS PAGE and subjected to Western blot analysis.
For in vitro binding assays using total S. pombe protein, extract was prepared from
20ml cells as described in section 2.3.1. The binding assay was then carried out with
beads bound to GST or GST fusion proteins as for binding assays using E. coli
extract.
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2.4.2 Assays for DUB Activity
2.4.2.1 Ubiquitin Hydrolase Assay
Ubiquitin hydrolase peptidase activity was assayed using the fluorogenic substrate
Ubiquitin-AMC (Ubiquitin-7-amino-4-methylcoumarin) (Affiniti Research Products
Ltd). This substrate is ubiquitin fused to an AMC. The release of the fluorescent
AMC from the ubiquitin can be measured using Luminescence Spectrometer LS30
(Perkin Elmer) with 360nm excitation and 460nm emission wavelengths.
For assays with recombinant GST-fusion proteins, the proteins were prepared as
described in section 2.3.3. A sample of each of the proteins was analysed by SDS-
PAGE and Coomassie staining in order to determine the relative amount of each
protein. The volume of beads used in the assay was then adjusted to ensure equal
amounts of each protein were used. Assays using purified 26S proteasomes were
carried out using proteasomes that were either bound to IgG beads or in solution, cut
from the beads using TEV protease. The amount of 26S in was assessed using either
a Western blot or a Coomassie stained SDS-PAGE gel.
2.4.2.2 Tetraubiquitin Cleavage Assay
To assay ubiquitin isopeptidase activity proteins were expressed as GST fusions in E.
coli and extracts were prepared as described in section 2.3.3. 10|il of the extract was
then incubated with l(ig Tetraubiquitin (Affiniti Research Products Ltd), in a total
volume of 20ffr of GST binding buffer, at 30°C, overnight. Cleavage of




2.5.1 Antibodies used in this study
Each of the antibodies used in this study is listed in Table 2.1, together with its
conjugate, source and concentration used for Western and cytological analysis.
2.5.2 Affinity Purification of Antibodies
A 10% SDS-PAGE gel was run with all the wells containing the protein to which the
antibody was made. The gel was western blotted and the filter Ponceau S stained
and the protein strip was cut out. This strip was then blocked in PBS containing
0.1% Tween-20 (PBST) and 5% Sainsburys Dried Skimmed Milk Powder. The filter
was cut into tiny pieces using a scalpel and transferred to an eppendorf tube
containing 800pl TBS and 200gll of the antisera. This was incubated for 3h to
overnight on a wheel at room temperature. The supernatant was then removed and
the filter rinsed three times in PBST. The supernatant was removed and the filter
was washed three times in PBST with incubation on a wheel for 30 minutes for the
first wash and for 10 minutes for each of the final two washes.
The filter was then incubated with 200|il 200mM Glycine pH2.5 containing 1.1%
BSA for 20 minutes on a wheel. The supernatant was removed and transferred to a
fresh tube. The filter was incubated twice with 50|il Glycine/BSA on a wheel for 10
minutes and the supernatants added to the original 200|il. The supernatant was
neutralised to approximately pH 7.0 by the addition of up to 30jil 1M Tris, with the
pH tested by spotting onto pH paper. The filters were stored in TBST containing
0.02% Sodium Azide for reuse several times. The neutralised supernatant was
dialysed using a 0.025|Lim filter in a petri dish containing PBS. The antibody was
then used for Western blotting and immunofluorescence.
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Anti-Mts4 in house 1:1000 1:100
Anti-Uch2 in house 1:1000 1:100
Anti-Uch3 in house 1:2000 1:100
Anti-HA in house 1:100
Anti-Mts3 in house 1:1000
Anti-Ubiquitin Dako Ltd UK 1:2000
Anti-Sheep Alexa Fluor 488 Molecular
Probes
1:10 000
Anti-Sheep Alexa Fluor 594 Molecular
Probes
1:10 000
Anti-Mouse Alexa Fluor 488 Molecular
Probes
1:10 000
Anti-Mouse Alexa Fluor 594 Molecular
Probes
1:10 000
Anti-Rabbit Alexa Fluor 488 Molecular
Probes
1:10 000

















Table 2.1: Antibodies Used in this Study
Each of the antibodies used in this study is listed, together with its conjugate, source
and concentration used for Western and cytological analysis.
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Chapter 3 Uch2 and Ubp6 are Associated with the 26S
Proteasome
3.11ntroduction
The DUBs are a large family of conserved proteins with 18 putative members in the
S. pombe genome (C. Semple and M. Stone, unpublished). Studies in S. cerevisiae,
where 19 DUBs have been identified, show that there is a high level of redundancy
within the family. Deletion strains were created for 17 of the DUBs; however, it was
found that none was essential for cell viability. These mutants were then crossed, but
in the resulting double mutants no synthetic enhancement of the single mutant
phenotypes was observed. Indeed, when up to five DUBs were deleted in one strain,
the cells remained viable (Amerik et al., 2000). This result was surprising as DUB
activity is presumed to be essential for editing ubiquitin precursors and recycling
ubiquitin.
Although there appears to be a high level of redundancy amongst the DUBs, the fact
that they form such a large family suggests that specificity is likely to exist. One aim
of this study was to consider the hypothesis that the specificity of the DUBs may be
determined by their cellular location. DUB activity is required to remove
multiubiquitin chains from 26S proteasome substrates prior to degradation and to
recycle ubiquitin from multiubiquitin chains for reuse. Therefore, it seems likely that
a subset of redundant DUBs may be localised at the proteasome to perform these
functions. In S. pombe, Uch2 and Ubp6 were identified as candidates for proteasome
associated DUBs.
Uch2 was recently identified in S. pombe as a Ubiquitin C-terminal Hydrolase due to
its homology to mouse UCH-L5. The Uch2 protein was tagged with GFP and
fluorescence microscopy revealed that it was localised in a punctate pattern at the
nuclear periphery (Li et al., 2000). The localisation was proposed to reflect a
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proteasome-like location for Uch2, as several subunits of the S. pombe proteasome
have previously been shown to localise in this manner (Li et ah, 2000; Wilkinson et
al., 1998; Wilkinson, et al 2000). As the localisation studies suggested that Uch2
might be proteasome associated, fractions from glycerol gradient centrifugation were
analysed. This demonstrated that Uch2 cofractionated with 26S proteasome
subunits, providing further evidence of its association with the proteasome. This
association was shown to be mediated by the C terminus of Uch2, which contains
KEKE motifs that may function in protein-protein interactions with large protein
complexes including the proteasome (Li et al., 2000).
Ubp6 was the second protein to be identified as a potential proteasome-interacting
DUB. It is a member of the UBP family and was identified in a sequence homology
search for proteins in S. pombe that contain a UBL domain (C. Semple and C.
Gordon, unpublished). The UBL domain was first shown to mediate an interaction
with the proteasome in the S. cerevisiae protein, Rad23 (Schauber et al., 1998). Its
homologue in S. pombe, Rhp23, and the Dphl protein have both been shown to
associate with the proteasome via UBL domains (Wilkinson et al., 2001). It was
therefore proposed that Ubp6 might associate with the 26S proteasome via its UBL
domain.
This chapter describes experiments to verify the proteasome association of Uch2 and
to establish Ubp6 as a proteasome-associated DUB. This was carried out using two
approaches: biochemically by copurification and in vivo by immunofluorescence.
Firstly, in order to facilitate these studies, antibodies were produced to Uch2 and
Ubp6. Association with the proteasome was then investigated using affinity purified,
tagged 26S proteasomes, followed by Western blot analysis to determine whether
Uch2 and Ubp6 were present. To examine the proteasome-association in vivo,
immunofluorescence microscopy was used to confirm the Uch2 localisation observed
by GFP, to determine the Ubp6 localisation and to ascertain whether Uch2 and Ubp6
colocalise with the proteasome.
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3.2 Association of Uch2 with the 26S Proteasome
3.2.1 Antibodies to Uch2
Antibodies to Uch2 were made in order to facilitate experiments to determine
whether Uch2 could coimmunoprecipitate and colocalise with the proteasome.
To obtain Uch2 protein to raise an antibody, Uch2 was overexpressed in E. coli as a
recombinant GST-fusion. Uch2 was first subcloned into the pGEX-KG expression
vector and the resulting plasmid was transformed into BL21 pLysS cells. Expression
of the GST-Uch2 fusion was induced by the addition of IPTG. Samples were taken
before and after induction and analysed by SDS-PAGE and Coomassie staining.
This showed expression of a protein of 60kD, the expected size for the fusion protein
(Figure 3.1A). The GST-Uch2 protein was purified using glutathione sepharose
beads and Uch2 was cleaved from the GST tag using thrombin. The purified and
cleaved proteins were observed by SDS-PAGE and Coomassie staining and were
found to be 60kD and 34kD as expected (Figure 3. IB). The amount of purified Uch2
protein was determined using the BioRad Protein Assay. For production of the
antibody, 700jig of protein was used. The antibody was raised in rabbit, by
Diagnostics Scotland.
Before use, the Uch2 antibody was affinity purified using GST-Uch2 bound to
nitrocellulose membrane. Three bleeds of the anti-Uch2 serum were supplied, and
the terminal bleed was used, as it was likely this would contain the highest titre of
anti-Uch2 antibodies. To test that the antibody was specific, a Western blot was
prepared using total protein extracts from S. pombe wild type and uch2 deletion
strains (see section 4.2). The blot was probed using the affinity purified terminal
bleed anti-Uch2 with anti-Mts4 as a loading control. A band of 34kD, the predicted
size for Uch2, was observed in the wild type extract, but was absent in the uch2E
extract (Figure 3.2). This showed that the antibody was able to detect Uch2 and was
specific for Uch2.
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Figure 3.1: Expression and Purification of Uch2
A. GST-Uch2 expression from the pGEX-KG plasmid was induced by IPTG. SDS-
PAGE and Coomassie staining of samples taken before (-) and after (+) induction
show the expression of GST-Uch2.
B. SDS-PAGE and Coomassie staining shows that GST-Uch2 was purified by
binding to glutathione sepharose (GST-Uch2). Uch2 protein was cleaved from the












Figure 3.2: Anti-Uch2 is Specific for Uch2
Western blot analysis using anti-Uch2 on total protein extract from wild type (wt)
and uch2 deletion (Auch2) strains. A band of 34kD is detected in the wild type
extract only, indicating that the anti-Uch2 antibody is specific for Uch2. Anti-Mts4
was used as a loading control.
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3.2.2 Proteasome Association of Uch2 by Copurification
3.2.2.1 Affinity Purification of the 26S Proteasome
In order to determine whether Uch2 was proteasome associated, the first approach
used was to purify the 26S proteasome and to examine whether this proteins was
present in the purified complex. Purification of the 26S proteasome was carried out
using a strain tagged at the pusl+ genomic locus with a Protein A (PA) tag
containing a TEV cleavage site. This tag allows efficient immunoprecipitation of the
proteasome using IgG sepharose. The resulting proteasomes can be observed by
SDS-PAGE followed by Coomassie staining; the larger 19S subunits and smaller
20S subunits can be seen clearly (Figure 3.3A). The purified proteasomes were
released from the IgG sepharose using TEV protease, which cleaves between the PA
tag and the Pusl protein. Removal of the protein A tag is useful prior to Western
blot analysis; protein A is detected by any antibody, resulting in the appearance of a
band which may obscure the protein of interest. In addition, release of the
proteasomes into solution allows for easier quantification using the BioRad Protein
Assay. The presence of proteasomes was confirmed by Western blotting of the SDS-
PAGE gel and staining with Ponceau stain. Further Western blot analysis confirmed
the presence of the known subunits Mts4 and Mts3 (Figure 3.3B).
3.2.2.2 Uch2 copurifies with the 26S proteasome
26S proteasomes purified using the pusl:PA strain were run on a SDS-PAGE gel and
Western blotted. The membrane was Ponceau stained to confirm the presence of
proteasomes (data not shown) and then probed using anti-Uch2 and an anti-Mts4
loading control. The blot shows that Uch2 is present in the purified proteasomes as a
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Figure 3.3: Purification of the 26S Proteasome
A. Coomassie stained SDS-PAGE of the 26S proteasome purified from a pus 1: PA
tagged strain using IgG sepharose.
B. Western blot of purified 26S proteasome bound to IgG sepharose confirms the
presence of Mts3 and Mts4. The PA tagged Pusl subunit is also detected, as
indicated by the arrow. Treatment of the IgG sepharose bound proteasomes with
TEV protease cleaves between the PA tag and Pusl, releasing proteasomes into
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Figure 3.4: Uch2 is Present in Purified 26S Proteasomes
Western blot analysis using anti-Uch2 reveals the presence of Uch2 in purified
proteasomes from a pusl:PA tagged strain (+) but not in a control
immunoprecipitation using an untagged strain (-). Anti-Mts4 was used to indicate
the presence of proteasomes.
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3.2.3 Localisation of Uch2
Uch2 had previously been tagged with GFP and observed to localise in a punctate
pattern at the nuclear periphery, in a manner reminiscent of that seen for 26S
proteasome subunits. In order to determine whether this localisation pattern reflected
a colocalisation of Uch2 with the proteasome, immunofluorescence microscopy was
performed.
Cells tagged at the endogenous padl+ locus with HA were fixed in paraformaldehyde
for 10, 20 and 30 minutes at 25°C. Each sample of cells was then stained with anti-
Uch2 and an Alexa Fluor 594 anti-rabbit secondary antibody. In addition, DAPI was
used to stain the nuclear DNA. Microscopic analysis showed that Uch2 was
localised at the nuclear periphery, with the clearest signal obtained using cells fixed
for 10 minutes. The confirmed the localisation that had been observed for GFP-
Uch2.
The same cells were then stained using anti-HA and an Alexa Fluor 488 anti-mouse
secondary antibody to detect Padl :HA. Microscopic analysis revealed that the Uch2
and Padl:HA proteins localised at the nuclear periphery with punctate staining
(Figure 3.5). When the red anti-Uch2 signal and the green anti-HA signal were
merged, yellow overlapping signal was observed (Figure 3.5). Therefore, it was
clear that Uch2 was colocalising with the 26S proteasome at the nuclear periphery.
These results showed that the GFP localisation previously observed for Uch2 was the
same as that of the endogenous protein, and suggested that Uch2 is closely associated
with the proteasome, possibly as a subunit of the proteasome.
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Merged
Figure 3.5: Cellular Localisation of Uch2
Immunofluorescence microscopy of paraformaldehyde fixed padl:HA cells using
anti-Uch2 and anti-HA shows that Uch2 and Padl localise in a punctate pattern at the
nuclear periphery. DAPI staining was used to detect the nucleus. The merged Uch2
and padl:HA signals reveal that Uch2 and Padl colocalise.
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3.3 Association of Ubp6 with the 26S Proteasome
3.3.1 Antibody to Ubp6
For examining the association of Ubp6 with the proteasome, an anti-Ubp6 antibody
was made as for anti-Uch2, except that it was raised in sheep. Expression and
purification were assessed by Coomassie stained SDS-PAGE gels (Figure 3.6).
The terminal bleed of the Ubp6 antibody was affinity purified using GST-Ubp6
bound to nitrocellulose membrane. Western blot analysis was used to test the
specificity of the antibody using total protein extracts from a wild type strain and a
ubptt deletion strain (see section 4.3). The blot was probed using the affinity
purified terminal bleed anti-Ubp6 with anti-Mts4 as a loading control. A doublet at
about 52kD, the predicted size for Ubp6, was observed only in the wild type extract
(Figure 3.7). This showed that the antibody was able to specifically detect Ubp6.
3.3.2 Ubp6 copurifies with the 26S proteasome
To determine whether Ubp6 could associate with the 26S proteasome, the pusl:?A
strain was used to purify proteasomes. The purified proteasomes were run on a SDS-
PAGE gel and Western blotted. To confirm the presence of proteasomes, the
membrane was stained using Ponceau Stain (data not shown). It was then probed
using anti-Ubp6 and anti-Mts4 to confirm the presence of proteasomes and as a
loading control. The blot shows that Ubp6 is present in the purified proteasomes as a






Figure 3.6: Expression and Purification of Ubp6
A. GST-Ubp6 expression from the pGEX-KG plasmid was induced by IPTG. SDS-
PAGE and Coomassie staining of samples taken before (-) and after (+) induction
show the expression ofGST-Ubp6.
B. GST-Uch2 was purified by binding to glutathione sepharose (GST-Ubp6). Ubp6













Figure 3.7: Anti-Ubp6 is specific for Ubp6
Western blot analysis using anti-Ubp6 on total protein extract from wild type (wt)
and ubp6 deletion (Aubp6) strains. A band of 52kD is detected in the wild type
extract only, indicating that the anti-Ubp6 antibody is specific for Ubp6. Anti-Mts4





Figure 3.8: Ubp6 is Present in Purified 26S Proteasomes
Western blot analysis using anti-Ubp6 reveals the presence of Ubp6 in purified
proteasomes from a pusl:PA tagged strain (+) but not in a control
immunoprecipitation using an untagged strain (-). Anti-Mts4 was used to indicate
the presence of proteasomes.
89
3.3.3 Localisation of Ubp6
As Ubp6 had been detected in the 26S proteasome pulldown, it was then important to
show that this was reflected in its cellular localisation. Immunofluorescence
microscopy was used to determine whether Ubp6 could associate with the 26S
proteasome in vivo.
Wild type cells were paraformaldehyde fixed for 10, 20 and 30 minutes at 25°C. A
sample of cells from each time point was stained with anti-Ubp6 and an Alexa Fluor
594 anti-sheep antibody. The cells were observed under a microscope and the
clearest signal was obtained using the cells fixed for 30 minutes. The red signal
indicating Ubp6 was seen as a punctate pattern at the nuclear periphery. This
indicated that Ubp6 localised in a proteasome-like pattern.
Cells stained for Ubp6 were washed and stained using antibodies to the proteasome
subunit Mts4 and Alexa Fluor 488 anti-rabbit secondary antibody. In addition, DAPI
was used to stain the nuclear DNA. Microscopic analysis revealed that both Ubp6
and Mts4 proteins localised at the nuclear periphery with punctate staining. When
the red Ubp6 and green Mts4 signals were merged they were found to overlap,
indicated by the appearance of yellow patches of signal (Figure 3.9). Therefore,
Ubp6 colocalises with the 26S proteasome at the nuclear periphery.
3.3.4 Interaction of Ubp6 and the 26S Proteasome
3.3.4.1 Ubp6 Associates with the Proteasome via its UBL domain
Ubp6 was first identified as a candidate for a proteasome associated DUB due to the
presence of a UBL domain at its N terminus. Other proteins containing the UBL




Figure 3.9: Cellular Localisation of Ubp6
Immunofluorescence microscopy of paraformaldehyde fixed wild type cells using
anti-Ubp6 and anti-Mts4 shows that Ubp6 and Mts4 localise in a punctate pattern at
the nuclear periphery. DAPI staining was used to detect the nucleus. The merged
Ubp6 and Mts4 signals reveal that Ubp6 and Mts4 colocalise.
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this domain. Experiments were therefore undertaken to determine whether the UBL
domain ofUbp6 was mediating its interaction with the proteasome.
Firstly, two truncations of Ubp6 were created in the pGEX-KG plasmid to allow
their expression in E. coli. The first truncation, NA1, removed the 76 N-terminal
amino acids that make up the UBL domain and the second truncation, CA1, consisted
of only the UBL domain (Figure 3.10A). GST-Ubp6, GST-Ubp6NAl, GST-
Ubp6CAl and GST were expressed in E. coli and bound to glutathione sepharose
beads. The amount of each protein bound to the beads was determined using a
Coomassie stained SDS-PAGE gel and the volume of beads was adjusted to give an
equal amount of protein in each assay (Figure 3.1 OB). These beads were then used to
carry out in vitro binding assays using wild type total S. pombe protein extract.
A sample of each pulldown assay was analysed by SDS-PAGE followed by Western
blotting. To detect the presence of proteasomes bound to the GST fusion proteins,
the membrane from the Western blot was divided into two and the high molecular
weight half probed using anti-Mts4 and the lower molecular weight half using anti-
Mts2 (Figure 3.IOC).
Mts4 and Mts2 proteins were detected in the GST-Ubp6 and GST-Ubp6CAl
pulldowns indicating that full length Ubp6 and the UBL domain of Ubp6 are able to
bind the proteasome in vitro. Neither proteasome subunit was detected in the
pulldowns with GST-Ubp6NAl, which lacks the UBL domain, and the GST negative
control. Therefore, this demonstrates that Ubp6 binds the proteasome in vitro and
that its UBL domain is both necessary and sufficient for this interaction.
3.3.4.2 Ubp6 has a direct physical interaction with Mts4
In order to determine whether the association of Ubp6 and the proteasome is the



















































Figure 3.10: The UBL Domain of Ubp6 Binds to the 26S Proteasome
A. Truncations of Ubp6 were constructed to delete the UBL domain (Ubp6NAl) or
to include only the UBL domain (Ubp6CAl).
B. A Coomassie stained SDS-PAGE gel shows that equal amounts of GST-Ubp6,
GST-Ubp6NAl, GST-Ubp6CAl and the control GST were used in in vitro pull¬
down assays.
C. GST-Ubp6, GST-Ubp6NAl, GST-Ubp6CAl and GST were assayed for their
ability to bind the 26S proteasome from fission yeast total protein extract.
Western blot analysis of the assays using antibodies to the Mts2 and Mts4
proteasome subunits indicates that only GST-Ubp6 and GST-Ubp6CAl were able
to bind the 26S proteasome.
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carried out. As the UBL domain of Rhp23 interacts with Mts4, this was the best
candidate for the Ubp6 binding subunit. His tagged Mts4 was expressed from the
pET plasmid in E. coli and extracts were prepared. Binding assays were then carried
out using GST and GST-Ubp6 bound to glutathione sepharose beads with the Mts4
extract. A sample of each of pulldown was run on a SDS-PAGE gel and Western
blotted. The blot was then probed with anti-Mts4. Mts4 protein was detected in the
GST-Ubp6 pulldown but not the GST control pulldown (Figure 3.11). This indicates
that Ubp6 can bind directly to Mts4 in vitro (R. Hartmann-Petersen and M. Stone).
3.5 Discussion
The first aim of this study was to verify the proteasome association of two DUBs,
Uch2 and Ubp6. Antibodies were made to these proteins using recombinant proteins
expressed in E. coli. These antibodies were affinity purified and shown to be
specific for the desired protein by probing Western blots of protein extracts from
wild type and deletion strains.
Uch2 was found to coimmunoprecipitate with the 26S proteasome and to colocalise
with the known 19S subunit, Padl, in a punctate pattern at the nuclear periphery
(Penney et al., 1998; Wilkinson et al., 1998; Li et al., 2000). This reinforced
evidence from a previous study that showed that Uch2 was localised in a
proteasome-like manner and cofractionated in glycerol gradients with the 26S
proteasome. The C-terminus of Uch2 was found to be essential for this association,
which is not surprising as the N-terminus contains the catalytic domain (Li et ah,
2000). Therefore, it appears that Uch2 is a novel proteasome subunit. Recently,
during biochemical characterisation of Drosophila melanogaster 19S complexes by
2D gel electrophoresis, a homologue of Uch2, p37a, was identified. This 37kD
protein is 43% identical to Uch2 and was found to have a homologue in human
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Figure 3.11: Ubp6 Interacts Directly with Mts4
GST-Ubp6 was tested for its ability to bind Mts4 from E. coli extracts expressing
His-tagged Mts4. Western blot analysis using anti-Mts4 shows that GST-Ubp6 is
able to bind Mts4. The control GST shows no binding to Mts4.
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complex was investigated by scanning transmission electron microscopy, using
Ubiquitin aldehyde, a potent UCH inhibitor, conjugated to colloidal gold particles.
This revealed that p37a is located at the interface of the base and lid subcomplexes,
in a similar location to RpnlO. It is possible that this position allows p37a to remove
ubiquitin from proteasome substrates prior to their degradation (Holzl et al., 2000).
Ubp6 was proposed as a proteasome associated DUB because of the UBL domain
found at its N terminus. Immunoprecipitation of the proteasome in S. pombe
revealed that Ubp6 coimmunoprecipitated with the proteasome. Mass spectrometry
of whole proteasomes has since identified the S. cerevisiae homologue of Ubp6, as a
proteasome interacting protein. This interaction was confirmed by
coimmunoprecipitation of proteasome subunits with Ubp6 (Verma et al., 2000). In
support of these findings, the human homologue of Ubp6, USP14, is detected in
Superose 6 fractions containing the 26S proteasome and in immunoprecipitated
proteasomes. The activity of USP14 was proposed to be functionally coupled to
proteasome activity, as binding of an active site directed probe was increased 15 fold
when proteasome activity was inhibited (Borodovsky et al., 2001). S. pombe Ubp6
was found to have a proteasome-like localisation at the nuclear periphery and was
shown to colocalise with the Mts4 proteasome subunit (Wilkinson et al., 1998). This
makes Ubp6 the first of the proteasome-associated ubiquitin-like domain proteins
(UDPs) to be observed to colocalise with the proteasome in S. pombe, as Dphl and
Rhp23 do not show a proteasome-like localisation (C. Gordon, unpublished).
Although this may indicate that Ubp6 is more abundant at the proteasome than the
other proteasome associated UDPs, the Dphl homologue hPLIC-2 has been found to
partially colocalise with the proteasome at the cytoskeleton and in the cytosol of
differentiated human keratinocytes (Kleijnen et al., 2000). Both Dphl and Rhp23 are
proposed to shuttle between the proteasome and other cellular locations. Therefore,
it would be useful to examine fractions from glycerol gradient centrifugation to
ascertain whether free Ubp6 is present in addition to the proteasome associated form
and, if appropriate, to assess the relative amounts and activities of each form
(Wilkinson et al., 2001). Western blot analysis revealed there are two bands
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corresponding to Ubp6 in S. pombe extracts, suggesting that it may be
posttranslationally modified. The band detected in the purified proteasomes does not
appear to be a doublet, which implies that only one form associates with the
proteasome, and that the posttranslational modification may regulate the interaction
of Ubp6 with the proteasome. In order to characterise this modification, Ubp6 could
be tagged and purified from S. pombe and subjected to mass spectrometric analysis.
As phosphorylation is a major mechanism of posttranslational modification, Ubp6
could also be treated with phosphatase to determine whether phosphorylation is
responsible for the change in mobility.
Several UDPs have been found to be proteasome-associated, therefore, it was
proposed that Ubp6 would also interact with the proteasome via its UBL domain. In
pulldown experiments, GST-Ubp6 was found to bind the 26S proteasome from S.
pombe total protein extracts, as shown by the presence of Mts2 and Mts4 subunits.
Using truncated versions of Ubp6 it was demonstrated that the UBL domain is
necessary and sufficient to mediate this interaction. A similar association has been
found with the S. pombe UCPs Rhp23 and Dphl, which both interact with the
proteasome in vitro in a UBL domain dependent manner (Wilkinson et al., 2001).
The Rhp23 homologues in S. cerevisiae (Rad23) and human (HHR23-B) have also
been shown to interact with the proteasome via their UBL domains (Schauber et ah,
1998). In addition, Dphl homologues in budding yeast (Dsk2) and human (hPLIC-1
and hPLIC-2) were found to associate with the proteasome (Funakoshi et ah, 2002;
Walters et ah, 2002). Mutation of three potential proteasome interacting sites of the
UBL domain of hPLIC-2, was found to abolish binding (Walters et ah, 2002).
Another UDP which has also been reported to interact with the proteasome is BAG-
1, a Hsp70 regulator (Luders et ah, 2000). Therefore, the UBL domain may have a
general function in targeting of proteins to the proteasome. In the case of Rhp23, the
role of the UBL domain in mediating the interaction with the proteasome has been
demonstrated to have functional significance for its roles in the DNA repair response
pathway and in the recognition and targetting of proteasome substrates. A truncated
form of Rhp23 that lacks the UBL domain is unable to rescue the growth defect of a
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puslrhp23 double mutant and deletion of the UBL domain of S. cerevisiae Rad23
results in sensitivity to UV (Watkins et al., 1993; Wilkinson et ah, 2001). Further
experiments will elucidate the significance of the UBL domain for the function of
Ubp6.
As Ubp6 was proved to be proteasome associated, it was of interest to determine
whether this reflected a direct physical interaction with a proteasome subunit. GST
pulldown experiments were able to show that Ubp6 could bind to the Mts4 subunit,
an interaction that was predicted as Rhp23 had previously been shown to bind to
Mts4 (R. Hartmann-Petersen and M. Seeger, unpublished). In the case of Rhp23, the
UBL domain was found to mediate the interaction with Mts4, therefore, future
experiments will use the Ubp6 truncations to examine whether the UBL domain of
Ubp6 interacts with Mts4 (R. Hartmann-Petersen and M. Seeger, unpublished). The
region of Mts4 that interacts with the UBL domain of Rhp23 has been narrowed
down by the use of truncated forms ofMts4 in in vitro binding assays (R. Hartmann-
Petersen and M. Seeger, unpublished). Sequence homology analysis has identified a
putative domain, named the UBL-Binding Sequence (UBS) in the region of Mts4
that interacts with Rhp23. The UBS is found only in the Mts4 proteasome subunit in
S. pombe, between residues 180-352. Significantly, the UBS is highly conserved
amongst Mts4 homologues from a number of species, indicating that it is likely to be
a true, functional domain (M. Taylor and C. Gordon, unpublished). It will be
important to determine whether the UBL domains of Ubp6 and Dphl also bind to
this domain and whether there is competition between the UBL proteins for binding
to the proteasome.
In summary, biochemical and cytological analysis has revealed that Uch2 and Ubp6
are proteasome associated DUBs. Other DUBs have previously been suggested to be
associated with the proteasome, such as the S. cerevisiae Doa4 and Aplysia ApUbp
(Hegde et al., 1997; Papa et al., 1999). However, Doa4 is not conserved in any other
system that has been studied, and no homologue of ApUbp has been found in
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purified 26S proteasomes from other species (Voges et al., 1999; Verma et al., 2000).
Therefore, it is significant that both Uch2 and Ubp6 are highly conserved proteins as
this suggests that they may act as proteasome associated DUBS in pathways that are
conserved from yeast to humans (Wyndham et al., 1999; Li et al., 2000). The
discovery ofDUBs localised at the proteasome is in keeping with emerging data that
components of the ubiquitin pathway may be associated with the proteasome. Two
studies in S. cerevisiae have found that E3s are able to interact with the proteasome:
Ubrlp and Ufd4 were both shown to interact directly with proteasome subunits and
several SCF components were identified when purified proteasomes were analysed
by mass spectrometry (Verma et al., 2000; Xie and Varshavsky, 2000). The
proteasome has also been demonstrated to have E2 activity; four S. cerevisiae E2s
have been shown to associate with the proteasome, although it is unclear whether this
reflects a direct physical interaction with proteasome subunits (Tongaonkar et al.,
2000). Therefore, it appears that the ubiquitin pathway and proteasome mediated
degradation may be more intricately coupled than was previously assumed.
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Chapter 4 Genetic Interactions of Uch2 and Ubp6
4.11ntroduction
It has been shown in S. cerevisiae that the DUBs have high level of redundancy, and
as yet no feature of the DUBs has been linked to specificity (Amerik et ah, 2000).
One aim of this study was to ascertain whether DUB specificities are determined by
cellular localisation. The first part of this study established that Uch2 and Ubp6
share a similar cellular localisation, therefore, it was proposed that they might also
share functions within the cell. In addition, the colocalisation of Uch2 and Ubp6
with the 26S proteasome suggested that they might have a role in the regulation of
ubiquitin dependent proteolysis. To investigate these hypotheses, a series of genetic
experiments were undertaken.
The first step in the genetic analysis of uch2+ and ubp6+ was to determine whether
there were conditions under which either gene was essential. Uch2 had previously
been deleted from S. pombe, with no obvious phenotype, suggesting that another
DUB may act in a redundant manner (Li et al., 2000). This chapter describes
experiments designed to address the question of whether Ubp6 provides redundant
function with Uch2. This involved construction of uch2 and ubp6 null mutants and
the uch2 ubp6 double mutant followed by examination of the mutant phenotypes to
determine whether there was any synthetic interaction that would suggest
redundancy.
Regulation of proteolysis by the 26S proteasome is one of the major functions of
ubiquitination, and it would therefore be expected that certain DUBs would have
specific functions in this pathway. In S. cerevisiae, two DUBs have been found to
show genetic interactions with proteasome mutants. The phenotypes of ubpl4
(Isopeptidase T) and doa4 mutants increase in severity when combined with
mutations in 26S proteasome subunits (Amerik et al., 1997; Papa et al., 1999). In
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this study genetic crosses were undertaken in order to investigate whether the
association of Uch2 and Ubp6 with the proteasome reflects a role in ubiquitin-
dependent proteolysis. There are several well characterised 26S proteasome mutants
available in S. pombe (see section 1.3.3) and each of these was crossed to the uch2
and ubp6 null mutants. In addition, the deletion strain for the S. pombe Ubpl4
homologue, Ubpl4, was crossed to each of the single and double mutants to examine
whether Uch2, Ubp6 and Ubpl4 share functions in the regulation of proteolysis.
4.2 Deletion of uch2f
To further examine the role ofUch2 in the cell, the uch2+ gene was deleted from S.
pombe strain carrying the following nutritional markers: leul-32, ura4-D18, his3-Dl,
arg3-D4 and ade6-210. The deletion was carried out using the PCR-based method to
insert a ura4+ gene to replace the uch21 open reading frame (Bahler et al., 1998).
PCR primers to the inserted gene and a region upstream of uch2+ were used to
confirm that the deletions were successful (Figure 4.1A). In each case the
appearance of a band in a subset of colonies that were positively selected for the
inserted marker gene indicated correct insertion of the marker gene and therefore
deletion of uch2+. The successful deletion of the uch2+ gene was supported when the
anti-Uch2 antibody was used on extracts prepared from this strain. This showed that
the Uch2 protein was absent in these uch2A extracts (figure 3.2). The uch2A strain
was streaked out at 18°C, 25°C and 36°C and was found to have no obvious
phenotype, as it grew as the wild type strain at these temperatures on minimal and
complete media. To give greater flexibility for selection when crossing to other
ura4+ deletion strains, the ura4+ inserted into uch2+ was replaced by the G418R
cassette to give a uch2::G418R strain. Colonies were selected on plates containing
geneticin and then replica plated to FOA to select for loss of the ura4+ gene. The
replacement was then confirmed using a PCR test (Figure 4.IB).
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Figure 4.1: PCR Test of uch2+ Deletion Strains
A Following transformation with the uch2+ knockout construct containing the
ura4+ gene, ura4 transformants were selected. These were then tested by colony
PCR to ensure that the ura4+ had inserted into the uch2+ locus. Lanes 1-4 show the
postive colonies and lane 5 is the control PCR reaction using a wild type strain.
B The uch2::ura44 strain was transformed with a construct to replace the ura4+
marker with a G418R cassette. Colonies that were G418R were tested by colony
PCR to confirm that the ura4v had been replaced by the G418R cassette. Lanes 1
and 2 are the positive strains and lane 3 is a wild type control.
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4.3 Deletion of ubptf
The ubp6* gene had not previously been deleted in S. pombe, so in order to
determine the function of Ubp6, the ubp6+ open reading frame was replaced using
the arg3+ gene in the leul-32 ura4-Dl8 arg3-D4 his3-Dl ade6-210. strain. The
deletion was carried out and confirmed by PCR and using the anti-Ubp6 antibody as
for uch2+ (Figure 4.2 and Figure 3.7)(Bahler et al., 1998). The ubp6 deletion strain
showed no obvious phenotype and grew as the wild type strain at 18°C, 25°C and
36°C on minimal or complete media.
4.4 uch2A ubp6A Double Mutant
As Uch2 and Ubp6 had both been shown to be proteasome associated, it was
proposed that they might have redundant functions. It was therefore predicted that
they might show a genetic interaction and that deletion of both uch2+ and ubp6^ in
the same cell would be lethal or would result in a growth defect. To test this
hypothesis, the uch2A and ubp6A strains were crossed together to create a
uch2Aubp6A double mutant strain.
The double mutant strain was isolated by tetrad analysis and was found to be viable
with no obvious phenotype. The strain was streaked out at 18°C, 25°C and 36°C but
was found to grow as the wild type strain at each temperature on both minimal and
complete media.
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Figure 4.2: PCR Test of ubp6* Deletion Strain
A Following transformation with the ubp6*~ knockout construct containing the
arg3+ gene, arg3 transformants were selected. These were then tested by colony
PCR to ensure that the arg3+ had inserted into the ubp6* locus. Lanes 1-4 show the
postive colonies and lane 5 is the control PCR reaction using a wild type strain.
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4.4 Crosses of uch2A and ubp6A with ubp14A
The deletions strains for uch2 and ubp6 were both crossed to the only other available
DUB mutant in S. pombe, ubpl4A. ubp!4+ encodes the S. pombe homolgue of
Isopeptidase T (Hadari et al., 1992; Amerik et ah, 1997; C. Semple, unpublished).
The double mutants resulting from these crosses, uch2A ubp!4A and ubp6Aubp!4A
were both viable. These two strains were then crossed to create the triple mutant
uch2A ubp6A ubp!4A, which was also viable. The double and triple mutant strains
were tested for viability at 18°C, 25°C and 36°C and were found to grow as wild
type cells at each temperature (Table 4.1).
4.5 Crosses of uch2A and ubp6A Deletion Mutants with Proteasome
SubunitMutants
uch2A and ubp6A were each crossed to mutants for several proteasome subunits:
Mtsl, Mts3, Mts4, Padl and Pusl, which are non-ATPase subunits of the 19S
regulator; Mts2, which is an ATPase subunit of the 19S regulator and Mts8, which is
a (3-subunit of the 20S core (Gordon et ah, 1993; Gordon et ah, 1996; Wilkinson et
ah, 1997; Wilkinson et ah, 2000; Penney et ah, 1998; C. Gordon, unpublished). For
each cross approximately 20 tetrads were analysed (see table 4.1 for summary). The
double mutants resulting from the uch2A crosses were all found to be viable and
showed no enhancement of the single mutant phenotypes.
Tetrad analysis revealed that ubp6A was synthetically lethal with three of the mts
mutants, mtsl-46, mts2-l and mts3-l. ubp6Amtsl-46, ubp6Amts2-l and ubp6Amts3-
1 had similar phenotypes: in some cases spores did not germinate and cells from
those that did germinate divided a maximum of three times and were therefore never
found to grow to colonies. The double mutant cells were swollen and in some cases





























Table 4.1: Crosses of the uch2A and ubp6A strains with Proteasome Mutant
Strains
The uch2A and ubp6A single mutants and the uch2A ubp6A strains were crossed to
strains containing mutations in proteasome subunits in the 19S lid, 19S base or the
20S core. SL indicates that the two mutations are synthetically lethal, x indicates that
there is no difference between the double/triple mutant and the single/double mutants
used for the cross, n indicates that the strain has not yet been constructed and -
indicates that the triple mutant cannot be made as one of the double mutants is not
viable.
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at the restrictive temperature (Gordon et al., 1993; Gordon et al., 1996; Wilkinson et
al., 1997; Penney et al., 1998).
The ubp6Amts4-3, ubp6Amts4-l 7, ubp6Apadl-l, ubp6ApuslA and ubp6Amts8A
strains were all viable and demonstrated no enhancement of the single mutant
phenotypes.
4.6 Overexpression of uch2+ and ubp6+
Overexpression of a given gene can often provide insights into its function. In order
to observe the phenotype of cells overexpressing uch2+ or ubp6+, both genes were
subcloned into the pREPl S. pombe expression vector. The pREPl-Uch2 and
pREPl-Ubp6, and empty pREPl plasmids were used to transform a wild type S.
pombe strain, and leu+ colonies were selected. Analysis of the strains overexpressing
uch2+ or ubp6* revealed that there was no effect on growth at 18°C, 25°C and 36°C.
4.7 Discussion
In order to investigate the function of the proteasome-associated DUBs, uch2 and
ubp6 null strains were constructed. As previously reported, deletion of uch2A was
not found to have any noticeable effect on cells. The ubp6A strain also grew as wild
type, which was not surprising as its S. cerevisiae homologue has been deleted and
found have no phenotype under normal growth conditions (Amerik et al., 2000). The
uch2A and ubp6A strains both grew as wild type at 20°C, 25°C and 36°C. To assess
whether Uch2 and Ubp6 have redundant functions, the two single mutant strains
were crossed to give the uch2A ubp6A double mutant. It was expected that deletion
of both proteasome-associated DUBs might have a noticeable effect, as
deubiquitination at the proteasome is presumed to be required for normal growth.
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However, the uch2Aubp6A strain grew as wild type and was not cold or temperature
sensitive. This indicates that if the deubiquitinating activity of the proteasome is
essential, there must be other DUBs that can act at the proteasome.
To further examine the cellular roles of Uch2 and Ubp6, the deletion strains uch2A
and ubp6A were crossed to a series of proteasome mutant strains (Table 4.1). If
Uch2 and Ubp6 have a function in regulating 26S proteasome-mediated proteolysis,
then it would be expected that they would show genetic interactions with these
mutants. A synthetic lethal phenotype was found for three of the resulting strains,
namely ubp6Amtsl-46, ubp6Amts2-l and ubp6Amts3-l. It was surprising that loss of
Ubp6 was only synthetically lethal with a subset of the proteasome mutants tested, as
all the proteasome mutants apart from puslA show a very similar metaphase arrest
phenotype (Gordon et al., 1993; Gordon et al., 1996; Wilkinson et al., 1997;
Wilkinson et al., 2000; Penney et ah, 1998; C. Gordon, unpublished). It appears
unlikely that these synthetic interactions are due to a physical interaction of Ubp6
with these subunits as Mts2 is found in the base of the complex and Mtsl and Mts3
in the lid (see section 1.3.2.1). Overexpression ofmts3+ has been found to rescue the
mtsl mutation and in vitro binding assays show that these two subunits interact
directly, taken together, these results suggest that Mtsl and Mts3 will interact in
vivo. However, neither Mtsl nor Mts3 has been shown to bind to Mts2 (R.
Hartmann-Petersen, G. McGurk and C. Gordon, unpublished). If these three
subunits are not clustered in the proteasome complex, it is not expected that Ubp6
would be able to interact with all of them. This evidence suggests that the synthetic
lethality is not caused by a physical interaction between Ubp6 and the proteasome.
In support of this finding, the ubp6Amts4 mutants were found to be viable despite the
fact that Ubp6 has been shown to interact directly with Mts4. If a physical
interaction is not responsible for the synthetic lethality, there must be subtle
differences between the phenotypes of the mts mutants that result in the varied
phenotypes when combined with ubp6A.
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In S. cerevisiae, two DUBs have been found to have genetic interactions with
proteasome mutants, Ubpl4 and Doa4 (Amerik et al., 1997). Deletion of UBP14
does not result in any gross growth defect at 30°C or 36°C, but does confer
sensitivity to canavanine and a strong sporulation defect. Examination of extracts
from the ubpl4 strain reveals an accumulation of ubiquitin species, most likely to be
unanchored chains. Overexpression of UBP14 was found to inhibit the degradation
of proteasome substrates in vivo. Therefore, it is possible that the role of Ubpl4 is to
maintain the balance between having sufficient preformed multiubiquitin chains for
addition to proteasome substrates and keeping multiubiquitin levels low enough to
prevent inhibition of substrate proteolysis (Amerik et al., 1997). When combined
with deletion of ubpl4, both the doa3 and doa5 20S complex proteasome mutants
become more sensitive to increased temperature. In addition, the doa3ubp!4 and
doa5ubp!4 double mutants have a dramatically increased number of unanchored
ubiquitin chains, especially tetraubiquitin. A model has been proposed where
mutation of the proteasome would lead to higher levels of ubiquitin chain release as
multiubiquitinated substrates are stalled at the proteasome. Ubpl4 would normally
process these chains, even at the increased levels, but in the absence of Ubpl4
multiubiquitin chains accumulate and inhibit proteolysis (Amerik et al., 1997)
Deletion of either S. pombe Ubp6 or S. cerevisiae Ubpl4 results in enhancement of
proteasome mutant phenotypes. For ubp6A this interaction is seen with mutants of
19S subunits. However, for ubp!4 the synthetic phenotype was seen with 20S core
subunit mutants (Amerik et al., 1997). There was no enhancement of the single
mutant phenotype of the 20S core mutant mts8 in the ubp6Amts8 double mutant.
Furthermore, neither ubp6A or uch2A showed a genetic interaction with ubp!4A.
This suggests that if Ubp6 and Uch2 are involved in the regulation of proteolysis, it
is unlikely to be via the same mechanism as Ubp 14.
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A second S. cerevisiae DUB, Doa4, has been suggested to have a role in proteolysis
by the 26S proteasome. In some cases, Doa4 appears to be associated with the
proteasome, however it is not reliably found in proteasome preparations, indicating
that this may be a weak or transient interaction (Papa et al., 1999; Voges et ah,
1999). Furthermore, in certain mutant backgrounds, Doa4 colocalises with vacuolar-
sorting pathway proteins in a late endosome-like compartment near the vacuole
(Amerik et ah, 2000a). Deletion of DOA4 also results in a pleiotropic phenotype
suggesting that it has multiple roles in vivo (Papa and Hochstrasser, 1993). Studies
so far indicate that its major functions are the regulation of proteasome-mediated
proteolysis, vacuolar proteolysis and endocytosis and that it mediates these roles by
controlling ubiquitin homeostasis (Papa and Hochstrasser, 1993; Swaminathan et ah,
1999; Papa et ah, 1999; Dupre and Haguenauer-Tsapis, 2001; Amerik et ah, 2000a).
In the doa.4 mutant, known proteasome substrates are stabilised and there is
accumulation of small, ubiquitinated species, which have been proposed to be the
remnants of ubiquitinated proteins that have been degraded by the proteasome (Papa
and Hochstrasser, 1993). When doa4 is crossed to the doa3 proteasome mutant, the
resulting double mutant is slower growing and the restrictive temperature is reduced
compared to either single mutant (Papa et ah, 1999). However, although there is
synthetic enhancement of the doa3 temperature sensitive phenotype, the
accumulation of ubiquitinated proteins seen in the doa4 single mutant is much
reduced in the double mutant. In addition, ubiquitin levels in doa4 are often reduced,
but in the doa4doa3 mutant, ubiquitin is restabilised (Papa et ah, 1999). Therefore, it
appears that the change in ubiquitin levels in doa4 cells is separate from the
proteolytic defect as the levels of ubiquitin and small ubiquitinated species are
rescued by the doa3 mutation, but its proteolytic defect is enhanced. Mutations in
the vacuolar protein-sorting pathway suppress the accumulation of 26S proteasome
substrates in doa4, suggesting that Doa4 may act to coordinate vacuolar and
proteasome mediated protein degradation. It is unclear what mechanism Doa4 uses
to carry out this function, but examination of the mutant phenotypes suggests that it
is not simply by regulating ubiquitin levels in the cell (Amerik et ah, 2000a).
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Although, Doa4 is similar to Ubp6 in that loss of either protein is synthetically lethal
with proteasome mutants, it seems unlikely that both proteins have analogous
functions as the doa4 mutant has multiple defects but the ubp6A mutant grows as
wild type (Papa and Hochstrasser, 1993). Ubp6 may have a specific role in the
regulation of 26S proteasome mediated proteolysis, whereas Doa4 may have a more
general role in processing ubiquitinated species that may affect the degradation of
proteasome substrates indirectly.
There are many possible mechanisms for the synthetic lethality of ubp6A with the
proteasome mutants. The first is that there is a direct physical interaction of Ubp6
with the proteasome subunits, but as mentioned above, the observations so far are not
in favour of this model. It could be further tested with in vitro pulldowns of
individual proteasome subunits with Ubp6 and also genetic experiments to determine
whether expression of particular domains of the proteins is able to rescue the
lethality. If a physical interaction is not responsible for the lethality, it is most likely
that a loss of deubiquitinating activity combined with loss of proteasome activity
causes the phenotype. Three ways in which this might work are discussed below.
Synthetic lethality may indicate that two proteins work in the same or related
pathways, depending on the mutant phenotypes (Guarente, 1993). One explanation
for the synthetic interaction is that both Ubp6 and the proteasome are on the same
pathway for the essential degradation of a proteasome substrate. The lethality in this
case would be due to a decrease in flow through the pathway (Figure 4.3A). If it is
assumed that the substrate must be deubiquitinated by one of several DUBs prior to
degradation, then deletion of Ubp6 alone may reduce the amount of substrate that is
deubiquitinated ready for the proteasome, but not to a level that has an observable
effect under normal growth conditions. A defect in the proteasome would reduce
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Figure 4.3: Possible Mechanisms for the Synthetic Lethality of ubp6A and mts
Mutants
A. Ubp6 and the proteasome may be in the same pathway for the essential
degradation of a substrate. Loss of Ubp6 results in a decrease in DUB activity and
therefore a decrease in substrate for the proteasome. In the mts mutant proteasome
activity is reduced. In the double mutant, flow through the pathway is too slow to
retain viability.
B. Both Ubp6 and the proteasome may act to promote release of free ubiquitin - loss
of both activities in the double mutant may result in a lethal reduction in free
ubiquitin levels.
C. Ubp6 may act to degrade chains that can inhibit the proteasome; when combined
with the proteasome defect in the mts mutant, proteasome activity is too low for
viability.
See text for a detailed explanation of each mechanism.
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However, when Ubp6 is absent and the proteasome is impaired, there is a reduced
pool of deubiquitinated substrate for the proteasome and reduced proteolysis of this
deubiquitinated substrate. This would result in accumulation of the substrate to
lethal levels. If this model is correct, then it would be expected that the ubp6A
mutant would show some stabilisation of one or more substrates and that its
phenotype would resemble a milder version of the mts phenotype. This hypothesis
could be tested by looking at the levels of multiubiquitin conjugates in the ubp6A
cells, as this might indicate a defect like that seen in proteasome mutants.
A second mechanism for the synthetic lethality is that Ubp6 and the proteasome act
in parallel pathways. One way in which this could happen is that both are involved
in generating free ubiquitin (Figure 4.3B). It may be that deubiquitination of
proteasome substrates is mediated by a different DUB rather than Ubp6 and that this
deubiquitination is tightly associated with degradation. Therefore, when proteolysis
is efficient, the release of free ubiquitin will be efficient. Ubp6 may also act to
release free ubiquitin from chains or from other ubiquitinated proteins not destined
for the proteasome. This would mean that if Ubp6 was lost and the proteasome was
compromised, that two parallel pathways for the release of ubiquitin would be
defective, resulting in a reduction in free ubiquitin to a level where cells are no
longer viable. For this model to be true, it would be expected that both the
proteasome and ubp6A mutants would have reduced ubiquitin levels and that the
phenotype could be rescued by supplementation ofubiquitin.
Finally, it is possible that Ubp6 acts in a similar manner to Ubpl4 in S. cerervisiae,
in that it acts to break down ubiquitin chains that can inhibit the proteasome (Figure
4.3C). In this case the ubp6A mutant would have a slight impairment of proteolysis
due to the accumulation of multiubiquitin chains, but this would not affect cell
viability. However, when combined with the decrease in proteasome activity seen in
the mts mutants, the inhibition by multiubiquitin chains may cause activity to drop to
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a lethal level. To test this model, the ubp6A strain could be examined to determine
whether it shows a similar chain accumulation phenotype to S. cerevisiae ubpl4.
The fact that ubp6A and ubpl4A, have no genetic interaction in S. pombe argues
against this model.
One problem with the models suggested here is that none can explain why ubp6A is
only synthetically lethal with certain proteasome mutants. Therefore, it will be
important to examine the levels of ubiquitin, multiubiquitin and ubiquitin conjugates
in the ubp6A mutant and also in the mts mutants, to detect any differences in
phenotype. It is known that proteasome mutants accumulate high molecular weight
ubiquitin conjugates so it would be interesting to investigate whether these are also
found in the ubp6A and uch2A mutants (Gordon et ah, 1993; Penney et al., 1998).
Another way in which the role of Ubp6 and Uch2 in proteasome dependent
proteolysis could be assessed would be to look at whether ubp6A and uch2A are
sensitive to canavanine, which is an arginine analogue that incorporates into proteins.
Mutations in subunits of the proteasome confer sensitivity to canavanine as the
defective proteasomes are unable to cope with the high levels of canavanine
containing proteins to be degraded (Wilkinson et ah, 2000; C. Gordon, unpublished).
Therefore, sensitivity to canavanine can provide a good indicator of a defect in
proteolysis. In S. cerevisiae and A. thaliana, several DUBs have been shown to be
required for resistance to canavanine, including the Ubp6 homologue (Amerik et ah,
2000a; Yan et ah, 2000). This provides further support for the finding that S. pombe
Ubp6 appears to be involved in proteasome mediated degradation.
One way that the involvement of Uch2 and Ubp6 in ubiquitin dependent proteolysis
could be further investigated genetically would be to look at interactions of the
uch2A and ubp6A mutants with other ubiquitin pathway mutants. This method has
proved informative in the characterisation of the Faf UBP in Drosophila. Faf is
known to be involved in the regulation of presynaptic growth at the neuromuscular
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junction (NMJ) (DiAntonio et al., 2001). The first indication that Faf functions in
ubiquitin dependent proteolysis was provided by genetic data showing that mutations
in either a proteasome subunit, or an E2 were able to suppress the faf mutant
phenotype (Huang et al., 1995; Wu et al., 1999). In addition, overexpression offaf
causes overgrowth of the NMJs, a phenotype that is similar to high-wire (hiw) loss of
function mutants. This finding was significant as hiw encodes a protein that is
though to be a ubiquitin ligase, based on its homology to known E3s (DiAntonio et
al., 2001). Following characterisation of the hiw, faf and double mutant phenotypes,
it was proposed that Faf and Hiw may act antagonistically to regulate synaptic
development by maintaining the balance between ubiquitination and deubiquitination
(DiAntonio et al., 2001). Further experiments will be required to determine whether
Faf and Hiw share a common substrate or act on separate pathways. Further genetic
analysis used a candidate gene approach to identify ubiquitinated Liquid Facets, an
epsin, as a Faf substrate (Cadavid et al., 2000). It will be thus be interesting to see
whether ubiquitination of Lqf is mediated by Hiw. These studies show that genetic
analysis using ubiquitin pathway and candidate substrate mutants can reveal
information about the pathways and mechanisms of the DUBs and could be used for
investigation ofUch2 and Ubp6 function.
Recently, the first genetic interaction between two DUBs in S. pombe was described.
The first of the UBPs, Ubpl5 (also named Ubp21) was found as a high copy
suppressor of a point mutant in the Prp4 protein kinase, which phosphorylates the
Prpl protein to control spliceosome formation (Richert et al., 2002). Prp4 protein
was shown to be stabilised by Ubpl5, suggesting that it works antagonistically to the
proteasome, perhaps by removing the multiubiquitin chain required to target it for
degradation. A second UBP, Ubp5 (or Ubp22) is very similar to Ubpl5 in sequence
and genetic analysis showed that ubpl5A and ubp5A are synthetically lethal at 20°C
and 36°C. However, the high sequence similarity between these two proteins
suggests that they may be paralogues (Richert et al., 2002).
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Although more experiments are required to clarify the situation, the finding from this
work is that uch2A and ubp6A do not show synthetic phenotypes. Therefore,
assuming that DUB activity at the proteasome is essential, these data indicate that
Uch2 and Ubp6 are not the only DUBs responsible for deubiquitination at the
proteasome. Uch2 does not yet show any indication that it is involved in proteasome
activity, a finding which is surprising as it is a subunit of the complex. Conversely,
the genetic analysis has shown that Ubp6 is likely to have a role in the regulation of
proteolysis by the 26S proteasome.
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Chapter 5 Biochemical Activities of Uch2 and Ubp6
5.11ntroduction
In order to cleave ubiquitin from a variety of different substrates the family ofDUBs
must be able to catalyze two different reactions. Firstly, there is a requirement for
ubiquitin peptidase activity, cleaving at the aNH-peptide bonds between ubiquitin
and other species, to process the ubiquitin proproteins and to cleave ubiquitin from
small adducts such as glutathione. In addition, it is necessary for DUBs to hydrolyze
the eNH-isopeptide bonds found between each ubiquitin in a multiubiquitin chain, or
between ubiquitin and other proteins which, for example, may be targeted for
degradation via the proteasome (Chung and Baek, 1999; Wilkinson, 2000).
Several assays have been developed to test the activity of the DUBs against various
ubiquitin-containing substrates. Peptidase activity may be assayed using either an
artificial substrate ofubiquitin fused to a peptide or protein sequence, such as GST or
PESTc, or alternatively by using substrates such as the polyubiquitin or ubiquitin-
ribosomal protein fusions that are the in vivo precursors of ubiquitin (Baker et al.,
1992; Park et al., 1997; Larsen et al., 1998; Wyndham et al., 1999). This activity can
also be measured in a model in vivo system where DUBs and Ubiquitin-X-p-
Galactosidase are coexpressed in E. coli (Baker et al., 1992). However, the most
sensitive and precise assay for peptidase activity of the DUBs uses Ubiquitin-AMC
(7-amino-4-methylcoumarin) as a substrate; the reaction is followed by monitoring
the fluorescence that accompanies the release of AMC from ubiquitin (Dang et al.,
1998). Isopeptidase activity is normally measured by incubating a DUB with
synthetic Lys48 linked multiubiquitin chains, which may be as short as diubiquitin
(Baker et al., 1992). Synthetic substrates comprising ubiquitin linked through an
isopeptide bond to another protein have also been tested. To investigate in vivo
activity, some studies have examined the general level of high molecular weight
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ubiquitin conjugates or the level of ubiquitin conjugates of a specific protein in DUB
mutant strains or in cells overexpressing a particular DUB (Hadari et al., 1992;
Amerik et al., 1997; Chen et al., 2002).
Members of both the UCH and UBP families have been shown to have isopeptidase
and peptidase activities. However, the majority of studies support the general trend
that UCHs prefer to cleave small leaving groups from ubiquitin and that UBPs
process fusions irrespective of their size and also have activity in disassembling
multiubiquitin chains (Wilkinson, 2000; Chung and Baek, 1999). In addition,
deubiquitinating activity has also been found in the 26S proteasome. Studies of
bovine 19S complexes lead to the identification of a deubiquitinating activity that
was capable of editing multiubiquitin chains. This activity was not sensitive to Ubal,
which specifically inhibits cysteine proteases by binding to the thiol side chain of the
active site Cys. Therefore, this deubiquitinating activity was not thought to involve a
cysteine protease (Mayer and Wilkinson, 1989; Eytan et al., 1993; Dang et al., 1998;
Johnston et al., 1999). Deubiquitinating activity was also identified in 26S
proteasome preparations from rabbit reticulocytes, which were found to be capable
of releasing free ubiquitin from conjugates or ubiquitin-protein fusions. This activity
was distinct from the previously identified isopeptidase as it was sensitive to
ubiquitin aldehyde (Ubal), suggesting that it was mediated by a cysteine protease
(Lam et al., 1997).
This chapter describes characterisation of the DUB activity of Uch2, Ubp6 and the
26S proteasome. Firstly, recombinant forms of Uch2 and Ubp6 proteins were tested
for peptidase activity against UbAMC and isopeptidase activity against Lys48 linked
tetraubiquitin. The effect of mutation of the active site Cysteine on Uch2 activity
was also analysed. The DUB activity of the S. pombe 26S proteasome was then
examined and the contribution of Uch2 and Ubp6 to this activity was investigated.
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5.2 Ubiquitin Peptidase Activity of Uch2 and Ubp6
To characterise the biochemical activities of the Uch2 and Ubp6 enzymes the first
step was to use the Ub-AMC assay for ubiquitin peptidase activity. To obtain
purified Uch2 and Ubp6 proteins they were expressed in E. coli as GST fusion
proteins and purified as described in sections 3.2.1 and 3.3.1. GST was also
expressed from the pGEX plasmid and purified in the same manner for use as a
negative control.
The amount of GST, GST-Uch2 and GST-Ubp6 protein was assessed using a
Coomassie stained SDS-PAGE gel. For the assay the amount of protein used was
enough to give a clear band on a Coomassie stained gel, which corresponded to
approximately 10|il of beads. The volume of beads for each of the bound proteins
was adjusted to ensure equal amounts of each protein were used in the assay.
The assays were set up with the GST protein bound to the sepharose beads and l|il
50pM Ub-AMC in a total volume of lOOpl GST binding buffer. A control sample
containing empty glutathione sepharose beads was also set up. The reactions were
incubated for 3h at 30°C, and then the ubiquitin hydrolase activity was measured
using a luminescence fluorimeter. The fluorescence obtained with the glutathione
sepharose only sample was used as a zero and 2-3 readings were taken for each
reaction. Each assay was performed in at least three independent experiments. The
resulting data subjected to statistical analysis allowing for the variance between
experiments (Andrew Carothers).
Using GST a background level of fluorescence was seen, however, when GST-Uch2
was used the level of fluorescence dramatically increased indicating that Uch2 has
ubiquitin peptidase activity (Figure 5.1). When GST-Ubp6 was subjected to this





Figure 5.1: Ubiquitin Peptidase Activity of GST-Uch2 and GST-Ubp6
GST-Uch2 and GST-Ubp6 were expressed in E. coli and bound to glutathione
sepharose. The proteins were then assayed for ubiquitin peptidase activity by
measuring the change in fluorescence coupled to cleavage of ubiquitin-AMC.
GST was used as a negative control to assess background fluorescence. See
text for details
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5.3 Mutation of the Uch2 Active Site Cysteine
Uch2 was predicted as a DUB due to its sequence homology to other known UCHs.
This family of proteins have homology to other well characterised families of
cysteine proteases such as papains and calpains (Rawlings and Barrett, 1994; Barrett
and Rawlings, 2001). This strongly suggested that Uch2 would have a Cys residue
in its active site and that mutation of this residue would result in loss of activity.
Based on its homology to Mouse UCH-L5 and human UCH-L3, Cys 83 was
identified as the putative active site Cys for Uch2 (Figure 1.6; Li et al., 2000). This
residue was mutated to an Ala using the Stratagene site directed mutagenesis kit.
The mutation was made such that a novel SacII restriction site was introduced
concurrently with the Cys-Ala mutation. Following mutagenesis miniprep DNA was
prepared from 12 colonies and digested with SacII. All of the plasmids cut with
SacII, indicating that the mutagenesis was likely to have been successful. Four of the
positive clones were then sequenced to ensure the presence of the Cys to Ala
mutation and the absence of any additional mutations resulting from the mutagenesis.
To determine whether mutation of the putative active site Cys would have an effect
on the activity of Uch2, the activity of the Uch2C83A protein was assayed using Ub-
AMC. The Uch2C83A protein was expressed and purified as a GST fusion protein
from the pGEX vector as described. It was found to be expressed normally at the
expected size of 34kD. The GST-Uch2C83A protein was then subjected to the
UbAMC assay using GST-Uch2 as a positive control and GST alone as a negative
control. To assess the amount of each protein purified, a sample of each protein was
run on an SDS-PAGE gel, which was then Coomassie stained. The amount of beads
used was adjusted to give an equal amount of each protein in the assay. Readings
were obtained for at least three experiments and statistical analysis was carried out as
in section 5.2 (Andrew Carothers). The activity observed with GST-Uch2 was
completely absent when GST-Uch2C83A was used, indicating a total loss of activity





Figure 5.2: Mutation of the Uch2 Active Site Cysteine Abolishes
Ubiquitin Peptidase Activity
GST-Uch2 and GST-Uch2C83A were expressed in E. coli and bound to
glutathione sepharose. The proteins were then assayed for ubiquitin
peptidase activity by measuring the change in fluorescence coupled to
cleavage of ubiquitin-AMC. GST was used as a negative control to assess
background fluorescence. See text for details.
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5.4 Ubiquitin Isopeptidase Activity of Uch2 and Ubp6
A second assay was used to determine whether Uch2 and Ubp6 were able to cleave
isopeptide bonds. In this assay, extracts from E. coli expressing GST-Uch2, GST
Ubp6 and GST as a negative control were incubated with tetraubiquitin, which is
made up of four Lys48 linked ubiquitin residues. After incubation overnight, a
sample of each reaction was run on a SDS-PAGE gel and analysed by Western blot
probed with an anti-ubiquitin antibody.
In the GST control reaction, diubiquitin and triubiquitin are present in addition to
some residual tetraubiquitin. These probably represent breakdown products that
were either contained in the original tetraubiquitin preparation or created during the
incubation or the boiling step prior to SDS-PAGE. These bands are also present in
the reactions with GST-Uch2 or GST-Ubp6 but significantly, a large band of about
8kD representing monoubiquitin also appears in these lanes (Figure 5.3). Therefore,
GST-Uch2 and GST-Ubp6 both have ubiquitin isopeptidase activity, as they are able
to hydrolyse isopeptide linked tetraubiquitin to monoubiquitin.
5.5 Ub-AMC Cleavage Activity of the 26S Proteasome
Previous studies have reported intrinsic ubiquitin hydrolase activity for the 26S
proteasome in other organisms; however, this activity has not been described in S.
pombe (Eytan et al., 1993; Lam et al., 1997). Therefore, 26S proteasomes were
purified from thepusl\PA tagged strain as described in section 3.2.2.1 and examined
for ubiquitin peptidase activity using the Ub-AMC assay. Purified proteasomes were
run on a SDS-PAGE gel and the presence of proteasomes was confirmed by
Coomassie staining. Assays were carried out on wild type 26S proteasomes, data
was collected for three independent experiments and statistical analysis was






Figure 5.3: Ubiquitin Isopeptidase Activity of Uch2 and Ubp6
Extract from E. coli expressing GST, GST-Uch2 or GST-Ubp6 was incubated
with tetraubiquitin. The samples were then analysed by SDS-PAGE and Western
blot, using an anti-ubiquitin antibody. Monoubiquitin is only released when
GST-Uch2 or GST-Ubp6 is present, indicating that both proteins can act as
ubiquitin isopeptidases.
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background level (Andrew Carothers). The 26S proteasomes showed significant
activity in this ubiquitin peptidase assay, indicating that the activity observed in
proteasomes from other organisms is present in S. pombe (Figure 5.4).
5.6 Uch2 Provides the Ubiquitin Hydrolase Activity of the 26S
Proteasome
Having established that the 26S proteasome has ubiquitin hydrolase activity, it was
of interest to determine whether this activity could be assigned to either of the
proteasome associated DUBs, Uch2 or Ubp6. In order to answer this question, it was
necessary to obtain proteasomes that were lacking Uch2 and Ubp6. To purify
proteasomes from the uch2 and ubp6 single mutants and the uch2ubp6 double
mutant, the pusl:PA strain was crossed to each of the DUB mutants and tetrad
analysis was carried out. The presence of the uch2 or ubp6 deletions was indicated
by the auxotrophic markers used for the deletions and pusl:PA was detected by PCR.
Proteasomes were then purified from each of the mutant strains as described. The
amount of proteasome purified from each strain was assessed either by Coomassie
stained SDS-PAGE gel or by Western blot analysis. An equal amount of
proteasomes from each of the mutant strains as well as the wild type strain were then
assayed for their ability to cleave Ub-AMC. Activities for proteasomes from each
strain were obtained in at least three experiments and the data was subjected to
statistical analysis to allow for the variance between experiments and between strains
(Andrew Carothers). The proteasomes from the wild type strain showed activity as
expected, however when uch2+ was deleted almost all of this activity was abolished
(Figure 5.5). Deletion of ubptf had no effect on the level of activity observed in a
wild type or uch2 deletion background (Figure 5.5). Therefore, it appears that, using
this assay, Uch2 is the major ubiquitin hydrolase of the 26S proteasome.
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Figure 5.4: Deubiquitinating Activity of the S. pombe 26S Proteasome
26S proteasomes were purified and assayed for ubiquitin peptidase activity by
measuring the change in fluorescence coupled to cleavage of ubiquitin-AMC.
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Figure 5.5: Deubiquitinating Activity of 26S Proteasomes from uch2 and
ubp6 Mutant Strains
26S proteasomes were purified from wild type, uch2, ubp6 and uch2ubp6
strains. The proteasomes were then assayed for ubiquitin peptidase activity by
measuring the change in fluorescence coupled to cleavage of ubiquitin-AMC.
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5.7Discussion
The first observation from the analysis of the biochemical activity of the proteasome
associated DUBs was that Uch2 has ubiquitin peptidase activity. Recombinant GST-
Uch2 was able to cleave UbAMC. This observation is consistent with data showing
that the Drosophila homologue of Uch2, p37a, has this activity (Holzl et ah, 2000).
Many of the UCH family of DUBs, for example human UCHL-1 and UCHL-3, have
been shown to be active in removing aNH-linked fusions from ubiquitin (Larsen et
al., 1998).
Having established that Uch2 has ubiquitin hydrolase activity, it was of interest to
locate the active site Cys. Based on homology to other UCHs Cys83 was identified
as the putative active site Cys and was mutated to an Ala residue (Li et al., 2000).
Mutation of this residue resulted in complete loss of Uch2 activity in vitro, indicating
that, as predicted, this Cys is required for activity. Similar loss of activity has been
observed following active site mutation in other DUBs such as Isopeptidase T and
Ubpl5 (Amerik et al., 1997; Richert et al., 2002). Structural studies have revealed
the nature of the conserved UCH active site and its interaction with substrates. The
X-ray crystal structure of UCH-L3 has been determined and shows that the active
site triad of Cys, His and Asp (or Asn) is structurally related to that seen for the
papain family of cysteine proteases (Johnston et al., 1997). Further structural studies
using S. cerevisiae Yuhl bound to Ubal indicate the presence of a covalent bond
between the Sy atom of the active site Cys and the C terminal carbon of Ubal Gly76,
as well as many other interactions via Hydrogen bonding and van der Waals
contacts. The interactions observed between Yuhl and its substrate were found to be
in residues that are conserved between the UCHs, suggesting that a common catalytic
mechanism is shared between members of the UCH family (Johnston et al., 1999).
Therefore, the structural data, the observed sequence homology between UCHs and
the loss of activity found by mutation of the Uch2 Cys83 imply that Uch2 functions
as a cysteine protease. It will be interesting to further examine the role of Uch2 in
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the cell by use of the Cys83A active site mutant in vivo. The mutated protein may
act as a dominant negative and the phenotype resulting from its expression may
reveal the physiological relevance ofUch2 activity.
Surprisingly, Ubp6 was not found to have activity in the Ub-AMC assay. As other
UBP family members have been shown to cleave Ub-AMC, it would be expected
that this assay would detect Ubp6 ubiquitin peptidase activity (Baker et al., 1992;
Amerik et al., 2000). However, it remains possible that Ubp6 has a more specific
peptidase activity that does not cleave the UbAMC substrate, but may cleave
alternative Ub fusions. One possible reason for the lack of ubiquitin peptidase
activity for this protein is that it may not have this activity, however, this seems
unlikely as the S. cerevisiae homologue of Ubp6 shows activity in a peptidase assay
(Park et al., 1997). The activity of the human homologue ofUbp6, USP14, has yet to
be determined (Borodovsky et al., 2001). ScUbp6 was found to be optimally active
atmildly alkaline pH of 8.5, with very little activity seen at pHs below 7 or above 9.5
(Park et al., 1997). Therefore, as it was possible that the lack of activity was due to
the pH of the buffer, the effect of pH on S. pombe Ubp6 was tested using buffers of
pH7.5, 8.5 and 9.5 (data not shown). No activity was detected using any of these
buffers, suggesting that there is an alternative reason why Ubp6 is inactive in this
assay. In investigating Ubp6 in S. cerevisiae, it was also found that it was degraded
in E. coli extracts and that this resulted in loss of activity (Park et al., 1997).
However, as the Ubp6 purified in S. pombe appeared stable when analysed by SDS-
PAGE and GST-Ubp6 extracts were active in the isopeptidase assay degradation was
unlikely to be the cause of the inactivity. Another possible reason for the lack of
activity is that Ubp6 requires posttranslational modification in order to be converted
to an active form and that these modifications are not carried out in E. coli. One of
the predicted UBPs identified in S. cerevisiae, Ubp8, was also found to be inactive
when expressed in E. coli, indicating that there may be other UBPs whose activities
are regulated by modification (Amerik et al., 2000). In support of this hypothesis,
Western blots of Ubp6 in wild type extracts show that anti-Ubp6 detects two bands
in the wild type extract but not the ubp6A extract suggesting that Ubp6 may exist in
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two different forms (see section 3.3.1 and Figure 3.7). Therefore, the most
favourable explanation for the lack of observed Ubp6 activity is that Ubp6 requires
post-translational modification.
Uch2 and Ubp6 were analysed for their ability to cleave eNH-linked ubiquitin
conjugates, and both were found to have this isopeptidase activity. It is interesting
that Uch2 shows this activity as several other UCH type DUBs, such as Yuhl, UCH-
L1 and UCH-L3 are unable to cleave ubiquitin linked through Lys48 isopeptide
bonds in similar in vitro assays (Baker et al., 1992; Larsen et al., 1998). In the case
ofYuhl, structural studies have indicated that protein-ubiquitin substrates, including
ubiquitin-ubiquitin, may not be cleaved by this UCH due to the presence of an
'active site crossover loop'. This loop covers the active site and would only allow
the entry of substrates up to the size of a single helix. This suggested that only small
adducts fused to ubiquitin, or proteins that are flexible at the Ub-protein linkage
would be able to gain access to the active site cleft (Johnston et al., 1999). The loop
structure was disordered in the X-ray crystal structure ofUCH-L3, so it remains to be
seen if it is conserved amongst other members of the UCH family (Johnston et al.,
1997). It may be that Uch2 does not contain this loop structure, and may therefore
process a wider range of substrates. Indeed, in the context of the proteasome it
would be reasonable to expect that isopeptidase activity would be required to cleave
ubiquitin chains from proteasome substrates to allow their entry into the 20S core of
the proteasome. Ubiquitin isopeptidase activity has been reported for the 19S
complex of proteasomes purified from bovine red blood cells and the protein
responsible was of an estimated size of 37kD (Lam et al., 1997). This size matches
that of the Uch2 homologue in Drosophila, p37a and both are Ubal sensitive, so this
provides support for the suggestion that Uch2 may contribute this activity to the
proteasome (Lam et al., 1997; Holzl et al., 2000).
In the case of Ubp6, it was not surprising that isopeptidase activity was found, as
several members of the UBP family of DUBs have been shown to be active as
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ubiquitin isopeptidases. Both Ubpl and Ubp2 in S. cerevisiae were able to cleave
eNH-linked di-Ub when coexpressed in E. coli and Isopeptidase T and its
homologues in S. cerevisiae and A. thaliana, are all able to cleave K48-linked Ub-Ub
bonds (Baker et al., 1992; Hadari et ah, 1992; Doelling et ah, 2001). In the ubpl4
mutant an increase in the level of free ubiquitin chains was also observed, which
indicates that recycling of chains is likely to be its major role in vivo (Amerik et ah,
1997). The activity of Ubp6 in S. pombe appears to be similar to that ofUbpl4 as it
is only able to cleave isopeptide linked ubiquitin and not a ubiquitin fusion in vitro.
However, based on the data on S. cerevisiae Ubp6, it seems most likely that S. pombe
Ubp6 has both these activities in vivo (Park et ah, 1997). In addition, there is a
Ubpl4 homologue in S. pombe, which is likely to carry out this function (C. Gordon,
unpublished). Further experiments using alternative assays will be required in order
to confirm the activity of Ubp6. Firstly, an alternative ubiquitin fusion substrate
could be used for the peptidase assay. It may be that Ubp6, like Ubpl4, shows
specific activity in cleaving of bonds between two ubiquitins, so that peptide linked
Ub-Ub may be an appropriate substrate. Secondly, the GST-Ubp6 could be
incubated with S. pombe extract or Ubp6 could be purified from a tagged form
expressed in S. pombe in order to determine whether any modifications result in
peptidase activity. Finally, the levels of any putative substrates, such as high
molecular weight ubiquitin conjugates, could be measured in the ubp6 deletion strain
to reveal its role in vivo.
Further studies will be important to determine the in vivo specificities of Uch2 and
Ubp6. Although it the specificity of Uch2 and Ubp6 may be determined solely by
their cellular localisation, it is possible that other factors my narrow this specificity
further. It has been suggested that the specificity of DUBs can be conferred by
regions found either the N terminus or the C terminus. The testis specific DUBs,
UBP-tl and UBP-t2 are two very similar UBPs that share a common catalytic
domain and differ only in their N terminal residues. These divergent N terminal
regions have been shown to regulate the activity of the two UBPs against a variety of
substrates (Lin et al., 2001). In the case of the hematopoietic specific DUBs, which
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share a catalytic N terminus, sequence divergence is seen in only the C terminal
regions of the proteins, suggesting that these may mediate specificity (Zhu et al.,
1997; Baek et al., 2001). Isopeptidase T has been shown to have two ubiquitin
binding sites: the first binds Ubal and is thus suggested to be the catalytic site, and
the second does not bind Ubal, and may provide specificity for ubiquitin-only
substrates by binding a second ubiquitin (Hadari et al., 1992). By further sequence
analysis, in vitro assays and examination ofmutant phenotypes, it may be possible to
identify regions ofUch2 and Ubp6 that confer specificity. The only obvious domain,
apart from the catalytic domains, found in either Uch2 or Ubp6 is the UBL domain
of Ubp6. In S. cerevisiae, deletion of the UBL domain of Ubp6 was not found to
have any effect on its activity in vitro, implying that this domain is not involved in
mediating specificity by binding substrates (Wyndham et al., 1999). This is in
keeping with our finding that this domain binds to the proteasome. Therefore, the
UBL domain ofUbp6 may mediate specificity by targeting Ubp6 to the proteasome,
whilst other domains may further restrict its substrates.
This study has shown for the first time that the 26S proteasome of S. pombe has
intrinsic UCH activity. Previous work had reported this activity for proteasomes
purified from other species, so this result demonstrates that the activity is conserved
(Eytan et al., 1993; Lam et al., 1997; Holzl et al., 2000). However, the subunits of
the proteasome that provide the DUB activity had not been identified. This work has
revealed, through purification of proteasomes from mutant strains, that Uch2 is
responsible for the majority of the UCH activity of the proteasome. As Uch2 is
highly conserved amongst eukaryotes, it is likely that its role in S. pombe reflects the
situation in higher organisms. The finding that Uch2 is the major ubiquitin peptidase
for the proteasome is unexpected, as deletion of uch2 does not result in an observable
phenotype. Therefore, unless there are other DUBs providing an activity that is not
detected by this assay, it must be assumed that the UCH activity of the proteasome is
not essential for viability. Although Ubp6 is found associated with the proteasome, it
was not found to contribute to its ubiquitin peptidase activity. This finding lends
further support to the fact that Ubp6 is unable to catalyse the hydrolysis of the Ub-
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AMC substrate, as was observed using recombinant GST-Ubp6. However, it is
likely that Ubp6 may be present at low concentrations in the proteasome: Ubp6 and
its homologues have not always been detected in purified proteasomes, and other
UDPs have been suggested bind transiently with the proteasome (Wilkinson et al.,
2001). Analysis of the ubiquitin peptidase and isopeptidase activity of proteasomes
from wild type and mutant strains with alternative assays will clarify the situation.
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Chapter 6 Discussion
In this study, the proteasome-associated DUBs, Uch2 and Ubp6, were characterised
using a number of biochemical and genetic methods. This work has lead to several
conclusions about the functions of these proteins in the cell. Here the implications of
these findings and directions for future study are considered.
6.1 Uch2 is the Major Ubiquitin Hydrolase of the Proteasome
The first finding of this study was that Uch2 is associated with the proteasome in
vivo and in vitro. Studies in Drosophila have since shown that this proteasome
association is conserved (Holzl et al., 2000). The identification of Uch2 as a
proteasome associated DUB explains the previously observed UCH activity seen at
the proteasome (Lam et al., 1997). Uch2 provides the major UCH activity to the
proteasome and the fact that deletion of uch2 causes no obvious cellular defects,
indicates that unexpectedly, the observed UCH activity of the proteasome is not
essential for normal growth.
6.2 Alternative Mechanisms for Deubiquitination at the Proteasome
It is surprising that the UCH activity of the proteasome is not essential, as it is known
that proteasome substrates must be deubiquitinated prior to degradation. One
possibility is that other DUBs that are not subunits of the proteasome might associate
to provide activity. As proteasomes purified from the uch2A strain do not have
activity, any DUB that could substitute for Uch2 must not be present in the purified
complex, suggesting that it would have a weak association with the proteasome.
Ubp6 was considered as a candidate but it is present in the purified proteasomes and
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appears not to contribute to the activity. In S. cerevisiae, the Doa4 DUB associates
with the proteasome and has been proposed to remove ubiquitin from proteasome
substrates (Papa et al., 1999). Doa4 is not an ideal candidate as it appears to have a
general role in the regulation of ubiquitination for more than one cellular function,
suggesting that its role in ubiquitin dependent proteolysis may be indirect (Papa and
Hochstrasser, 1993; Papa et al., 1999; Swaminathan et al., 1999; Dupre and
Haguenauer-Tsapis, 2001; Amerik et al., 2000a). Furthermore, the absence of a
Uch2 homologue in S. cerevisiae shows that the situation is clearly different from
that in S. pombe and higher eukaryotes. In addition, higher eukaryotes such as
Drosophila and human do not appear to have a Doa4 homologue. Despite these
observations, it would be useful to rule out the Doa4 homologue in S. pombe as the
DUB that provides redundant function with Uch2, by creating a double knockout
strain. As S. pombe contains only two DUBs of the UCH family (Uchl and Uch2), it
would also be of interest to determine whether Uchl, has redundant function with
Uch2. The Uchl homologue in S. cerevisiae, Yuhl, has been minimally
characterised and does not yet show any obvious association with the proteasome,
either physically or functionally (Baker et al., 1992; Amerik et al., 2000). In
addition, Yuhl is the only UCH in S. cerevisiae and its deletion is not lethal,
suggesting that it is likely to act redundantly with members of the UBP family
(Baker et al., 1992). However, construction of uchl and uchluch2 mutants in S.
pombe would allow these questions to be addressed.
An alternative reason for the observation that deubiquitinating activity of the
proteasome is dispensable may be that an activity in the proteasome that is not
detected by the ubiquitin-AMC assay is responsible for this function. One piece of
evidence that this may be the case, is that a second DUB activity has been detected in
purified proteasomes and was found to be insensitive ubiquitin-aldehyde, suggesting
that the enzyme responsible may not be a cysteine protease (Eytan et al., 1993).
There is only one report of such an activity, however, in light of the observations in
this study, it appears that it may warrant further investigation to identify the
proteasome subunit or associated factor responsible. Firstly, the activity attributed to
Uch2 could be tested to confirm that it is the Ubal sensitive, which would be
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expected as a cysteine active site has been identified. Secondly, the observed Ubal
insensitive activity could be tested with other inhibitors of thiol proteases such as the
alkylating agents NEM and iodoacetamide. The findings from these experiments
would facilitate further analysis of proteasome associated deubiquitinating activity.
6.3 The Role of Uch2Activity in the Proteasome
Although there are alternative mechanisms for the deubiquitination of substrates at
the proteasome, this still leaves the conundrum of the highly conserved yet non¬
essential UCH activity of the proteasome. The fact that the proteasome associated
UCH activity, the presence ofUch2 in the proteasome and the active site of Uch2 all
appear to be highly conserved amongst eukaryotes suggests that this activity does
have a significant cellular function (Li et al., 2000; Holzl et ah, 2000). One possible
explanation is that the UCH activity of the proteasome is required only under certain
cellular conditions, such as stress. The role of the UCH activity of the proteasome
therefore remains elusive, however, the fact that the uch2 null mutant shows no
genetic interaction with proteasome mutants suggests that despite the fact that Uch2
is a proteasome subunit, it may not have a direct influence on proteasome mediated
proteolysis. There are several ways in which any previously undetected involvement
of Uch2 in proteolysis at the proteasome could be identified. The uch2 mutant could
be further analysed for characteristics of mutants that have a defect in proteolysis,
such as canavanine sensitivity and accumulation of high molecular weight ubiquitin
conjugates. In addition, mutants of other ubiquitin pathway, such as E2s or E3s,
could be crossed to the uch2 mutant to determine whether there is a genetic
interaction that might indicate that they operate in the same pathway.
Although Uch2 was found to have isopeptidase and peptidase activities, the members
of the UCH family are generally found to act only as ubiquitin peptidases (Chung
and Baek., 1999; Wilkinson, 2000). If the role of Uch2 in vivo is to act in a similar
manner this may explain why it does not have a direct function in ubiquitin
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dependent proteolysis at the proteasome. Uch2 may instead regulate ubiquitin levels
by removing small adducts attached to ubiquitin or by processing the ubiquitin
precursor levels. However, it remains difficult to accept that the function of Uch2, a
UCH that is a subunit of the proteasome, is entirely separate from the proteolytic
function of the complex. Further investigation will therefore be required to identify
the in vivo substrates and the role ofUch2.
6.4 Deubiquitination and Deneddylation in Protein Complexes
An interesting parallel with the DUB activity of the proteasome is the deneddylating
activity of the COP9/signalosome, as the proteasome lid and the COP9/signalosome
are related complexes (see sections 1.2.5 and 1.3.2.2.1). There are two possible
scenarios if these activities are related: firstly, the signalosome and the proteasome
may each contain the two separate activities or alternatively, the deneddylase activity
of the signalosome may be analogous to the DUB activity of the proteasome. An
obvious starting point to analyse this problem is to examine purified proteasomes for
deneddylating activity and purified signalosomes for DUB activity. It will also be
important to determine whether the activity of the COP9/signalosome can be
assigned to a subunit or to an associated factor. If a subunit of either the 19S lid or
COP9/signalosome is identified as having either DUB or deneddylating activity, this
might suggest that the homologous subunit in the other complex also have the same
activity. Therefore, studying the two systems concurrently may accelerate
understanding of these complexes and activities. Two conserved proteins that found
in the proteasome (Rpnll) and the COP9/signalosome (Csn5/Jabl) show homology
to each other, but also to the UCH family of deubiquitinating enzymes (Penny et al.,
1998; Lyapina et al., 2001). Although no activity has been detected for either
protein, Rpnl 1 and Csn5 are candidates that will need to be investigated to assess
whether they contribute to the deubiquitinating and deneddylating activities of the
proteasome and COP9/signalosome complexes enzymes (Penny et al., 1998; Lyapina
et al., 2001).
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6.5 Mts4 - a general receptor for UDPs?
S. pombe Ubp6 was shown in this study to be associated with the proteasome, and
more recently this interaction has also been observed in S. cerevisiae and human
(Borodovsky et al., 2001; Verma et al., 2000). This interaction between Ubp6 and
the proteasome was found to be mediated by the Ubp6 N-terminal UBL domain. In
addition, the Mts4 proteasome subunit was demonstrated to be the Ubp6 binding
proteasome subunit. This was in keeping with previous studies, which demonstrated
that Rhp23, which is also a UDP, bound to Mts4 via its UBL domain (R. Hartmann-
Petersen and M. Seeger unpublished). Another UDP that has been found to bind to
the proteasome is BAG-1, a chaperone cofactor (Luders et ah, 2000; M. Stone and C.
Gordon, unpublished). Binding studies of Rhp23 with truncated versions of Mts4
and sequence homology analysis have revealed a putative domain of the Mts4
protein, named the UBS domain, that may mediate the association with the UBL
domain (R. Hartmann-Petersen, M. Seeger and M. Taylor, unpublished). These
observations suggest that Mts4 may act as a general UBL binding protein, bringing
the UDPs and their associated functions to the proteasome (Figure 6.1). The
implication of this model is that all the UDP proteins compete for binding at the
Mts4 UBS domain. There are a number of experiments that would clarify the
situation. Firstly, it will be important to test whether all of the UDPs can bind the
Mts4 UBS domain via their UBL domains. The binding affinities of these proteins
could be determined using the surface plasmon resonance analysis. This involves
conjugation of a purified protein to a sensor chip and exposure to a binding partner,
which allows the dissociation constants to be determined. The binding of Rhp23 to
Mts4 has already been assessed using this method, and was found to have a Kd of
70nM (Rasmus Hartmann-Petersen, unpublished). In vitro competition assays could
be used to test whether binding of one UDP to the UBS domain can be inhibited in
the presence of other UDPs. Following these in vitro studies it would be important
to show that the competition also exists in vivo. If the UDPs do compete for the
binding to the UBS domain, then it might be expected that there would be genetic
interactions between the UDPs. To test this hypothesis, experiments could be carried















Figure 6.1: UDPs Bring Diversity to Proteasome Function
Several UDPs have been shown to interact with the proteasome via their UBL
domains, suggesting that their role may be to bring other factors to the proteasome
(see text for full explanation).
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gaining access to the UBS site. This could be done by looking for a genetic
background where a particular UDP becomes essential: for example, in the pusl
mutant, loss of the Pusl multiubiquitin binding protein means that either Rhp23 or
Dphl must be present (Wilkinson et al., 2001). Therefore, overexpression of another
UDP, such as Ubp6, might prevent access of Rhp23 and Dphl to the proteasome and
cause the same lethal phenotype seen in thepuslrhp23dphl triple mutant.
6.6 The Role of Ubp6 in Proteasome-dependent Proteolysis
Although the genetic data so far does not implicate Uch2 in proteasome dependent
proteolysis, the evidence for Ubp6 implies that it has a function in this pathway.
This finding was surprising, as Ubp6 is thought to have a weaker association with the
proteasome than Uch2. In both human and budding yeast, the Ubp6 homologues are
found only associated with proteasomes and are not thought to be present in
stoichiometric amounts compared to the other subunits. In contrast, S. pombe Uch2
is present in stoichiometric amounts and its Drosophila homologue, p37a, has been
observed in proteasomes by electron microscopy (Li et al., 2000; Holzl et al., 2000).
The use of mass spectrometry and glycerol gradients may confirm the amount of
Ubp6 associated with proteasomes. An additional aspect of Ubp6 function that needs
to be investigated further is the fact that exists in two forms. It would be interesting
to determine whether a specific form of Ubp6 associates with the 26S proteasome
and whether one or both forms are active. In addition, the nature of the modification
could be studied by subjecting Ubp6 purified from S. pombe extracts to mass
spectrometric analysis.
As ubp6 was found to be synthetically lethal with certain proteasome subunit
mutants, it is thought that it may function in promoting proteolysis. Several
mechanisms for this role have been suggested, although it is unclear why only the
mtsl, mts2 and mts3 mutants, and not the mts4 and padl mutants, are synthetically
lethal with ubp6. The most likely explanation is that there are subtle differences in
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the phenotypes of the mts mutants that make mtsl, mts2 and mts3 more sensitive to
loss ofUbp6. Biochemical analysis of Ubp6 function revealed that it is able to act as
a ubiquitin isopeptidase, suggesting that it could regulate proteasome function by
degrading multiubiquitin chains, or by removing ubiquitin from conjugated
proteasome substrates. In order to understand the synthetic lethality that has been
observed, the mtsl, mts2 and mts3 mutants could be crossed to a ubp6 deletion strain
expressing ubptf under the control of a repressible promoter. This would allow
viable ubp6mts double mutants to be obtained, and the expression of ubpi? could be
repressed in a controlled manner to allow observation of the ubp6mts terminal
phenotype. In addition, the use of ubptf truncations and an active site mutant in this
system would reveal whether it is activity or a particular domain of Ubp6 that is
required for viability in the mts mutant background. As with uch2, the ubp6 mutant
could be tested for canavanine sensitivity and accumulation ofhigh molecular weight
ubiquitin conjugates, as well as being crossed to mutants of other ubiquitin pathway.
These tests might clarify the role ofUbp6 in ubiquitin dependent proteolysis.
6.7 Redundancy of the DUBs
In this study, the hypothesis that DUB specificity is determined by cellular
localisation was investigated using two proteasome associated DUBs, Uch2 and
Ubp6. However, the genetic and biochemical experiments have not yet shown any
evidence to support this hypothesis. This may be due to the presence of other, as yet
uncharacterised DUBs being present at the proteasome. It is possible to identify
candidates for this activity, the first example being the ubiquitin aldehyde insensitive,
proteasome associated activity discussed above (section 6.2). In S. cerevisiae, the
deletion strains for each of the DUBs have been tested for sensitivity to canavanine,
which may indicate a defect in proteolysis. Several DUBs (Doa4, Ubp3, Ubp6,
UbplO, Ubpl4 and Ubpl5) were found to be required for resistance to canavanine,
so these are good candidates for DUBs that have a role in proteolysis, possibly acting
at the proteasome (Amerik et al., 2000). S. pombe has homologues of Doa4 (Ubp4),
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Ubp3, Ubp6, Ubpl4 and Ubpl5, so these could be tested for redundancy with Uch2
and Ubp6 by the creation of null strains to be crossed to the uch2 and ubp6 mutants.
Another way in which a genetic approach could be used to identify other DUBs that
are redundant with Uch2 or Ubp6 would be to use a genetic screen. In a method that
has previously been described, mutants that are dependent on a high level of either
DUB could be identified (Cullen et al., 2000). Firstly, a plasmid containing either
uch2+ or ubp6' under the control of the nmtl thiamine repressible promoter would be
integrated into the uch2ubp6 double mutant strain, to allow controlled
overexpression of the DUB. The resulting strain could then be mutagenised, for
example using EMS, and mutants that are able to grow only when uch2+ or ubp6^ is
overexpressed could be identified by replica plating to medium containing thiamine.
Those mutants that require high levels of one of the DUBs would be viable on
medium lacking thiamine where uch2+ or ubp6+ is overexpressed, but would be
unable to grow on medium containing thiamine, where uch2+ or ubp6^ expression
would be repressed. The mutated genes could then be identified by using an S.
pombe genomic library to rescue the lethality on medium lacking thiamine. This
screen might identify other DUBs that act redundantly, as these would only be able
to survive when high levels of Uch2 or Ubp6 were available to compensate for loss
of their function. It would probably be most useful to carry out the screen using
ubptf~ overexpression, as Ubp6 has already been implicated as having a role in
proteasome dependent proteolysis.
6.8 Conclusions
The study of the proteasome-associated DUBs in S. pombe has resulted in several
significant findings in the understanding of the interaction between deubiquitination
and the proteasome. Firstly, Uch2 was identified as the major ubiquitin hydrolase of
the proteasome, despite its apparent lack of involvement in ubiquitin dependent
proteolysis. Secondly, a function for Ubp6 in proteasome dependent proteolysis was
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implied by the synthetically lethal interaction of ubp6 with several proteasome
mutants. However, the absence of any observable phenotype for the uch2, ubp6 and
uch2ubp6 mutants indicated that other DUBs must be providing redundant function
with Uch2 and Ubp6. Finally, the characterisation of the interaction of Ubp6 with
the proteasome supported the hypothesis that UDPs function to bring diverse
activities to the proteasome and indicated that the Mts4 proteasome subunit may be a
general UDP binding factor. The high level of conservation of Uch2 and Ubp6
between S. pombe and higher eukaryotes suggests that the characterisation of these
proteins will prove to be of general relevance to the study of proteasome mediated,
ubiquitin dependent proteolysis.
Since this thesis was submitted for examination, three significant reports have been
published regarding the deubiquitinating activity of the proteasome. Deshaies and
coworkers have identified that, as proposed in this discussion, the Rpnll/Padl 19S
lid subunit is a deubiqutinating enzyme. In contrast to the classical DUBs,
Rpnl 1/Padl was found to be insensitive to ubiquitin aldehyde, but instead displayed
sensitivities characteristic of a metalloprotease. Rpnll/Padl contains a distinct
conserved motif, named the JAMM (for Jabl/Padl/MPN domain metalloenzyme)
motif, which is composed of two histidines followed by an aspartate and preceded by
a glutamate. Mutation of the conserved histidines to alanines was found to be lethal
in S. cerevisiae. Furthermore, proteasomes containing this mutant Rpnll/Padl
protein were defective in both deubiquitination and degradation of Ub-Sicl
suggesting that that Rpnll/Padl provides the link between these two processes
(Verma et al., 2002). These findings are supported by a similar study identifying
Rpnl 1/Padl as a Zn2+ dependent DUB (Yao and Cohen, 2002).
In complementary study, the Csn5/Jabl subunit of the COP9/signalosome was also
shown to contain the JAMM motif and mutation of residues within this motif or
treatment with metal chelators abolished the COP9/signalosome dependent Nedd8
modification of Cull (Cope et al., 2002). Therefore, the Rpnl 1/Padl and Csn5/Jabl
isopeptidases appear to have analogous functions acting as metalloproteases, rather
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